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A b stract
The publication of the S. coelicolor genome sequence has stimulated interest in the possibility of 
rationally engineering strains by predicting the effect(s) of altering specific genes on secondary 
metabolite production. The work described here aims to design a general approach that copld be applied 
to enhance the production of commercially important antibiotics that have similar biosynthetic routes as 
actinorhodin (ACT).
It has been observed that a negative correlation between ACT production and the carbon flux through 
the pentose phosphate pathway (PPP) exists. As a result, strains with deletions for either one of the two 
zwf isogenes (encoding the enzyme that catalyses the initial PPP reaction) and for the devB gene (whose 
product catalyses the subsequent reaction in the pathway) were constructed and assessed. All strains, 
with the exception of the A devB mutant, were found to generate increased levels of ACT compared to 
the parental strain. In addition to these strains, the above genotypes were accompanied by the pIJ8714 
insert, containing an additional copy of the pathway-specific activator gene, actII-ORF4. These strains 
displayed precocious and significantly increased ACT levels compared to their corresponding controls. 
In order to compare the carbon flux distribution profiles of the various strains and conditions tested, 
metabolic flux analysis (MFA) was performed. Correlation analysis was applied to such data to identify 
reactions that either positively or negatively correlated with ACT synthesis.
Both MFA results and in vitt'o enzyme analysis showed that both Azwf strains had elevated carbon 
fluxes through the initial reaction of the PPP. This was unexpected but may reflect some co-regulation 
between the two zw/isogenes. When either one of the two genes was deleted, the presumed repression it 
exerted was removed, resulting in more activity. Such elevated fluxes allowed more NADPH to fuel the 
high yielding elementary mode that was identified for ACT synthesis and, presumably amplified to 
saturation by the pIJ8714 insert.
MFA from batch and chemostat cultures showed that greater flexibility at the glucose-6-phosphate 
principal node was found at the lower growth rates (and in the pIJ8714 strains) which coincided with 
greater ACT production. Biomass and ACT synthesis compete for the same cofactors, hence at lower 
growth rates, more e.g. NADPH, was available for ACT production.
Furthermore it was shown that microarray analysis could not be used to predict carbon fluxes in 
S. coelicolor strains, as little correlation between the two techniques was observed. However, it was 
found to be a useful method for highlighting genes that were more than two-fold up/down-regulated in 
the strain(s) that generated the most ACT.
These findings could be exploited in future metabolic engineering studies to enhance ACT production, 
as well as for other bioactive compounds that undergo similar biosynthetic pathways.
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1.1 Introduction to Streptomvces
The genus Streptomyces belongs to the Streptomycetaceae Family, Order Actinomycetales, 
which was first reported in 1887. Actinomyces is Greek for ‘ray-fungus", indicating that 
initially, these microorganisms were classed as Fungi. However, electron microscopy studies 
(Glauert and Hopwood, 1961) revealed that they lacked a nuclear membrane and hence their 
classification changed to the Prokaryotae Kingdom.
These Gram positive, aerobic, chemoheterotrophic, filamentous, soil-dwelling bacteria grow 
as branching hyphae, secreting extracellular hydrolytic enzymes that degrade insoluble 
organic matter to obtain nutrients from the surrounding environment. The branching mycelia 
then differentiate to erect specialised aerial hyphae, which upon nutrient limitation, 
metamorphose into uninucleoidal spores that act as a dispersal mechanism in order to colonise 
new environments. This ability to morphologically differentiate is what distinguishes the 
streptomycetes from other Prokaryotes. Figure 1.1 is an electron micrograph image of aerial 
hyphae that have undergone such spore formation.
Figure 1.1: Scanning electron micrograph image showing aerial mycelium and uninucleoidal spore 
formation in Streptomyces coelicolor. Mark Buttner and Kim Findlay, John Innes Centre.
1.1.1 Genome Sequence o f Streptom yces coelicolor
With the sequencing of the entire S. coelicolor genome completed in July 2001 (Bentley et 
al., 2002) alongside the vast biochemical research known, Streptomyces coelicolor has 
become the model streptomycete in which to study antibiotic production. Streptomyces are 
known to have a high GC content, ranging from 67% to 74% (72.12% in S. coelicolor) 
(Bentley et a l, 2002).
1
The S. coelicolor genome (excluding the two plasmids, SCP1 (linear, 365kb) and SCP2 
(circular, 31kb)) consists of 8,667,507 base pairs, containing 7825 protein coding sequences 
which is significantly more than the 4829 and 6203 genes found in Escherichia coli and 
Saccharomyces cerevisiae strains, respectively. 965 proteins (12.3%) have been identified as 
possessing regulatory functions, 614 (7.8%) a transportation function and 819 (10.5%) are 
secretory proteins (such as hydrolases, proteases, peptidases, cellulases and amylases), 
Bentley et al., (2002). These figures indicate that Streptomyces are excellent at exploiting the 
surrounding nutrients in the soil.
The possession of one of the largest bacterial genomes sequenced is accompanied by another 
distinguishing feature, a linear chromosome (Kieser et al, 1992), whose origin of replication 
(oriC) is located centrally (Musialowski et al, 1994).
The central area of the S. coelicolor chromosome (accounting for approximately 5Mb) 
contains the essential ‘housekeeping genes’. It has been shown that this region has some 
synteny with the whole chromosome of the phylogenetically related (but pathogenic) species, 
Mycobacterium tuberculosis and Corynebacterium diphtheriae (Bentley et al, 2002). This led 
to the hypothesis that the remaining S. coelicolor chromosome was formed through the 
accretion of new genes (many of which code for secondary metabolite production). This 
expansion has allowed a more complex life cycle to develop and hence S. coelicolor strains 
may grow successfully within a highly competitive soil environment due to the ability to 
utilise a number of different carbon sources by possessing the aforementioned enzymes. 
Comparing the genomes of such pathogenic bacteria with S. coelicolor may provide clues as 
to the mechanism of their pathogenicity (Paradkar et al., 2003).
Studies carried out by Karoonuthaisiri et al, (2005) supports the genome organisation theory 
proposed by Bentley et al, (2002). Microarray techniques were used to investigate if the 
genes located in the central 5Mb core region were expressed differently to those ‘auxiliary’ 
genes (e.g. those involved in differentiation) located on either side, under different growth 
conditions and phases. Indeed it was shown that the genes in the central core were more 
highly expressed than the ‘auxiliary’ genes on the left (1.5 Mb) and right (2.3Mb) 
chromosome aims, during vegetative growth (i.e. non-growth limiting conditions).
1.2 Antibiotic Producing Microorganisms
The most reported and outstanding property of the genus Streptomyces, is its ability to 
produce antibiotics, and is one of the main reasons for the large research interest into these 
microorganisms. Streptomyces are clinically important as they produce over two-thirds of 
naturally derived antibiotics, which have provided the majority of novel antibiotics for the 
past 50 years. These include those with antibacterial (tetracycline, kanamycin),
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immunosuppressive (rapamycin, FK506, ascomycin), anticancer (bleomycin, doxorubicin, 
staurosporin), antiparasitic (avermectin, milbemycin), antifungal (candicidin, amphotericin B, 
nystatin) and herbicidal (phosphinothricin) properties.
One of the reasons why .S', coelicolor has been so extensively studied is due to the fact that it 
is capable of producing at least four structurally distinct types of antibiotic, two of which are 
pigmented, (ACT and RED).
• Actinorhodin (ACT):
A dimeric isochromanequinone, that acts as a litmus-like pigment, blue in alkaline conditions 
and red in acidic conditions. It has weak antibacterial properties, mainly acting on Gram- 
positive bacteria and is normally produced in stationary phase cultures (section 1.7). 
The chemical structure of this antibiotic is presented in Figure 1.2.
0 OH OH 0
0 ' ^ '
t l if
^ " 0
V -
COOH 0 OH OH 0
I
COOH
Figure 1.2: The chemical structure of actinorhodin.
® Undecvlprodigiosin (RED):
A red pigmented tripyrrole metabolite found to be growth associated under specific nutrient 
limitations (Hobbs et al, 1990).
• Calcium-Dependent Antibiotic (CPA):
A non-ribosomal lipopeptide acting against other Gram-positive bacteria but only in the 
presence of calcium, (Hopwood and Wright, 1983).
® Methvlenomvcin (MMY):
SCP1-encoded antibiotic that acts against both Gram-positive and Gram-negative organisms 
particularly the Proteus species, (Haneishi et al., 1974).
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Figure 1.3 shows Streptomyces coelicolor (AredD) grown on solid and liquid media before 
and after ACT production has occurred.
Figure 1.3: S. coelicolor strains grown on SFM solid media (Al) pre- and (A2) post- ACT production. 
S. coelicolor strains grown in liquid culture (Bl) pre- and (B2) post- ACT production in a bioreactor.
1.3 Production of Secondary Metabolites
Antibiotics are frequently synthesised via multigenic and complex pathways and are generally 
classed as secondary metabolites, which are chemical compounds that are not directly 
required by an organism for growth, development or reproduction (Queener and Day, 1986). 
Antibiotic production on solid media usually occurs during the late stages of aerial hyphae 
formation (onset of morphological differentiation), whereas in liquid cultures, it is usually 
associated with the onset of the stationary phase (Chater, 1993). Based on the fact that 
antibiotic biosynthesis is associated with sporulating processes (Chater, 1993), it is believed 
that under conditions of nutrient limitation, antibiotics may inhibit the growth of competing 
organisms allowing streptomycetes to use the scarce nutrients to complete their differentiation 
(Challis and Hopwood, 2003).
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1.3.1 Role o f the Growth Rate and Protein Synthesis on Antibiotic Production
Despite playing a role in the life cycle, secondary metabolites (unlike primary metabolites) 
are not essential for growth. For instance, in the study carried out by Bushell et al, (1997), a 
relationship between the growth/protein production rate and erythromycin production in 
Saccharopolyspora erythraea was established. The rate of antibiotic production was at its 
maximum once the growth rate (in carbon-limited media) began to decrease - confirming the 
characteristic growth dissociated production pattern seen with secondary metabolite synthesis.
In agreement with these findings, Lynch and Bushell, (1995) demonstrated that antibiotic 
production (in cyclic fed-batch cultures) was enhanced if the growth rate was down-regulated. 
Furthermore, a negative correlation between the protein production rate and antibiotic 
synthesis was observed. This was also observed by Wilson and Bushell, (1995), who 
demonstrated that antibiotic synthesis was initiated upon a decrease in the protein production 
rate in S. erythraea and Streptomyces hygroscopicus strains. Erythromycin production 
occurred precociously when strains were grown in nitrogen-limited media (compared to when 
carbon limited cultures were used) causing a reduction in the protein synthesis rate. This study 
also demonstrated that antibiotic production is induced when the ratio of uncharged tRNA to 
charged tRNA increases. Down-regulating the growth rate of a culture causes a decrease in 
die protein synthesis rate, which leads to an accumulation in the uncharged tRNA 
concentration. This induces the stringent response, which was found to initiate antibiotic 
production and sporulation processes in Streptomyces strains (Ochi, 1986).
1.3.2 The Stringent Response
When the level of uncharged tRNA accumulates, ppGpp synthetase activity occurs, catalysing 
the reaction generating guanosine tetraphosphate (ppGpp), which leads to the stringent 
response (Lamond and Travers, 1985). This highly phosphorylated nucleotide has been found 
to have a role in inducing antibiotic production, in S. coelicolor, under conditions of nitrogen- 
limitation (Lamond and Travers, 1985; Chakraburtty and Bibb, 1997; Kang et al, 1998) and 
in cephamycin C production by Streptomyces clavuligerus strains (Jin et al, 2004).
Studies carried out by Kang et al., (1998), used S. coelicolor ArelA (the relA gene codes for 
ppGpp synthetase) strains to investigate the role of ppGpp in antibiotic production. These 
strains presented similar growth kinetics to the wild type strains, but ACT and RED 
production were either reduced or eliminated depending upon the growth-limiting nutrient 
used. Sun et al, (2001) demonstrated that in nitrogen-limited conditions, A relA mutants
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generated no ACT production, however, when grown in phosphate-limited conditions, no 
such deleterious effect on ACT production was observed. This corroborated previous findings 
that indicated the relA gene product is required for antibiotic production when nitrogen is the 
limiting nutrient (Chakraburtty and Bibb, 1997).
It was also found (Strauch et al, 1991) that during the transition from the exponential to 
stationary phase (and at the stationary phase itself), the transcript level of the actII~ORF4 gene 
significantly increased, as did the level of intracellular ppGpp. However, whether this 
suggests that ppGpp is directly required (e.g. to activate the transcription of the actII-ORF4 
gene) or that ppGpp production occurs due to a decrease in growth/protein synthesis rate, is 
not known. However, the most convincing evidence demonstrating a direct role for ppGpp (in 
activating actll-ORF4 transcription) was reported by Hesketh et al, (2001). They found that 
in a strain forced to generate ppGpp (not as a result of a reduction in the growth rate, but by 
inducing the expression of the N-terminal segments of the relA gene), actII-ORF4 
transcription occurred. The mechanism underlying this is not understood, however.
1.4 Molecular Regulation of Actinorhodiii Production
In S. coelicolor strains, the production of secondary metabolites is triggered by a variety of 
conditions and as such is regulated by both pathway-specific regulatory genes and by 
pleiotropic protein regulators (Bibb, 1996, 2005).
1.4.1 Actinorhodin Biosynthesis
Polyketides are produced by sequential reactions catalysed by polyketide synthases (PKSs) 
which are multienzyme protein complexes related to fatty acid synthases. The biosynthesis of 
polyketides occurs from 2-, 3-, or 4-carbon building blocks, e.g. acetyl-CoA, propionyl-CoA, 
butyryl-CoA (that are attached to the active site of a ketosynthase) and their activated 
derivatives, e.g. malonyl-CoA, methyl-malonyl-CoA, ethyl-malonyl-CoA (that are attached to 
the structural component of the PKS, the acyl carrier protein, ACP). The ketosynthase 
catalyses condensation reactions that join both these compounds (resulting in the loss of 
carbon dioxide), while the extending polyketide chain is transferred back to the ketosynthase. 
For example, when acetyl-CoA (2C) is condensed with malonyl-CoA (3C), one carbon is lost 
and a chain of four carbons results (attached to the ACP). Further condensation reactions 
extend the chain by two carbons at a time. This results in the formation of a keto-group (C=0) 
at every alternate carbon atom (hence the name polyketide).
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There are at least three types of polyketide synthases; actinorhodin is produced by the type II 
polyketide synthase. This complex consists of a ketosynthase (KSa, ICS (3 subunits), a chain 
length factor and an acyl-carrier protein. The various polyketide synthases determine the 
different properties of each polyketide as they determine the chain length, oxidation-state and 
branching patterns, all of which can generate numerous different structures. Figure 1.4 
illustrates the steps that lead to ACT synthesis, one acetyl-CoA starter unit and seven 
malonyl-CoA extender units are required to make one half-molecule of the ACT dimer.
Figure 1.4: Reactions leading to actinorhodin production. Reaction (1) is catalysed by the actl gene 
product, directing the first ring cyclisation. Reaction (2) is catalysed by the actlll gene product, a 
ketoreductase. Reaction (3) catalysed by the actVII gene product, aromatase. Reaction (4), catalysed by 
the actIV gene product, a cyclase, a second ring is formed. Reaction (5), catalysed by the products of the 
actVI, actVA and actVB genes, completing the formation of the dimeric ACT molecule. The encircled E  
denotes where the corresponding enzyme is attached to the ACP. Adapted from Bentley (2001).
1.4.2 The act Gene Cluster
The act gene cluster consists of at least six gene transcripts and 20 ORFs (Anderson et al., 
1999). The actl genes encode the actinorhodin polyketide p-ketoacyl synthases, a- and p- 
subunits (actl-l and actI-2, respectively) and an acyl-carrier protein (actI-3). These genes are 
associated with the initial stage of ACT production. The actll genes include the pathway- 
specific activator gene, actII-ORF4 and actII-2, actII-3 are associated with exporting ACT 
from the mycelium (Fernandez-Moreno et al., 1991). The actlll gene encodes a ketoacyl 
reductase, which is associated with the second step of ACT synthesis. The actIV gene product 
is a cyclase, involved in the fourth step of ACT production. The actVII gene product is an 
aromatase involved in the third step of the ACT synthetic pathway, converting the first ring 
into an aromatic structure. The actVA genes are a collection of six ORFs, including various 
hypothetical proteins and integral membrane proteins, involved in the final stages of ACT 
synthesis. The actVB genes encode dimerases that are associated with the last reaction of ACT 
production.
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The production of ACT is regulated by the pathway-specific activator gene, actII-ORF4 
(Fernandez-Moreno et al, 1991). The transcription of this gene in liquid cultures was found to 
dramatically increase during the transition from the late exponential to stationary phase of the 
life cycle (Gramajo et al, 1993). Gramajo et al, (1993) demonstrated that by inducing the 
transcription of such a pathway-specific activator gene during the exponential phase, 
precocious antibiotic production occurred. Furthermore they found that the transcription of 
the actlll and actVI-ORFl genes occurred after maximal transcript levels of the actII-ORF4 
gene were reached, suggesting that perhaps a threshold level of actII-ORF4 expression is 
required before ACT production is initiated.
Plasmids containing multiple copies of the actll-ORF4 gene were used in S. lividans strains 
engineered to synthesise ACT and RED (Braheim et al, 2002b), this was found to be a 
rational strategy towards enhancing ACT synthesis in future studies.
1.4.3 Pleiotropic Regulatory Genes
The production of secondary metabolites is additionally regulated by pleiotropic proteins. A 
pleiotropic gene is one that has multiple effects e.g. can influence the production of more than 
one antibiotic. Three of the best-characterised in S. coelicolor are described below, one of 
which is found to promote not only antibiotic production but also morphological 
differentiation in certain Streptomyces strains.
• afsR
The N-terminal region of the AfsR protein has a 33% amino acid sequence similarity with 
both the ActII-ORF4 and RedD proteins. However, despite this similarity, it has been shown 
that the afsR gene cannot act as a substitute for the pathway-specific proteins in AactlI-ORF4 
and AredD strains (Floriano and Bibb, 1996). The inclusion of multiple copies of the afsR 
gene however was found to induce ACT production in Streptomyces lividans strains (Kim et 
al, 2001). The AfsR protein needs to be phosphoiylated by a serine-threonine protein kinase 
(e.g. AfsK) in order for it to become an active regulator of ACT synthesis as it allows the 
transcription of the afsS gene (Kim et al, 2001). Phosphorylation of the afsR gene still 
occurred in AafsK strains, however, (Matsumoto et al, 1994), showing that other kinases e.g. 
PkaG and AfsL are also capable of phosphorylating the AfsR protein (Horinouchi, 2003).
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• sM
This gene is not located within any of the chromosomal gene clusters it targets and hence is 
defined as a high level regulatory gene (Petrickova and Petricek, 2003). The afsS gene is 
located immediately downstream from afsR and codes for a 63 amino acid protein that 
stimulates antibiotic production in Streptomyces strains (Bibb, 1996). The phosphorylated 
form of the afsR gene product binds efficiently to the afsS promoter region initiating its 
transcription (Lee et al, 2002). The afsS gene product then activates (either directly or 
indirectly) the transcription of the actII-ORF4 gene. The stimulatory effect on ACT synthesis 
by afsS was not observed in AafsR S. coelicolor mutants and hence Floriano and Bibb (1996) 
concluded that AfsS was dependent on the AfsR protein for its action. However, these 
observations were not reported in S. lividans strains (Vogtli et al, 1994) where the afsS 
counterpart, afsR2, was studied and hence this dependence on AfsR may be specific to S. 
coelicolor.
• bldA
Many bid genes have been implicated as having a role in both antibiotic and morphological 
differentiation in Streptomyces strains. Strains lacking this gene were unable to generate aerial 
mycelium (hence the term bald) and failed to produce any of the four main antibiotics 
produced by S. coelicolor. Lawlor et al, (1987) and Leskiw et al, (1991), discovered that the 
bldA gene codes for the only tRNA in S', coelicolor that can translate the rare leucine codon, 
UUA, which can be found within the actII-ORF4 gene transcript. However, no regulatory role 
for the bldA gene in ACT production has been identified. Studies have shown (Fernandez- 
Moreno et al, 1991), that by replacing the UUA codon in the actlI-ORF4 transcript with a 
UUG codon, ACT production occurred in A bldA strains, the substitution relieved the bldA- 
dependence of ACT production.
In addition to the genes described above, recent evidence has shown (Huang et al, 2005) that 
genes believed to be pathway-specific can also have pleiotropic effects, acting on other 
antibiotic pathways. In undecylprodigiosin synthesis, the transcriptional regulator RedZ, has 
been designated as the transcriptional activator of redD (White and Bibb, 1997) -  the 
pathway-specific activator gene. It was observed (Huang et al, 2005) that overexpressing 
redZ, caused an increase in the expression of the genes in both the cda and act gene clusters. 
This demonstrated that antibiotic-specific genes can have an effect on genes from disparate 
antibiotic pathways, hence the redZ can be said to have pleitropic properties. Constitutive 
expression of cdaR was additionally found to cause an increase in the expression of genes
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associated with the actinorhodin biosynthetic pathway, along with a reduction in the 
transcription of the genes associated with the type I polyketide cluster.
1.5 v-butvrolactones
In addition to pathway-specific activator genes, pleiotropic genes and ppGpp, various low 
molecular weight molecules (effective at low concentrations) known as y-butyrolactones, 
have been found to play an important role in triggering morphological differentiation and/or 
secondary metabolite production in many, if not all, streptomycetes (Horinouchi and Beppu, 
1992).
Kawabuchi et al., (1997), found that seven y-butyrolactones produced by S. coelicolor A3(2), 
are capable of inducing morphological changes. In S. coelicolor, these compounds have been 
associated solely with antibiotic production, no role in morphological differentiation has been 
found. Bibb (1996), studied the activity of y-butyrolactones during the cell cycle and found 
that in S. coelicolor A3 (2), such compounds were only detected during the late exponential 
(transition) to stationary phase. The different types of y-butyrolactones include:
• A-factor: (2-isocapryloyl-3R-hydoxymethyl-y-butyrolactone), the most studied compound 
of the y-butyrolactones, is required by Streptomyces griseus for both sporulation and for 
streptomycin and grixazone production, (Horinouchi and Beppu, 1993; Bibb, 2005).
• Virginiae butanolides fVBk these compounds are produced by Streptomyces virginiae for 
virginamycin production (Yamada et ah, 1987).
• IM-2: these compounds are required by Streptomyces lavendulae FRI-5, for showdomycin 
and minimycin production (Sato et al., 1989).
® I-Factor: these compounds induce antibiotic production in S. viridochromogenes, S.
bikiniensis and S. cyaneofuscatns (Grafe et al., 1983).
These factors are believed to have the ability to either:
® induce secondary metabolism upon an unknown physiological response/signal e.g. once a 
nutrient has become limited etc. (Bibb, 2005).
Or
• quorum sense - i.e. induce secondary metabolism when the population has reached a 
critical cell density (Fuqua and Greenberg 2002).
It is not known which of the above hypotheses (or in fact if it is a combination of the two) is 
the mechanism employed by these autoregulators.
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1.5.1 The Role of the SCB1 Protein in ACT Production
The scbA gene (homologous to the afsA gene in S. griseus associated with streptomycin 
synthesis) encodes the y-butyrolactone, SCB1, (27/3J?, 1 ’R)-2 -( l5-hydroxy-6-methylheptyl)-3- 
hydroxymethyl y-butanolide. SCB1 is believed to have a stimulatory effect on antibiotic 
production, capable of inducing ACT and RED production in S. coelicolor strains. However, 
studies using Streptomyces lividans 6 6  strains (Butler et al., 2003) showed that AscbA strains 
with a multicopy plasmid carrying the pathway-specific activator genes for ACT and RED, 
generated significantly increased antibiotic levels compared to control strains (up to eight-fold 
in shake-flask experiments). Takano et al, (2001) proposed a working model to explain how 
this y-butyrolactone, SCB1, regulates antibiotic production in S. coelicolor strains. This 
autoregulator has two associated genes; scbA, involved in its synthesis and scbR, encoding a 
binding protein. For effective scbA transcription, both scbA and scbR genes are required. 
AscbA and AscbR strains were found to have either no or reduced levels of scbA transcription, 
respectively. The ScbR protein is known to be a negative repressor for its own transcription 
and hence this protein has both activator (for scbA transcription when in a complex with 
ScbA) and repressor (for scbR transcription) functions. This is achieved by the binding of 
ScbR to specific sequences on both the scbR and scbA genes, which is inhibited by SCB1.
During the exponential phase, the levels of ScbR present are sufficient to repress the 
transcription of its own gene but are too low to activate scbA gene transcription (resulting in 
low SCB1 levels). ScbA levels are as a result too low for effective binding to ScbR and hence 
scbA transcription is not initiated. Low levels of the ScbR protein cause the production of a 
negative regulator of secondary metabolism (RSM).
However, during the transition phase, ScbA accumulates to a concentration that allows the 
ScbR-ScbA complexes to form (that are required to activate scbA transcription). This 
generates the SCB1 y-butyrolactone, which binds to ScbR, inhibiting its binding with the scbA 
and scbR genes. This relieves its self-repression and inactivates the ScbR-ScbA complex, 
causing a decrease in scbA transcription. The decrease in SCB1 levels alongside such high 
ScbR concentrations causes repression of RSM synthesis and hence an increase in antibiotic 
production. Streptomyces strains featuring a deletion in the scbA gene were tested (Takano et 
al, 2001, Butler et al, 2003). The low levels of SCB1 and the presence of ligand-free ScbR 
found as a result of the deletion caused repression of RSM synthesis and hence the 
overproduction in antibiotic synthesis that was observed.
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With the sequencing of entire genomes, the use of genome-scale microarray analysis and 
proteomics techniques, understanding how such pleiotropic and pathway-specific regulatory 
genes trigger antibiotic production can be better understood (Bibb, 2005).
1.6 Optimising Media Formulation for the Production of Actinorhodm
There have been numerous studies analysing the effects of using different nutrient-limitations 
upon the production of antibiotics.
Hobbs et al., (1990) investigated the effects of nutrient composition on antibiotic synthesis in 
S. coelicolor strains. Strains were grown on different nitrogen and phosphate sources, at 
varying concentrations to see if ACT production was subject to any nitrogen/phosphate 
catabolite repression mechanisms. It was observed that ACT production was completely 
inhibited by phosphate concentrations of 24mM and above, and its production was inversely 
related to the phosphate concentration. A phosphate concentration of ImM was found to be 
the optimal level for the production of the two pigmented antibiotics. This study also 
investigated the relationship between ammonium and phosphate in respect to antibiotic 
production. It was found that no ACT was produced when a concentration of ImM 
ammonium was used in conjunction with a phosphate concentration of 1 ImM. However, once 
the phosphate concentration was reduced to ImM, it required an ammonium concentration of 
greater than 50mM for ACT production to be inhibited, indicating that there is a 
compensatory control mechanism between these two systems.
Actinorhodin production was found to be prevented by high concentrations of phosphate 
(Hobbs et al, 1990) and hence results published by Bruheim et al, (2002b) corroborated such 
findings, as phosphate-limited cultures were found to support the greatest ACT production.
It has been additionally documented that high levels of phosphate may cause an increase in 
ATP concentration. Studies (Liras et al, 1977) have shown that prior to antibiotic production, 
ATP levels drop significantly and so high ATP levels may inhibit the production of specific 
antibiotics (e.g. candicidin production in S. griseus).
Phosphate has been shown to regulate the production of many different types of antibiotic 
(Martin, 2004) by exerting a negative feedback mechanism on their production, hence 
phosphate-limited conditions are believed to be the optimal way in which to grow strains for 
antibiotic production. Evidence has shown, that this negative control can also be seen at the 
transcription level, (Martin, 2004). Phosphate control of antibiotic synthesis in S. lividans and 
S. coelicolor is mediated by the two-component PhoR-PhoP system (controlling the alkaline 
phosphatase-encoding gene, phoA). S. lividans strains with deletions for either of the phoP or
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phoR genes were unable to generate PhoA blit overproduced ACT and RED, which was 
partially insensitive to phosphate control (ranging from ImM to lOmM), (Martin, 2004). This 
hyperproduction of ACT in hphoP and AphoR strains was reduced when excess phosphate 
levels were used in the culture media (Sola-Landa et al, 2003). It has been stated that the 
AfsS protein has a positive effect on ACT synthesis by enhancing the transcription of the 
actII-ORF4 gene (Floriano and Bibb, 1996). Martin (2004) postulated a hypothesis for the 
phosphate repression seen for ACT synthesis. The phosphorylated PhoP protein exerts a 
negative effect on the expression of the afsS gene causing a down-regulation in the 
transcription of the actII-ORF4 gene and hence low/no ACT production occurs. Hence in 
AphoR, AphoP strains no such repression of the afsS gene occurs, which allows the actll- 
ORF4 gene to be constitutively expressed.
Dauner et al, (2001) also found that carbon fluxes through the TCA cycle were lower when 
phosphate was the limiting nutrient as opposed to nitrogen or carbon, when Bacillus subtilis 
strains were grown. If the same mechanism occurs in Streptomyces strains it may be another 
reason for the increased levels of ACT seen when P-limited cultures are used. A reduction in 
TCA cycle activity would allow more acetyl-CoA (involved in the initial TCA cycle reaction) 
for ACT synthesis, therefore.
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1.7 Microbial Growth Kinetics
When microbial cells are inoculated into a medium containing all the required nutrients, under 
appropriate temperature, pH conditions etc., its growth can be divided into three distinct 
growth phases:
• The Lag Phase: Occurs post-inoculation, cells adapt to the environment. The growth rate 
is either zero or a very low rate.
• The Log/Exponential Phase: During this phase, the biomass concentration doubles at a 
constant rate -  the maximum growth rate occurs in this phase (p m a x ) .
• The Stationary Phase: The exponential phase has caused the environmental conditions to 
change within the culture, causing secretion of end-products etc. and hence eventually 
growth can no longer be supported and the stationary phase ensues. This phase is 
associated with secondary metabolite formation e.g. antibiotics.
Lag Phase Exponential Phase Stationary Phase
Time (hrs)
Figure 1.5: Typical microbial growth curve generated from batch culture growth.
Primary metabolites are those that are produced during the exponential phase. All products 
associated with this phase are essential for cell growth. Examples include amino acids, 
proteins, lipids, nucleic acids, carbohydrates and nucleotides. Primary metabolites of 
commercial value include ethanol, citric acid, lysine and vitamins. Secondary metabolites are 
generally produced once the growth rate of a culture decreases. Unlike primary metabolites, 
secondary metabolites (e.g. antibiotics) are not growth-associated. However, it is often 
difficult to classify whether a product is either a primary or secondary metabolite. For 
example, the production of undecylprodigiosin (an antibiotic) is growth associated, under 
specific nutrient limitations, but is not considered to be a primary metabolite (as it is not 
essential for growth).
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1.7.1 Bioreactor Studies
Fermentation scientists have been investigating secondary metabolism production in 
Streptomyces strains for decades. Excluding yeast fermentations (for the brewing and food 
industry), more fermentation research has involved Streptomyces strains than any other 
microorganism. Growing such strains in bioreactors allows more reproducible results as 
conditions such as aeration, pH etc. can be better controlled than if flask-culture techniques 
were used. There are several challenges in growing Streptomyces strains in bioreactors 
however, as they are filamentous organisms rather than single cells and so are more 
susceptible to shearing. They also form ‘pellets’ causing non-homogeneous cultures to form 
(which may lead to reproducibility problems).
1.7.2 Batch Cultures
This process operates as a ‘closed’ culture system, where a fixed concentration of a limited 
nutrient is available at the start of the cultivation. The three growth phases described 
previously (Figure 1.5) all take place and hence batch fermentations are used to generate both 
primary and secondary metabolites, as well as to ‘characterise’ strains that have never been 
grown before.
When the production of a metabolite is growth associated, an increase in the growth rate will 
cause an increase in the production of the metabolite. Therefore, a logical strategy to increase 
primary metabolite production would be to increase both the growth rate and the biomass 
concentration.
The strategy for increasing the production of a compound not growth associated would 
therefore be quite different. Conditions whereby a short exponential phase is followed by an 
extended stationary phase would be optimal.
1.7.3 Chemostat Cultures
The use of chemostat cultures allows specific growth rates (below the jimax) to be defined and 
maintained over an indefinite period of time, and has been reviewed extensively by Pirt 
(1975). Fresh medium is added to the culture at a specific rate that defines the growth rate. All 
the constituents needed for growth are included in the medium, except one that is to be the 
‘growth-limiting’ nutrient and is supplied at a concentration that supports a limited amount of 
growth. When this medium is supplied to the culture, growth can continue but only at a rate 
that is proportional to the rate that the growth-limiting nutrient is supplied. Simultaneously, an 
overflow device is fitted so that the same volume of media that enters the bioreactor is 
displaced, thereby maintaining the same culture volume. In this way, ‘steady-states’ can be 
achieved, whereby the formation of new biomass equals the biomass leaving the vessel (via
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the overflow device). The rate of the media feeding into the vessel, in relation to the volume, 
is termed the ‘dilution rate5, D, defined as,
D =  F/V
where:
D =  dilution rate (h'1)
F = flow rate (dm3h'1)
V = volume (dm3)
The net change in biomass concentration can be expressed as;
increase =  growth - output 
dx/dt =  px = Dx
where:
x =  biomass (g/L) 
p ~ growth rate (h_1)
At ‘steady-state’ conditions, biomass concentration remains constant, hence dx/dt =  0, 
meaning px =  Dx therefore, p =  D. The growth rate (dilution rate) can therefore be defined 
and controlled. The growth rates used in chemostat cultures must be lower than the P m a x  
(determined from chemostat culture experiments) for that particular organism so as to avoid 
‘washing-out’ of cells (Pirt, 1975).
Antibiotics are generally produced at lower growth rates and hence by using chemostat 
cultures, cells can be grown for an indefinite period of time (without the accumulation of 
potentially toxic by-products) at growth rates that are optimal for their production. 
Furthermore, Piper et al, (2002), reported that investigating the effect of genetic 
modifications and environmental conditions on the fluxome and transcriptome, by using fixed 
specific growth rates, was a useful tool for functional genomics and metabolic engineering 
studies. Growing strains in such controlled environments allows accurate 
comparisons/conclusions to be made between different strains, as well as enhancing the 
reproducibility of the results generated.
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1.8 The Association Between PPP Activity and ACT Synthesis
The pentose phosphate pathway (PPP) supplies the precursors needed for the synthesis of 
biomass components, as well as supplying NADPH required for reducing power. 
Additionally, NADPH is often used as an essential cofactor for the synthesis of many 
antibiotics (e.g. actinorhodin), and it is through specific steps of the PPP that the majority is 
synthesised, Bminenberg (1983a).
Studies carried out by Obanye et al., (1996) demonstrated that there was a direct correlation 
between methylenomycin production and the carbon flux through the PPP. NADPH is 
required for the synthesis of this antibiotic and hence the positive correlation. Findings made 
by Avignone-Rossa et al., (2002) were therefore unexpected where an inverse relationship 
between the carbon flux through the PPP and ACT synthesis was observed in S. lividans 
strains. Studies carried out by Jonsbu et al, (2002) were also in agreement with this whereby 
nystatin production in Streptomyces noursei strains was assessed. All these findings led to the 
basis of the work earned out by Butler et al, (2002), in which S. lividans strains featuring 
gene deletions coding for enzymes associated with the oxidative part of the PPP, were 
constructed. For the majority of microorganisms, NADPH is produced by two reactions of the 
oxidative part of the PPP, catalysed by glucose-6 -phosphate dehydrogenase (zM>f) and 6 - 
phosphogluconate dehydrogenase (zwf3).
In the studies carried out by Butler et al, (2002), S. lividans strains with deletions for either 
one of the two zwf genes were constructed, along with a AdevB strain, and one that featured 
all three gene deletions, Azwfl, Azwf2, A devB. This study showed that a reduction in the 
carbon flux through the oxidative step of the PPP caused an increase in the production of 
ACT, and that its production is not limited by NADPH availability. This was therefore in 
agreement with studies carried out by Avignone-Rossa et al, (2002) but not with those of 
Obanye et al, (1996), which is most likely due to the fact that methylenomycin is not a 
polyketide. It would be interesting therefore, to create similar* gene deletions to those used in 
the Butler et al, (2002) study in 5. coelicolor strains to investigate whether similar results 
would be generated.
Bruheim et al, (2002b), observed that ACT production in S. lividans strains doubled if nitrate 
was replaced by ammonium as the nitrogen source. Studies by Bruinenberg et al, (1983b) 
grew Candida utilis strains in chemostat culture and found that strains grown on a nitrate 
nitrogen source displayed elevated levels of PPP activity, compared to those grown on an 
ammonium nitrogen source. Although these results are derived from two distinct
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microorganisms, this could be more evidence to highlight that an inverse relationship between 
PPP activity and ACT production exists.
1.9 Introduction to Metabolic Engineering
Metabolic engineering techniques have been applied to improve die productivity of native 
products made by specific microorganisms and also to extend the range of substrates that an 
organism can utilise. A further application is to generate compounds from an organism which 
under ‘normal’ conditions, would not otherwise be produced (Stephanopoulos and Stafford, 
2002). Metabolic engineering can also be used for the production of intermediates utilised for 
die synthesis of pharmaceuticals e.g. chiral compounds (Stafford and Stephanopolous, 2001).
The production of secondary metabolites is often at low concentrations, hence many efforts in 
the past have attempted to increase the yield of these products using fermentation studies and 
genetic engineering techniques for strain improvement. The production of such metabolites is 
often a useless drain of resources, (which can also be inhibitory to future cellular growth) and 
hence poses a great challenge to scientists who wish to increase antibiotic yields from 
microorganisms. This can be aided by applying metabolic engineering techniques.
Metabolic engineering has been defined as “the directed improvement ofproduct formation or 
cellular properties through the modification o f specific biochemical reaction(s) or the 
introduction of new one(s) with the use of recombinant DNA technology ” Stephanopoulos et 
a l, (1998). Metabolic flux analysis allows such reactions to be identified, molecular 
biological techniques can be subsequently employed to either insert or delete the associated 
gene(s) in order to construct ‘improved’ strains for the production of the desired product.
In order to have success in genetically manipulating Streptomyces coelicolor strains, an 
understanding of its physiology is vital, which has been greatly aided by the publication of its 
entire genome sequence (Bentley et al, 2002).
1.9.1 Metabolic Flux Analysis: An Overview
Metabolic Flux Analysis (MFA) is an invaluable technique used in metabolic engineering 
studies, allowing the determination of carbon fluxes through individual metabolic reactions. 
This gives the metabolic profile of a cell, for example, during high levels of antibiotic 
production. Pathways that appear to be the most affected under such conditions can be 
genetically manipulated to generate strains that overproduce a desired product.
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For this technique, a stoichiometric metabolic model is required consisting of reactions 
associated with central metabolism, amino acid metabolism, product formation etc. Applying 
mass balancing around the relevant intracellular metabolites, intracellular fluxes can be 
determined using specialised MFA software e.g. FluxAnalyzer (Klamt et al, 2003). If the rate 
of e.g. glucose consumption is known (input), as well as the various output rates from that 
consumption (i.e. CO2 evolution, antibiotic production, biomass production etc), the 
intracellular carbon fluxes can be determined so as to satisfy these measured (extracellular) 
constraints. The use of flux balancing analysis requires linear algebraic equations to calculate 
the carbon flux values, the main advantage is that no kinetic or regulatory data is required. 
MFA uses mass balancing of metabolites, expressed as dx/dt =  S ‘ v - b, where dx/dt is the 
accumulation rate of metabolites, S is the stoichiometric matrix containing the stoichiometric 
coefficients of the reactions in the network, v is the vector of fluxes and b is the vector of 
measured rates. Under the steady state assumption, intracellular metabolite concentrations are 
constant and therefore dx/dt =  0. The system is therefore represented by the equation 
S ' v =  b. Depending on the number of reactions (m) and metabolites (n), the system can be 
solved according to its determinacy and its redundancy (Klamt and Schuster, 2002). If exactly 
(m -  11) or more fluxes are measured, the system is determined, and the metabolic flux 
distributions within cells can be deciphered by finding, for example, the least squares solution 
to the system.
1.9.2 Applications of MFA
Determining the metabolic flux profile for a particular organism and condition allows the 
understanding of the principals underlying cellular* metabolism. The real potential of such a 
technique is realised when fluxomes at different conditions (i.e. high antibiotic production) or 
of different strains, are compared, giving us insights as to how to rationally improve 
microorganisms to maximise the biosynthesis of a desired product (Stephanopolous, 1999).
Edwards and Palsson, (2000), used MFA to investigate the effect of in silico gene deletions in 
E. coli models. An in silico deletion for the zwf gene (encoding the glucose-6 -phosphate 
dehydrogenase enzyme) was constructed and MFA results showed that this gene is non- 
essential for the growth of E. coli on glucose-limited media. In fact, the zwf deletion mutant 
had very similar growth kinetics to that of the wild type strain. The devB gene was also found 
to be non-essential for the growth of E. coli strains, and supports data presented by Butler et 
al, (2003), in which such S. lividans mutants were constructed and found to have similar* 
growth properties as the wild type strain. This type of analysis is therefore invaluable for 
metabolic engineering purposes, as it is possible to investigate whether a specific deletion
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would be potentially fatal, before such mutants are constructed and tested, saving valuable 
time and resources.
Metabolic flux analysis programs such as FluxAnalyzer, can be used to identify elementary 
modes. Schuster et al., (1999), defined an elementary flux mode as ‘'the minimal set of 
enzymes that can... operate independently of any others, with each reaction proceeding in the 
appropriate direction (that is according to their thermodynamic feasibilityf \ The yield of e.g. 
ACT, for each elementary mode, can be determined and hence pathways generating the most 
antibiotic can be highlighted. Results from such analysis can then be used to construct 
overproducing str ains that incorporate these findings.
Strategies that have used metabolic engineering principles to enhance product formation from 
microorganisms generally have used enzyme amplifications. However, if carbon fluxes (in 
primary metabolism), are to be redirected, it is important to evaluate the rigidity at specific 
branch points, as some branch points have evolved to become rigid, i.e. resisting flux 
alterations in order to i.e. maximise growth (Stephanopoulos and Vallino, 1991).
Vallino and Stephanopolous (1994), analysed the flexibility status at the glucose-6 -phosphate 
branch point (by calculating the flux-split ratios at this node) in Corynebacterium glutamicum 
str ains. The study showed that in using different carbon sources and mutants, the flexibility at 
this node changed. It was found to be flexible under conditions of lysine production (which 
requires NADPH for its synthesis). The enzymes around this node could therefore optimise 
e.g. lysine production, by directing carbon through either the glycolytic or PP pathway. The 
flexibility status at the pyruvate/ phosphoenolpyruvate node was found to be rigid under 
conditions of lysine production. These results could be exploited in future studies for the 
enhanced production of lysine, therefore, and demonstrate further uses of MFA.
1.9.3 Examples of Metabolic Flux Analysis
Groups have applied MFA techniques for a number of different purposes. Aiba and Matsuoka 
(1979) are believed to be the first group to calculate intracellular fluxes from extracellular 
metabolite measurements, analysing citrate production in Candida lipolytica strains. It was 
observed that by comparing the actual rates measured for extracellular metabolites, with those 
obtained from MFA techniques, iterative improvements to the models could be performed so 
that carbon flux values calculated were in better agreement with those that could be measured 
in vitro.
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De Hollander, (1994) investigated lysine production in Corynebacterium glutamicum strains. 
This microorganism is the most important producer of lysine in industrial fermentation 
processes. However, wild type strains are unable to produce lysine and it is only through 
specific mutations that they are capable of doing so, (mainly due to eliminating the feedback 
inhibition mechanism exerted by aspartate kinase). This ‘bottleneck’ was identified by MFA 
techniques and hence gives an example whereby MFA methods have been used successfully.
Continuous culture studies have shown that the production of lysine is directly related to the 
growth rate of the culture (De Hollander, 1994). From metabolic flux analysis techniques, it 
was observed that a negative and positive correlation was observed between lysine production 
and the carbon flux through the glycolytic and PP pathway, respectively. Lysine synthesis 
requires NADPH and MFA studies showed that it is through the oxidative part of the PPP that 
the majority of this cofactor is generated in C. glutamicum (Marx et al, 1997). Ohnishi et al, 
(2005), focussed on the PPP-associated enzyme, 6 -phosphogluconate dehydrogenase 
(encoded by gnd) and discovered that by substituting a specific serine for a phenylalanine, the 
enzyme became less sensitive to allosteric inhibition by intracellular metabolites. MFA 
studies showed that this strain had an 8 % increase in the carbon flux through the PPP during 
lysine biosynthesis, resulting in a 15% increase in lysine production, confirming the existence 
of a positive correlation between lysine and NADPH production.
Ethanol production from microorganisms has been the basis of many studies. The organisms 
most researched for this purpose are Saccharomyces cerevisiae and Zymomonas mobilis. The 
glycolytic pathway is the main pathway by which ethanol is produced, but its complexity and 
regulation has hindered research in this field (Schaaff et al, 1989). Hatzimanikatis et al., 
(1998), engineered an E. coli strain to overproduce pyruvate kinase, which lacks inhibition 
from ATP. This caused ethanol production to increase by 11%.
1.9.4 Metabolic Flux Analysis Studies in Streptomyces strains
A few studies have applied MFA techniques to Streptomyces strains. Daae and Ison (1999) 
constructed a stoichiometric network for S. lividans strains, which consisted of 57 reactions. 
Their research showed that changes in oxygen consumption had the greatest impact on the 
carbon flux distributions and that the use of such MFA techniques should be employed on a 
regular basis for strain development and experimental design.
Naeimpoor and Mavituna, (2000), used S. coelicolor strains and MFA methods to determine 
how intracellular fluxes differed when different nutrient limitations were used. They found 
that actinorhodin production was greatest under nitrogen-limited conditions.
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Kirk et ah, (2000) grew S. clavuligerus strains in chemostat cultures under different nutrient- 
limited conditions. It was observed that the greatest clavulanic acid yields occurred when 
strains were grown in P-limited cultures. MFA analysis was used to assess how carbon flux 
distributions altered when different nutrient limitations were used to grow S. clavuligerus 
strains,
Avignone-Rossa et al, (2002), grew S. lividans strains in phosphate-limited, chemostat 
cultures to investigate the effects of varying the carbon source (and growth rates) upon 
antibiotic production. The results obtained showed that there was an inverse relationship 
between the carbon flux through the PPP and antibiotic production (e.g. ACT and RED). It 
was also observed that by varying the growth rate of the culture and in using different carbon 
sources (glucose and gluconate), variations in the carbon fluxes through the central metabolic 
pathways were generated. A decrease in the biomass yield and ACT production was found 
when gluconate was used, however, RED production decreased when glucose was used. The 
results generated from MFA, showed that there was an increase in the carbon flux through the 
PPP as the growth rate increased, (indicating the higher demand for NADPH), which 
coincided with a decrease in antibiotic production.
ACT production was found to correlate negatively with PPP activity, hence at the lower 
dilution (growth) rates, more ACT was generated. These findings were exploited by Butler et 
al, (2002). This demonstrates how powerful a technique MFA can be for strain development 
research.
Kim et al, (2004), applied MFA techniques to study CDA synthesis in S. coelicolor strains 
and found that its production was affected by nitrogen assimilation, a-ketoglutarate and PPP 
fluxes. These findings were used to construct strains, in silico (with deletions for the 
appropriate enzymes) and were found to generate increased specific CDA production rates. 
These strains were not investigated in vitro hence whether such strains would actually result 
in enhanced levels of CDA remains to be determined but such analyses are a useful stalling 
point in metabolic engineering studies.
Borodina et al, (2005) were the first group to design a genome-scale metabolic model for 
Streptomyces coelicolor consisting of 971 reactions. With some adjustments, the network 
devised could be species-specific, hi that it could be used for MFA in a variety of 
Streptomyces species. Constructing such genome-scale models must be the optimal way in 
which to study carbon fluxes in microorganisms and hence should be how future MFA studies 
are undertaken.
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1.10 M icroarrav Analysis
1.10.1 Microarrav Technology: Overview
Microarray analysis is used to study the expression profile of numerous genes within an 
organism under specific conditions, so as to identify, for example, genes that are up/down- 
regulated at high/low ACT production states. Microarray technology has been used to study a 
number of bacterial species for example, Escherichia coli (Richmond et al., 1999), pathogenic 
strains such as Mycobacterium tuberculosis (Wilson et al., 1999) and Streptococcus 
pneumoniae (Hakenbeck et al., 2001). Additionally, microarray analysis has been applied to 
iteratively improve reaction networks used for MFA, thereby increasing the accuracy of the 
results generated (Akesson et al., 2004). DNA microarrays may highlight gene targets for 
metabolic engineering that would otherwise be difficult to identify.
DNA probes (composed of sequences that are complementary to specific genes) are spotted 
on to the surface of a glass slide in an orderly manner. Samples (referred to as ‘targets’) in the 
form of cDNA, gDNA etc. are incorporated with a particular dye and are mixed with a control 
sample that has been labelled with a different dye. These are subsequently allowed to 
hybridise to the slide. Targets that feature sequences complementary to those that are on the 
slide will then bind and will be identified using fluorescence detection. Signal intensities 
(which are proportional to the amount of transcript in the sample) for both the sample and 
control are then measured. A composite picture of the two channels (Cy3/Cy5) is then formed 
(Figure 1.6).
Figure 1.6: The “CoelicolorArray” designed specifically for Streptomyces coelicolor, taken from 
www.bi.umist.ac.uk/research/staff/cpsmith/lmagel.jpg The sample (target) is labelled with a Cy3 (green) 
dye and the control sample labelled with a Cy5 (red) dye, for example. Both channels are scanned and a 
composite image is formed. The gene expression levels are then determined by measuring the signal 
intensities detected by the scanner (for both channels/samples), for each gene probe.
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The expression level for a particular gene in the test sample in relation to the control sample is 
then determined (showing whether the gene is up/down-regulated). The ratio of the two 
fluorescent emissions (Cy3/Cy5) represents the differential gene expression for that particular 
probe/gene. Values > 1.0 give an indication that the gene has been up-regulated and a value 
< 1 .0  indicates down-regulation of the gene (relative to the control/reference sample).
In the past twelve years, publications have progressed from presenting the sequence of a 
single gene, to papers that have stated the sequence of entire genomes. The number of 
genomes that are currently being sequenced is ever increasing and as a result, functional 
genomics is of great interest for many research groups. This is the area of science that assigns 
biological functions to DNA sequences. The role of individual genes and how they interact 
with others is of great importance, which can be facilitated by the use of DNA microarray 
technology.
There has been a significant increase in the number of papers published that have applied 
DNA microarrays, as can be seen from Figure 1.7.
Year
All microarray papers 
Microbial microarray papers
Figure 1.7: The number of publications that have applied DNA microarray technology. The number of 
studies that have used this technique for microorganism research is also shown. Adapted from Lucchini 
et al., (2001).
Microarrays therefore allow the transcription level of several thousand genes to be monitored 
and compared between different strains and conditions (on a large scale) and hence the impact 
that the technique has had in microbial research.
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1.10.2 Replicates
It is important when using microarray technology to carry out replicates. In doing so, formal 
statistical methods (i.e. t-tests) can be employed so that confidence levels can be assigned to 
the conclusions drawn.
Replicates can be one of two forms: technical replicates and biological replicates. Technical 
replicates can include having a repeated probe on the same microarray slide. The fluorescent 
intensity value generated from duplicate spots 011 the same array will be >  95% in accordance 
with one another, therefore this type of replicate is not optimal. However, having duplicated 
spots, in different areas of the slide, is a vast improvement to having them adjacent to one 
another as it gives better variability across the arrayed area.
The best form of replicate is the biological replicate. This uses RNA from different 
extractions obtained from different cultivations. In this way, independent experimental results 
are generated and good statistical analyses can be carried out. However, the majority of 
microarray experiments still do not use this type of replicate due to either the difficulty in 
obtaining feasible biological replicates or due to the nature of the enquiry. Many microarray 
experiments are exploratory, and therefore do not require statistics to support their 
conclusions, (Yang and Speed, 2002). However, as more and more research incorporates 
microarray technology, the need for biological replicates is becoming increasingly apparent in 
order that experiments from different laboratories can be compared, for example,
1.10.3 Applications
Many diverse branches of science have employed microarray techniques. Microarrays have 
been used to study how the gene expression profiles change in response to the administration 
of antibiotics, pharmaceutical products and agrochemicals, so as to improve their mode of 
action and to identify novel antimicrobials. The mode of action of novel drugs can be 
predicted by analysing how drugs with similar chemical properties have altered gene 
expression levels. As the cost of microarrays continues to decrease, they have become 
increasingly integral to the drug discovery process.
Huang et al., (2001), analysed how the gene expression profile within S. coelicolor strains 
changed in the transition from primary to secondary metabolism. They found that genes 
involved in antibiotic synthesis and morphological differentiation were up-regulated during 
this transition phase, but those genes coding for ribosomal proteins, tRNA synthetases and 
translation initiation factors were down-regulated.
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Studies have applied metabolic flux analysis (MFA) to Corynebacterium glutamicum cultures 
to gain insight into how D-pantothenate, L-isoleucine, L-lysine and L-threonine levels could 
be enhanced by manipulating its metabolism. However, with the recent publication of its 
entire genome sequence (Tauch et a l, 2002), microarray technology has been adopted to gain 
better insights into regulatory mechanisms and to identify other potential targets for strain 
development.
The use of both metabolic flux analysis and transcriptomics techniques is the optimal way in 
which to engineer strains. However, MFA relies on some assumptions (for example, that the 
enzyme catalysing a reaction is present and active) and transcriptomics alone cannot be used 
to elucidate that an increase in gene expression indicates an increase in the carbon flux 
through the associated reaction (particularly if the enzyme is able to catalyse more than one 
reaction). Therefore, using these techniques in conjunction with one another would allow 
more accurate conclusions to be drawn about the organism’s metabolism and physiology, and 
hence is invaluable for metabolic engineering strategies.
Transcriptome analysis can be of great use for placing constraints on stoichiometric networks 
designed for MFA. If a gene is not expressed, the corresponding protein and its related 
reaction can be eliminated from the network, thereby reducing the feasible solution space. 
This, therefore, would improve the results generated from metabolic flux analysis 
(Akesson et al, 2004).
1.10.4 Microarrav and Chemostat Studies
Reproducibility of microarray data is affected by variations in the strains, and culture 
techniques used. In chemostat cultures, cells are maintained at specific growth rates and 
parameters such as pH, temperature, aeration etc. are controlled throughout the cultivation. In 
doing so, gene expression profiles can be compared between different strains and growth 
conditions accurately. The effect of a single parameter e.g. the carbon source, can be studied 
without interference from growth-related effects.
This high level of reproducibility in using chemostat culture, in conjunction with analysing 
the impact of genetic modifications and environmental conditions at defined growth rates, is a 
valuable tool in metabolic engineering research, (Piper et al., 2002).
Daran-Lapujade et al, (2004) carried out microarray experiments on Saccharomyces 
cerevisiae strains grown in chemostat culture under aerobic, carbon-limited conditions and 
found that there was good reproducibility between triplicate samples.
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Piper et al, (2002), grew S. cerevisiae strains in chemostat cultures under both aerobic and 
anaerobic conditions. A 95% agreement between biological replicates was found, which was a 
significant improvement on the results obtained from shake-flask cultures.
All these findings suggested that chemostat culture is the optimal culture technique to use for 
microarray analysis.
1.10.5 Microarravs and Metabolic Flux Analysis
Data derived from DNA microarray analysis allows scientists to further understand the 
physiology of cells and to potentially identify associations between metabolic pathways and 
regulatory mechanisms that have been previously unknown.
There have been a few studies whereby the correlation between MFA data and gene 
expression levels have been investigated. Yoon and Lee (2002), found that in E. coli there 
was a poor correlation between the data derived from fluxomic and transcriptomic techniques, 
for reactions/genes of the glycolytic and pentose phosphate pathways. However, good 
correlations were observed between the two methods when reactions associated with the TCA 
cycle were analysed. The authors concluded that this was due to there being more 
translational regulatory mechanisms for the glycolytic and PP pathways compared to the TCA 
cycle genes.
Daran-Lapujade et al, (2004), found a poor correlation between the values generated from 
MFA techniques and transcript levels of genes associated with the glycolytic, pentose 
phosphate and the TCA cycle pathway. Only genes associated with gluconeogenesis and the 
glyoxylate cycle presented good agreement. This study was carried out using S. cerevisiae 
strains in carbon-limited chemostat cultures and suggest that certain pathways of central 
metabolism (e.g. glycolysis) in this organism are largely controlled via post-transcriptional 
modifications.
Oh and Liao (2000), analysed the gene expression profile in E. coli strains (in response to 
protein overexpression) and found that there was poor correlation between the transcript 
levels, enzyme activities and metabolic flux values determined. Any correlation found 
between the transcript data and values generated from metabolic flux analysis were merely 
qualitative.
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Yang and Speed, (2002), found that a 10-fold increase in the carbon flux value had no effect 
on the gene transcript level. They concluded that results from either method alone is not 
sufficient, therefore a combination of enzyme activity measurements, MFA, transcriptomic 
and proteomic data should be employed for optimal results.
There are many reasons to explain the lack of correlation between, for example, 
transcriptomic data and enzyme activity, for example, the presence of isoenzymes. One 
isoenzyme may be up-regulated but the other down-regulated — and hence any results 
generated from microarray data will be difficult to compare with MFA results. In addition to 
this, several enzymes accept different substrates and hence one gene may code for proteins 
that are able to catalyse a number of different reactions. This will cause further complications 
when comparing data from such techniques.
However, there have been some studies conducted that conflict with these findings. Gonzalez 
et al, (2 0 0 2 ) observed that there was a good correlation between the transcript levels found in 
E. coli strains (grown in batch culture) and in vitro enzyme activity. They also found that 
glycolytic gene transcript levels were in good agreement with MFA values determined. This 
conflicting evidence means that more research into this area (particularly in Streptomyces) is 
needed.
28
1.11 Concluding Remarks
With an estimated US$30 billion spent worldwide on antibiotics every year, research into this 
field is of great economical importance (Gavrilescu and Christi, 2005).
Metabolic engineering is a multidisciplinary area bringing together concepts associated with 
biochemistry (designing metabolic networks, enzyme kinetics; stoichiometries; and 
regulation), genetics and molecular biology (constructing ‘novel’ strains for the improved 
synthesis of specific products) and chemical engineering.
It has been shown that metabolic flux analysis can be used to:
i) study cell physiology of growing cells in various nutrient limited media
ii) identify potential ‘bottlenecks’ in metabolism
iii) calculate maximal yields of product formation (elementary modes analysis)
Using a variety of Streptomyces coelicolor strains, (Section 2.1) in association with metabolic 
engineering techniques to improve ACT production will hopefully give us an insight as to 
how to best increase the production of other commercially important compounds that have 
similar biosynthetic routes. The way in which this can be achieved is outlined in the 
objectives section that follows. A good strategy is to grow selected strains in bioreactors, 
obtaining the relevant data for MFA and analysing the results from this to identify potential 
targets. Targets could also be identified at the transcript level by applying microarray 
techniques.
The next few years are likely to witness large developments in this field since an increasing 
number of bacterial genomes have been sequenced and DNA microarrays have become 
increasingly accessible. The applications of such methods have been realised but are yet to be, 
highly significant in the microbial, medicinal, pharmaceutical and agricultural industries.
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Objectives
The main objective of this study was to improve our understanding of the relationship 
between primary and secondary metabolic routes that lead to actinorhodin (ACT) synthesis. In 
addition to this, it was important to develop a metabolic engineering strategy that would 
enhance the yields of bioactive compounds, such as antibiotics, for future studies. This would 
be accomplished by carrying out the following objectives.
• It is known that obtaining reproducible, high cell density liquid S. coelicolor cultures is 
difficult due to the lack of morphological homogeneity. One of the aims therefore, was to 
design an inoculum protocol that would allow S. coelicolor strains to be grown 
homogeneously for use in batch and chemostat cultures, allowing for more accurate 
comparisons between strains and conditions.
® Strains with an impaired PPP, and those with a scbA gene deletion, were to be grown in
batch culture to assess antibiotic yields. Furthermore, the effect of an additional copy of 
the actII-ORF4 gene was also to be examined. The findings from these results would aid 
future metabolic engineering studies by highlighting changes in carbon flux distributions.
® In order to investigate further the effect of the PPP-associated gene deletions (and growth
rate) on antibiotic production, strains were to be grown in chemostat culture. Such culture 
techniques are optimal for growing strains that are to undergo MFA and microarray 
analysis.
• To interpret any changes seen in antibiotic yields generated by the different strains and 
growth rates, metabolic flux analysis (MFA) techniques were performed. To achieve this, 
analytical techniques needed to be developed so that the various parameters required for 
MFA (e.g. glucose concentration, macromolecular composition analysis etc.) could be 
accurately measured. Additionally, a stoichiometric matrix specific for S. coelicolor 
needed to be designed, incorporating primary metabolic reactions and those leading to 
actinorhodin synthesis.
® To identify reactions that had carbon fluxes relating to ACT synthesis, correlation analysis
techniques were applied to MFA data. These reactions could then be the target for future 
metabolic engineering studies that aimed to enhance ACT production.
® The metabolic route(s) by which maximal concentrations of ACT are generated (achieving
the maximum theoretical yield), would be identified using elementary modes analysis 
(EMA), which finds all feasible routes through the network between substrate and product 
formation, the results from which may aid in strain development.
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® Genes that are up/do wn-regulated under conditions of low/high ACT production could be 
potential candidates for strain development. Identifying such genes would be achieved 
through the use of microarray techniques, which presents the gene transcription profile for 
a particular organism under a specific condition. Examining the correlation between MFA 
and microarray data would also give us an insight as to whether the fluxome can be 
predicted from transcriptomic data in S. coelicolor strains.
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2.1 Strains
The John Innes Centre, Norwich, provided the strains used in this study, and these are listed in 
tables 2 .1  and 2 .2 .
Table 2.1: Strains used in this study. All gene constructs have been made using in-frame deletions.
Strain Genotype Com m ents
M 510 A redD The control strain. Derived from S. coelicolor M l45 (S C P 1\ SCP2') Floriano and Bibb, 1996. 
Features a deletion for the redD  gene and is therefore unable to produce undecylprodigiosin 
(RED ), another pigmented antibiotic produced by S. coelicolor.
M 717 AredD, Azwfl Unable to produce RED  but also features a deletion for one o f the two genes encoding glucose- 
6-phosphate dehydrogenase, zw fl, catalysing the initial step o f the pentose phosphate pathway.
M 719 Ai'edD, AdevB Unable to produce RED and also contains a deletion for the devB  gene coding for 6- 
phosphoglucono-5-lactonase that catalyses the second reaction o f the pentose phosphate 
pathway.
M 716 AredD, AscbA Unable to produce RED  and also features a scbA  gene deletion coding for SC BI y- 
butyrolactone.
In addition to the strains presented in table 2.1, all genotypes described above were 
constructed in strains containing an additional copy of the actinorhodin pathway-specific 
activator gene, actII-ORF4. This gene was located on the pIJ8714 plasmid (featuring an 
apramycin resistance gene), based on pSET152 and integrated at the att attachment site under 
the control of the constitutive ermE* promoter (Bibb et al, 1985). This promoter drives the 
transcription of the erythromycin resistance gene in Saccharopolyspora erythraea. By plating 
strains on to SFM agar containing 20fig.ml"1 apramycin, ensured that the plasmid was still 
integrated (hence any observed effects could be attributed to the additional copy of the 
actII-ORF4 gene).
Table 2.2: Strains used that featured an additional copy of the actII-ORF4 gene (on the pIJ8714 plasmid).
Strain Genotype Com m ents
M 510pIJ8714 AredD, actll-ORF4 As M 510 but with an additional copy o f the actll-O RF4 gene.
M 717pIJ8714 AredD, Azwfl, actII-ORF4 As M 717 but with an additional copy o f the actlI-ORF4  gene.
M 718pIJ8714 AredD, Azwfl, actII-ORF4 Has a deletion for the zw fl gene encoding glucose-6-phosphate 
dehydrogenase. Contains an additional copy o f  the actll-O RF4 gene.
M 719pIJ8714 AredD, AdevB, actII-ORF4 As M 7 19 but with an additional copy o f  the actII-ORF4 gene.
M 716pIJ8714 AredD, AscbA, actIl-ORF4 As M 716 but with an additional copy o f  the actII-ORF4 gene.
M 720pIJ8714 AredD, Azwfl, AscbA, actll- 
ORF4
This strain is similar to strain M 717pIJ8714 in that it has a zwfl gene 
deletion but it also has a deletion for the scbA  gene seen in strain 
M 716pIJ8714. Synergistic effects by the two genes to be assessed.
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2.2 Cultivation of 5 . coelicolor strains
2.2.1 Media Composition
• Sov Flour Mannitol (SFM) Agar: a solid medium encouraging sporulation, composed of 
(g.f1): Soya Flour, 20; Mannitol, 20; Nutrient agar, 16.
• GG1: a complex medium used for die initial cultivation stages, composed of (g.l*1): 
Glucose, 15; Glycerol, 15; Soya Peptone, 15; NaCl, 3; CaCC>3, 1.
• G YB: a complex medium used for the subsequent cultivation stage, composed of (g.l"1): 
Glucose, 33; Yeast Extract, 15.
• Modified Evans Medium (P-limited): a minimal medium used for bioreactor studies, 
composed of (mM): NaH2P 04, 4*; KC1, 10; MgCl2, 1.25; (NH4)2S04, 50; Na2S04, 2 ; 
Citrate, 2 ;  CaCl2, 0.25; Glucose, 194. (* 3m M  N aH 2P 0 4 used for ch em ostat cu lture).
• Trace Element Solution: 5ml of trace element solution is required per litre of Modified 
Evans Medium, (mM): ZnO, 50; FeCl3, 20; MnCl2, 10; CuCl2, 10; CoCl2, 20; H3BO3, 10; 
Na2Mo04, 0.02; HC1, 80ml.
For all the liquid phase media described above, a concentrated glucose stock solution (added 
at a 1 0 % concentration v/v) was filter sterilised and added after the media constituents had 
been autoclaved, avoiding ‘caramelisation’ of the glucose.
The pH of each medium was set to 6.80 by the addition of 4N NaOH/ 4N HC1.
2.2.2 Culture Conditions
Strains (stored on agar slopes at 4 °C) were subcultured on to Soy Flour Mannitol (sporulating 
media) agar. Plates were incubated in a humid environment at 30 °C until sporulation 
occurred (approximately 4-6 days). A single colony was taken from these plates and used to 
make spread plates, which were incubated following the aforesaid conditions. These spread 
plates, once fully sporulated, were used to construct the master cell banks (MCB).
2.2.3 Preparation of Master Cell Banks (MCB)
To obtain consistent inoculum sources, master cell banks were prepared according to the 
following protocol. 8 mm plugs from the SFM spread plates were placed into 2ml cryotubes 
(Nunc) containing 1.5ml brain heart infusion and 20% glycerol, which were then stored at 
-80 °C. These plugs were subsequently used to prepare the working cell banks (WCB).
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2.2.4 Preparation of Working Cell Banks (W CB)
One plug from the MCB stock was used to inoculate 50ml GG1 media in a 250ml Erlenmeyer 
flask containing a magnetic triangular (in cross section) stirrer bar, 40mm x 14mm. This was 
placed on a magnetic stirrer platform and incubated at 30 °C for 48 horns. 900pl from the 
above GG1 grown cultures were placed into cryotubes containing 600pl (50% suspension) 
sterile glycerol solution. These WCB were then stored at -80 °C ready to be used for the 
subsequent inoculation stage.
2.2.5 Inocula Preparation and Shake-flask Cultures
5ml GG1/WCB culture was used to inoculate 45ml GYB medium in a 250ml Erlenmeyer 
flask containing a magnetic triangular (in cross section) stirrer bar, 40mm x 14mm.
These flasks were incubated at 30 °C for 24 horns. After the incubation stage, this culture was 
used to inoculate the modified minimal Evans medium (Evans et al, 1970) at a 10% final 
concentration and incubated for 24 hours at 30 °C. This was also used as the preculture for the 
bioreactor studies.
2.3 Bioreactor Studies
All bioreactor studies were carried out in a 5L capacity bioreactor (Adaptive Biosystem 7000 
Series) with working volumes of 4L and 3L for batch and chemostat cultures, respectively. 
Two Rushton turbine impellers were used to ensure good mixing. Air was introduced into the 
bioreactor via an air sparger (located directly under the impellers) through a Whatman 0.2pm 
air filter, to maintain sterility. The pH of the culture was maintained at 6.80 with the 
automatic addition of 1M NaOH/ 1M HC1. The stirrer speed for all batch cultivations was set 
to 500rpm and lOOOipm for chemostat cultures.
The temperature was automatically controlled to 30 °C by the use of a heating probe and a 
cooling finger. Exhaust gases were monitored using a Dual Gas Tandem Analyser (Adaptive 
Biosystems) for both oxygen and carbon dioxide levels. Antifoam (Breox FMT30, 
International Speciality Chemicals) was aseptically added to the culture at a final 
concentration of 0 .0 0 1 %.
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Figure 2.1: The 5L capacity bioreactor used for all cultivations carried out in this study, with some 
components highlighted.
2.3.1 Batch Cultures
The inoculation stages described in section 2.1 were carried out to obtain the preculture 
(grown in the minimal medium) for each bioreactor experiment, which was added at a 1 0 % 
final concentration (v/v) to a working volume of 4 litres. All parameters stated in section 2.3 
were maintained for the duration of the cultivation. Samples were taken at regular intervals 
with the frequency depending upon the growth phase of the culture. These were used to assess 
the biomass dry weight concentration (Section 2.4.1), antibiotic concentration (Section 2.4.3) 
as well as the concentration of glucose, phosphate and ammonium within the culture 
supernatant (Section 2.4.2). For the analysis of the culture supernatant, 10ml culture was 
centrifuged at 3500rpm for 7 min and the resultant supernatant filtered through a 0.2pm filter 
and stored at -20 °C for further analysis.
Batch cultures were continued until both biomass and ACT concentration decreased. In order 
to determine the macromolecular composition of the biomass, samples were taken at the lag, 
mid-exponential and stationary phases of growth, and centrifuged at 7000rpm for 10 min at 
4 °C (to avoid degradation of the macromolecular constituents). The resultant pellet was
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‘washed’ twice with chilled, sterile reverse osmosis (RO) water. The volume of culture taken 
was large enough to obtain a sufficient amount of biomass for all macromolecular assays but 
as small as possible to avoid perturbing the culture. The ‘washed’ pellet was stored at —80 °C 
and subsequently freeze-dried to remove all traces of moisture. Once dried, the samples were 
immediately placed into a dessicator until macromolecular composition analyses were 
performed (Section 2.4.4).
2.3.2 Chemostat Cultures
Inocula were prepared in exactly the same way as were carried out for batch cultures, 
however, 3mM NaH2P0 4  was used in the modified Evans medium, as opposed to the 4mM 
used for batch cultures. This was so as to obtain more manageable biomass concentrations for 
chemostat cultures, particularly at low dilution rates. A working volume of 3L was used and 
the stirrer speed was set to lOOOrpm. Media were inoculated as described for batch cultures, 
and the culture was grown batchwise until the mid-exponential phase. At this stage, fresh 
medium was fed into the bioreactor at a defined (growth) rate, via a peristaltic pump. The 
overflow device fitted ensured that the same volume of media that entered the bioreactor was 
displaced, maintaining the 3L volume.
Samples were taken after each volume change/retention time, (which equals the reciprocal of 
the growth rate) to monitor biomass, ACT concentration etc. as was done for batch cultures.
A ‘steady-state’ culture was considered reached after a minimum of two volume changes and 
where culture parameters such as the concentrations of biomass, antibiotic and substrates, 
CO2 production and O2 consumption levels were constant. Once the steady-state was reached, 
samples were collected (on ice) and processed in the same way as was done for batch culture 
samples. In addition to this, samples were collected for microarray analysis and processed 
following the protocol described in section 2.6. Samples at each steady-state were also taken 
for enzyme activity measurements (see section 2.4.5).
2.4 Analytical Procedures
2.4.1 Dry weight Determination
Gelman 0.45pm cellulose filters were dried in a microwave oven (AEG: 650W: two x 5 min 
cycles) and placed into a desiccator to cool for at least two hours before weighing. Weighed 
filters were soaked in 0.01% Tween 80 solution to decrease hydrophobieity, and subsequently 
placed into a filtering unit device. The excess Tween 80 was rinsed off with 20ml reverse
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osmosis (RO) water. The culture sample was well mixed and 5ml filtered through, followed 
by a further 30ml RO water to remove any soluble media constituents. These filters were 
subsequently dried in the microwave oven (650W for 2 x 5  min cycles) and placed into the 
desiccator to cool. After one hour, the filters were once again weighed, and the dry biomass 
concentration calculated and expressed in g.l'1. Biomass measurements were performed in 
triplicate, and the value reported is the average of these three values.
2.4.2 Supernatant Analysis
The filtered supernatant obtained from each sample was stored at -20 °C and used to analyse 
the concentration of media constituents (glucose, ammonium, phosphate) remaining in the 
culture medium at that particular time point.
Such constituents were measured reflectometrically using RQ-reflectoquant test strips and 
analyser (Merck/VWR International). Supernatant samples were diluted as required. 
Ammonium and phosphate concentrations were determined against appropriate standard 
curves. Standards were not required by the glucose assay as the read-out generated was found 
to be directly proportional to the concentration of glucose present (as confirmed by the 
Trinder assay using a commercially available kit (Sigma)).
• Glucose Determination
The glucose kit (VWR International) is based on the method described by Bergmeyer (1974). 
In this assay, glucose is converted into 8 -gluconolactone through the catalytic action of 
glucose oxidase. Hydrogen peroxide is also generated which reacts with (in the presence of a 
peroxidase) an organic redox indicator (tetramethylbenzidine), which in turn develops into a 
blue-green dye. The concentration of this dye (and therefore the glucose concentration) can be 
determined reflectometrically. The detection limits are 1-lOOmg.l"1.
® Ammonium Determination
In this ammonium assay kit (VWR International), 1ml sample was used with 2 drops NH4*1 
reagent supplied. In this assay, N H / ions react with Nessler’s reagent resulting in a yellow- 
brown compound, the concentration of which can be determined reflectometrically. The 
detection limits are 20 to lSOmg.l' 1 NH4+.
• Phosphate Determination
In this phosphate assay kit (VWR International), 1ml sample was used with 2 drops P04"1 
reagent supplied. Orthophosphate ions P 043' and molybdate ions form molybdophosphoric
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acid in a solution acidified with sulphuric acid. The resulting molybdophosphoric acid is then 
reduced to phosphomolybdenum blue (PMB) -  the concentration of which may be measured 
reflectrometrically, and hence the phosphate concentration can be determined. The detection 
limits of the method are S-llOmg.l"1 P 043".
2.4.3 Actinorhodin Determination
Actinorhodin measurements were earned out using the method described by Bystrykh et al. 
(1996) with modifications by Braheim et al., (2002b).
Extracellular actinorhodin (i.e. in the supernatant) was analysed by placing 500pl supernatant 
into a centrifuge tube to which a further 500pl 3M KOH was added. This was then vortexed 
and the absorbance measured at 640nm using a Pharmacia Biotech Ultraspec 2000. If 
necessary, samples were diluted ensuring the same ratio of KOH to supernatant was used.
In cultures where ACT accumulated intracellularly, the pellet (resulting from a 20ml sample) 
was resuspended in 5ml 3M KOH. This suspension was sonicated (Heat Systems), on ice, for 
a total of 7 min (30 sec on/off cycles). A further 15ml 3M KOH was then added and 
centrifuged. The process was repeated until no or negligible amounts of ACT remained in the 
pellet. The absorbance of the supernatant at each stage was measured at 640nm.
The concentration of ACT was calculated using a molar extinction coefficient (sg4o) value of 
25320 M' 1 cm' 1 (Bystrykh et al, 1996).
2.4.4 Macromolecular Composition of Biomass
2.4.4.1 Protein
The protein composition of biomass was determined using the method described by Lowry et 
al., (1951).
A standard curve ranging from 25 to 200fig.ml' 1 using bovine serum albumin was 
constructed. Biomass is generally known to consist of approximately 40-50% protein and 
hence 2 0 0 pg/ml freeze-dried biomass was used in order to have a protein concentration that 
was mid-range of the standard curve. All samples and dilutions made were carried out in 
triplicate. To solubilise proteins in the sample, 0.5ml IN NaOH was added to 0.5ml test 
sample and heated to 100 °C for 5 min. To 50ml 5% Na2CC>3 solution, 2ml 0.5% CuS0 4*5 H2 0  
in 1% potassium-sodium tartrate was added. 2.5ml of this mixture was added to each sample 
and left to stand for 10 min. 0.5ml 1.0N Folin-Ciocalteu reagent was rapidly added and left to 
stand for 30min (at room temperature). The absorbance was subsequently read at 750nm, and 
the protein concentration obtained from the standard curve.
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2.4.4.2 Carbohydrate
Carbohydrate was determined using the phenol/sulphuric acid method as described by Dubois 
et al, (1956). The method has a linear response between 10 and 200pg/ml of glucose. 
Biomass is generally known to consist of 10-15% carbohydrate, and therefore 1250pg/ml 
freeze-dried biomass was used in order to obtain a carbohydrate concentration that would lie 
mid-range of the standard curve. All samples and dilutions made were carried out in triplicate. 
To 2ml test sample/standard, 0.5ml 80% (w/v) phenol solution was added and mixed 
thoroughly. 5ml concentrated H2SO4 was then added and the tubes were incubated at 25-30 °C 
for one horn*. The absorbances of which were then read at 488nm, and the carbohydrate 
content determined from the standard curve.
2.4.4.3 Lipids
Lipid content was determined using the chloroform : methanol method as described by Folch 
et al, (1957), with modifications described by Bligh and Dyer (1959).
Approximately 0.5g freeze-dried biomass was used for lipid analysis. 10ml chloroform and 
5ml methanol were added to the biomass in a falcon tube and vortexed for 30 sec. 5ml RO 
water was then added. The contents were filtered through a Whatman #1 EPS filter and the 
filtrate collected in a separating funnel.
The layers were left to form and the lower phase (chloroform) collected in a pre-weighed 
falcon tube. The chloroform was then allowed to evaporate fully and the falcon tube 
subsequently weighed. The difference in weight was attributed to the lipid extracted from the 
biomass.
2.4.4.4 DNA
DNA analysis was carried out using the method described by Burton (1956). A standard curve 
ranging from lOOpg/ml to 500pg/ml was constructed using calf thymus (Type I, sodium salt) 
DNA. Perchloric acid (60%) was added to the biomass in order to extract the DNA (at 70 °C). 
To 1ml of the extracted DNA sample, 2ml diphenylamine reagent was added (100ml glacial 
acetic acid, 1.5g diphenylamine, 1.5ml C.H2SO4 and lOOpl 1.6% acetaldehyde was added per 
20ml of the diphenylamine reagent). These tubes were then incubated at 30 °C for 17 hours. 
The absorbance was subsequently measured at 600nm and the DNA content determined from 
the standard curve.
2.4.4.5 RNA
RNA analysis was earned out using the Orcinol method described by Herbert et al, (1971). 
An RNA standard curve was prepared using calf liver (Type IV) RNA ranging from 100pg/ml
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to 500pg/ml. 4 volumes 0.02g FeCl3.6 H2 0  in 100ml e.HCl, to 1 volume 1 % orcinol reagent 
was made, 2ml of which was mixed with 2ml of extracted RNA sample (biomass was treated 
with 60% perchloric acid at 70 °C). The tubes were heated to 100 °C for 15 min. After 
cooling, 11ml n-butanol was added and the absorbances measured at 640nm, and the RNA 
content determined from the standard curve.
2.4.5 Enzyme Analysis
2.4.5.1 Cell Free Extract
The in vitro activity of enzymes catalysing the NADPH-generating pentose phosphate 
pathway reactions, were measured in samples from bioreactor studies. 5ml culture sample was 
extracted (on ice) and centrifuged at 4 °C at 3500rpm for 5 min. The supernatant was 
discarded and the resultant pellet ‘washed’ twice with chilled lOOmM Tris-HCl and 2mM 
EDTA and centrifuged under the same conditions. A further 1.5ml of the Tris-HCl/ EDTA 
solution was added to the ‘washed’ pellet and sonicated for a total of 150 sec ( 2 0  sec on/off 
cycle). This sonicated suspension was then centrifuged under the same conditions and the 
supernatant filtered through a 0 .2 pm filter to obtain the cell free extract used for the enzyme 
analysis.
2.4.5.2 Enzyme Assay Theory
The activity of glucose-6 -phosphate dehydrogenase was measured using the method carried 
out by Butler, M J . (personal communication) based on the method described by van Dijken et 
al, (2002). The NADPH evolved from these reactions was measured by monitoring the 
change in absorbance at 340nm.
Glucose-6 -phosphate +  NADP+ ^  6 -phosphoglucono-8 -lactone + NADPH +  H4
6 -phosphogluconate +NADP+ ► ribulose-5-phosphate +  NADPH +  H4
However, as NADPH generation was measured, using glucose-6 -phosphate as the substrate 
also allowed the other NADPH-generating reaction to occur, hence the activity of the glucose- 
6 -phosphate dehydrogenase enzyme would be overestimated. To avoid this problem, and to 
allow the accurate measurement of the zwf gene product, one reaction used saturating 
concentrations of both glucose-6 -phosphate and 6 -phosphogluconate, and the other used 6 - 
phosphogluconate as the substrate alone, as was described by Glock and McLean (1953). The 
activity of the latter reaction was then subtracted from the activity rate measured from using 
both substrates, in order to obtain the activity for the glucose-6 -phosphate dehydrogenase 
enzyme alone.
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2.4.5.3 The Enzyme Assay
lOOpl cell free extract was placed into a cuvette, into which lOpl 1M MgCL; 50pl lOmM 
NADP+ and 820pl lOOmM Tris-HCl/ 2mM EDTA solution was added. This mixture was 
incubated at 30 °C for 2 mins, after which, 10pi glucose-6 -phosphate (75mg/ml) and 10pi 
6 -phosphogluconate (30mg/ml) was added and mixed. The absorbance was immediately 
measured every 30 sec over a 20 min period, using RO water as a blank. Simultaneously, a 
cuvette containing lOOpl cell free extract, lOpl MgCL, 50pl lOmM NADP+ and 830pl 
Tris-HCl/EDTA solution was incubated in the same way, at 30 °C for 2 min. 10 pi 6 - 
phosphogluconate (30mg/ml) alone was added to the cuvette and the absorbance measured 
every 30 sec over a 20 min period. Glucose-6 -phosphate dehydrogenase activity was therefore 
the activity measured in the latter cuvette (using 6 -phosphogluconate alone) subtracted from 
the activity measured in the cuvette that featured both substrates (glucose-6 -phosphate and 6 - 
phosphogluconate). The activity of the enzyme(s) could then be determined using the molar 
absorption coefficient for NADPH, 6.3mM'l.cm-1 (van Dijken et al, 2002).
2.4.5.4 Specific Activity of the Enzyme
Enzyme activity is better assessed by referring it to the amount of protein present, thereby 
giving the specific activity (pmol/min/mg protein) of the enzyme. To avoid the interference 
due to the blue pigment in the supernatant, the protein concentration in the cell free extract 
was determined by precipitating the protein with the Amersham Bioscienees Protein 
Precipitation Kit (for 2D-Gel analysis). The assay was carried out according to the 
manufacturer’s instructions, adjusting the recommended volumes so that only 12.5pl cell free 
extract was used.
2.5 Metabolic Flux Analysis
2.5.1 Construction of Metabolic Maps
A stoichiometric network containing all the essential reaction pathways was constructed, and 
using data generated from bioreactor cultivations, (substrate uptake and production rates etc.) 
the distribution of metabolic fluxes within a cell, under specific conditions could be 
determined by using dedicated software (Section 1.9.1).
A stoichiometric network consisting of 110 reactions and 106 metabolites was constructed 
focussing on the reactions of the central metabolic pathways (namely glycolysis, the pentose 
phosphate pathway and the tricarboxylic acid cycle). The network was developed using 
metabolic reactions found within Escherichia coli K12, (www.metacyc.org) and also from 
those found in the KEGG database (http://www.genome.jp/kegg/) that are S. coelicolor
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specific. A list of the reactions used can be found in Appendices E and F. The stoichiometric 
matrix designed was overdetermined, and hence could be solved with a number of measured 
parameters. The calculable rates were determined as a redundant system, using the 
constrained least squares estimation procedure found within FluxAnalyzer. Constraints 
(maximum and minimum rates, reversibility, etc) were placed for each reaction in the matrix, 
which was set as the specific glucose consumption rate (for that sample). If a reaction was 
irreversible, the minimum rate was set to zero. The measured, ‘extracellular’ constraints 
placed on the network (i.e. ACT production, CO2 production etc.) had to be fulfilled in order 
for the intracellular fluxes to be calculated.
2.5.2 Data Manipulation for Metabolic Flux Analysis for Batch Cultures
FluxAnalyzer was the software used to determine intracellular fluxes, which was kindly 
provided by Dr. Steffan Klamt (MPI -  Magdeburg, Germany). This program runs on a 
MATLAB (The Mathworks, MI. (www.matliworks.com) environment. A graphical interface 
is used so that the flux values generated can be easily visualised. The software also permits 
the analysis of the topological properties of a network and the determination of elementary 
flux modes.
It is generally accepted that batch cultures feature an exceptionally high turnover of 
metabolites, even following large perturbations in the environment, the metabolite pool 
concentrations rapidly adjust to new levels. For batch cultivations, metabolites are assumed 
therefore, to be in ‘/tfewdo-steady-state’, no accumulation of metabolites occurs. By assuming 
a ‘pseudo steady-state’ between consecutive time samples, accumulation rates were calculated 
using curve fitting algorithms in order to estimate transient quantities (ACT production rate, 
glucose consumption rate etc.). The concentration of each substrate or product was plotted 
against time, and the accumulation rate of the substrate/product could be determined by 
calculating the value of the first derivative of the function at this particular point. These 
accumulation rates were then used as inputs for the model in order to determine the 
intracellular carbon flux distributions.
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The following expression was used to determine, for example, the specific glucose 
consumption rate (qS), mmol x (g biomass x h)"1.
qS =  ( rate / DW ) / Mr x 1000
where;
qS specific glucose consumption rate (mmol x (g biomass x h) ' 1
rate rate of glucose consumption obtained from the curve-fitting procedure (g/L/hr)
DW dry weight (biomass concentration) (g/L)
Mr molecular weight (of glucose)
1 0 0 0  conversion factor
This method was carried out for all other parameters measured. The accumulation rates were 
entered into the program (expressed in mmol x (g biomass x h )'’) and used to solve the 
network. All fluxes were normalised to the glucose uptake in order to facilitate the 
comparison between different growth conditions and strains, and the carbon flux values 
shown in the schematic diagrams throughout this study are percentages of such glucose 
uptake values. Carbon balances between 90% and 110% were acceptable to obtain reliable 
metabolic flux analysis data. These limits were achieved for all batch cultures reported.
The growth curve was divided into the three phases of growth considered in terms of:
• lag (I)
• exponential (II)
• stationary (III)
Figure 2.2: How a growth curve is 
divided into the different growth 
phases for metabolic flux analysis.
The values generated from the lag phase were not reported due to the high variability of the 
culture during this stage. Substrate uptake and product formation rates were too low compared 
to the errors inherent to the experimental methods, and hence only those from the exponential 
and stationary phases were shown.
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2.5.3 Data Manipulation for Metabolic Flux Analysis for Chemostat Cultures
Determining the carbon flux values for strains grown in chemostat cultures was facilitated by 
having a defined growth rate (unlike batch cultures where curve-fitting procedures were used 
to estimate the accumulation rates).
It can be demonstrated (Pirt, 1975), that in a continuous culture
q “  DP
X
where,
q specific (production/consumption) rate of a constituent 
D dilution rate -  p =  growth rate 
P product concentration 
X  biomass concentration
The measured rates required for MFA for batch cultures were also required for chemostat 
culture analysis. These rates were calculated using the equation below (e.g. for substrate 
(glucose) consumption rate, Pirt (1975).
qS =  D • ((SR -  S)/X)/Mr x 1000
where: qS specific glucose consumption rate (mmol x (g biomass x h) -1)
D dilution rate (h'1)
S r  substrate concentration in reservoir media (g/L)
S substrate concentration in culture at steady state (g/L)
X biomass concentration at steady state (g/L)
Mr molecular weight (of glucose)
1 0 0 0  conversion factor
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2.6  M icroarray  Analysis
2.6.1 Samples for m icroarray analysis and stabilisation of RNA
25mg dry weight biomass (from steady-state samples) was used to obtain RNA for microarray 
analysis. The volume of culture required to obtain this quantity was calculated and one 
volume of this was added to two volumes of RNAprotect Bacteria Reagent (Qiagen) in RNase 
free tubes. The mixture was vortexed immediately for 30 sec and incubated at room 
temperature for 5 min. Each tube/sample was centrifuged at 3500rpm for 10 min (at room 
temperature). The supernatant was removed ensuring that no traces of the RNAprotect 
Bacteria Reagent remained. The pellets could then be stored at -20 °C for a maximum of 4 
weeks or at -80 °C for archival storage. The samples were then ready for RNA isolation.
2.6.2 RNA Isolation
Pellets stored at either —20 °C or —80 °C were thawed at room temperature. The RNeasy MINI 
Kit (Qiagen) was used to extract RNA from the steady-state samples. Due to the low RNA 
yields obtained using standard procedures, a modified protocol was used. Streptomycetes 
have complex cell walls (containing covalently associated peptidoglycans) and therefore 
cannot be disrupted by traditional methods such as detergent solutions, hence sonication and 
enzymatic methods were required. To reduce the occurrence of contamination and/or RNA 
degradation, gloves, bench equipment etc. were swabbed down with RNAZqp! (Ambion) and 
RNase-free tips used throughout.
Per sample, 200pl TE buffer (lOmM Tris-HCl, ImM EDTA, pH 8.0) was added along with
12 pi lysozyme stock (15mg/ml). The mixture was vortexed for 10 sec and incubated at room
temperature for 10 min (vortexing every 2 min). 700pl RLT buffer (containing lOpl (3-
mercaptoethanol per 1ml RLT buffer) was added and vortexed vigorously.
The mixture was then sonicated (on ice) for 6  cycles (30 sec ON/ 20 sec OFF) on full power.
The lysate was then transferred into a 15ml RNase free centrifuge tube.
5ml of a phenol/chloroform/isoamyl alcohol (24:24:1) mixture was added to the tube and
vortexed for 30 sec, and subsequently centrifuged at 4 °C for 10 jnin at 3000rpm.
The upper, aqueous phase was removed and placed into a new 15ml RNase free centrifuge
tube using a sterile glass Pasteur pipette and this extraction step was repeated. The aqueous
phase from this second extraction step was removed, and 5ml chloroform added. The mixture
was subsequently vortexed for 30 sec and centrifuged for 5 min at 4 °C at 3500rpm. The
aqueous phase from this was placed into a new 15ml RNase free tube and 2.5ml ethanol
(96%) was added. This step provided the appropriate binding conditions for the RNeasy MINI
columns. RNA was then extracted using the RNeasy MINI columns following the
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manufacturer’s instructions including an additional DNAse digest to eliminate DNA 
contamination that would otherwise interfere with the microarray method.
The collected RNA sample was then checked for its quantity (ng/pl) and quality (260:280 and 
260:230 ratios) using a Nanodrop ND-1000A UV-Vis Spectrophotometer (Nanodrop 
Technologies). This was convenient, as it only required a sample volume of lpl to read the 
absorbance ratio of nucleic acids. For ‘good’ quality RNA, (i.e. non-degraded) the 260:280 
ratio should lie between 1.9 and 2.0. A 260:230 ratio of below 2.0 is an indication of 
polysaccharide or reagent contamination.
The quality of the RNA was also analysed using the Agilent 2100 Bioanalyzer (Agilent 
Technologies) as an alternative to agarose gel electrophoresis. The extracted RNA was then 
stored at -80 °C awaiting subsequent steps in microarray analysis.
2.6.3 cDNA synthesis and labelling.
The RNA extracted was used to synthesise complementary DNA, (cDNA). This was to be 
labelled with a Cy3 (cyanine-3-fluorescent) dye (Amersham Biosciences). Approximately 
15fig RNA was required for the labelling stage. This volume was made up to 15.2pi using 
RNase free water, and mixed with 1.7pl random hexamer primers (Invitrogen) in RNase free 
tubes. These tubes were incubated at 70 °C for 10 min (away from light sources due to the 
‘photo-bleaching’ nature of the Cy dye) and subsequently snap cooled on ice, and centrifuged 
briefly. For each reaction the following was added, 6pl 5 x First Strand Buffer (Invitrogen), 
3 pi lOOmM DTT (Invitrogen), 0.6pl dNTPs (25mM each dATP/dGTP/dTTP, lOmM dCTP) 
(Invitrogen), 1.5pl Cy3 dye (Amersham Biosciences). The tubes were vortexed and 2pl 
Superscript III Reverse Transcriptase (Invitrogen) added. The tubes were incubated at room 
temperature for 10 min. After this time, the tubes were placed at 42 °C for a minimum of 110 
min. lOpl IN NaOH was then added to the reaction, and incubated at 70 °C for 10 min. lOpl 
IN HC1 was added to neutralise the mixture.
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2.6.4 gDNA labelling.
The test strains were compared against a ‘reference’ strain, S. coelicolor Ml45 (harvested at 
the stationary phase) using genomic DNA (gDNA), labelled with Cy5 dye (Amersham 
Biosciences). Microarrays carried out in this study were cDNA vs. gDNA, therefore. The 
gene expression levels obtained from microarrays would therefore be relative to this common 
reference, allowing comparisons between test samples to be made. 2-5 pg of sonicated gDNA 
was needed for each labelling reaction, to which 1 pi random primers was added. The volume 
was made up to 41.5 pi with autoclaved Milli-Q water. Each tube was placed at 95 °C for 5 
min, then snapped cooled on ice and centrifuged briefly.
5 pi Klenow Buffer (10X) (New England Biolabs) was added to each reaction along with lpl 
dNTPs (5mM each dATP/dGTP/dTTP, 2mM dCTP) (Invitrogen) and 1.5 pi Cy5 dye. The 
tubes were vortexed, lpl Klenow Fragment (5U/pl) (New England Biolabs) added and the 
tubes were flicked to mix the reagents. Each reaction was placed at 37 °C for at least 90 min 
and protected from direct light sources.
2.6.5 Purification of Probes
The following step required the probes to be purified by eliminating unincorporated-labelled 
nucleotides. This was achieved using MinElute columns (Qiagen) following manufacturer’s 
instructions. 30pl elution buffer was used to elute the probes. The concentration of Cy3 and 
Cy5 dyes (pmol/pl) incorporated was measured at 550nm and 650nm, respectively, using the 
nanodrop machine (Nanodrop technologies).
Approximately 40pmol of both the Cy3 (cDNA) and Cy5 (gDNA) labelled probes were 
placed into 1.5ml centrifuge tubes (ensuring that the same concentration of each dye was 
used). Both dyes were mixed together by gentle pipetting and placed into a speed vacuum 
machine to remove all traces of buffer. The tubes could then be placed at -20 °C (away from 
light sources) until the hybridisation steps took place.
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2.6.6 Hybridisation.
The microarray slides were made on site using the Microarray Facility Suite at the University 
of Surrey. The slides used were from Coming, (GAPS™ II Coated Slides). Each slide was 
designed to feature 4 ‘metacolumns' and 12 Tnetarows’. Figure 2.3 shows how the probes 
were arranged on the slides used for microarray analysis in this study.
Figure 2.3: The arrangement of probes on the slide 
used for microarray analysis. The majority of ORFs 
have probes designed for them ensuring that a 
comprehensive gene expression profile is analysed for 
each experiment. Taken from
wvvw. surrey. ac. uk/SB M S/F genom ics/M i croarravs/htm 1/ 
Downloads.html
The majority of the ORFs were represented as DNA probes of varying lengths ranging from 
150 to 500 base pairs. Cross-hybridisation was minimised by using short probe lengths. Each 
1 9 x 1 8  subgrid featured duplicated probes, acting as technical replicates. In total, each slide 
featured 16,416 spots, of which 14,354 were unique probes from the chromosome and SCP1 
plasmid. The positive controls were a set of 16S and 23S rRNA probes. Negative controls 
were a number of PCR products taken from the Pseudomonas aeruginosa genome. Empty 
spots were also a feature of the array, so that the quality of the results generated after 
hybridisation could be assessed.
The slides were presoaked and prehybridised using the Coming Pronto!1 M Universal 
Hybridisation Kit (Coming) following manufacturer’s instmctions. A series of wash steps 
were carried out and the slides were stored in a dust-free, light-proof container ready for the 
hybridisation steps.
45pl of the hybridisation solution (supplied in the Coming Pronto!1 M Universal Hybridisation 
Kit) was added to the Cy3/Cy5 mix. The tubes were then placed at 95 °C (so as to denature the 
labelled probes) for 5 min, and centrifuged briefly. During the 5 min incubation, the slides 
were gently air-blown to remove any dust particles that would otherwise interfere with the 
hybridisation process. The slides and the hybridisation chambers (Coming) were placed on a 
hot plate. 30pl 3 x SSC (saline sodium citrate) solution was placed into the two wells of the 
hybridisation chambers in order to keep the chambers humid during the hybridisation. After 
the 5 min incubation, the 45 pi hybridisation solution (including the Cy3/Cy5 mix) was placed
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evenly across the slide, on the arrayed layer and a plastic cover slip was placed gently over 
the area using curved-edge forceps. Any trapped air bubbles were tapped out (as these would 
interfere with the hybridisation process). The hybridisation chambers (Corning) were then 
sealed and placed into a darkened 42 °C water bath and incubated for 16 hours. After the 
hybridisation stage, slides were placed through a series o f washes (minimising exposure to the 
light) following the Corning Pronto!™ Kit manufacturer’s instructions and dried by 
centrifugation at 800rpm. The slides were subsequently scanned and stored in a dark and dust- 
free environment.
2.6.7 Scanning the Slides and Data Analysis.
An Asymetrix 428 Scanner (Asymetrix) was used to scan the arrayed area o f the slides. The 
fluorescence intensity was measured via laser excitation at 532nm and 635nm for the Cy3 and 
Cy5 dyes, respectively. The scanner allowed the user to pre-scan the slide adjusting the ‘gain’ 
on the laser so that the background and the ‘saturation’ o f the signal was minimised. The slide 
could then be scanned thoroughly at the chosen gain, for both the Cy3 and Cy5 channels, to 
create two TIFF files. These two image files were then entered into the image analysis 
software, ImaGene (BioDiscovery Inc.) which used a deformable template to identify each 
spot. The spots that were either absent or o f poor quality (due to either too high or too low 
signal) were ‘flagged’ and hence removed from the final data set. It was additionally possible 
to carry out manual checks, flagging the spots that should not be considered in any analysis. 
The signal intensity for each spot (and the background signal around the spot) was 
subsequently determined for the control signal (Cy5) and the test signal (Cy3). The 
information was then saved as a text file linking the gene identification with the signal and 
background levels. These text files were subsequently exported into the data analysis 
program, GeneSpring™ version 6.1 (Silicon Genetics) where filtering, normalisation and 
statistical analysis procedures were carried out.
Before the analysis o f the data generated took place, the intensity values were normalised. 
Normalisation adjusts for technical variations that occur throughout the microarray 
experiment, allowing for more accurate comparisons to be made between different 
experiments. The data was normalised on a per spot (divided by control channel) and a per 
chip (normalised to 50th percentile) basis. These adjustments were carried out for both the 
Cy3 (cDNA) and Cy5 (gDNA) data sets and ratios o f cDNA/gDNA signals were generated 
and exported to Excel. These were the values analysed and indicated whether a gene in the 
test strain/condition was up-regulated (value >  1.0) or down-regulated (value <  1.0) compared 
to the gene expression found in the reference strain.
Figure 2.4 gives an overview of all the steps carried out in microarray analysis.
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P r o d u c t i o n  a n d  C a r b o n  F l u x  
D i s t r i b u t i o n s .
3.1 Aims
The study described here, aims to assess how antibiotic biosynthesis and carbon flux 
distributions were affected by the presence o f an additional copy o f the actII-O R F4  gene (on 
the pIJ8714 plasmid) in S. co elico lo r  strains grown in batch culture. Differences in ACT 
production are explained by analysing the MFA data generated.
3.2 Introduction
Gramajo e t a l ,  (1993) and Bruheim et a l , (2002b) showed that ACT was produced 
precociously and at increased levels when additional copies o f the actII-O R F4  gene were 
introduced into S. co elico lo r  and S. lividans strains, respectively. This approach was 
implemented here, providing an excellent vehicle for studying metabolic fluxes in secondary 
metabolism (where fluxes are normally low in comparison to primary metabolism and, 
consequently mathematically insignificant). This approach to strain construction also has 
significant generic potential for modifying commercially important Streptom yces and related 
strains for targeted specific over-expression o f characteristics conducive to optimum 
bioreactor performance.
3.3 Results and Discussion 
Main Findings
© The presence o f an additional copy o f the actII-O R F4  gene caused ACT production
kinetics to shift from a non-growth to a growth-associated profile. This was due to the 
constitutive expression o f the erm E * promoter to drive the additional copy o f actII-O RF4. 
® ACT production was found to be up to ten-fold increased in pIJ8714 strains compared to
their corresponding strain that lacked the additional copy o f the actll-O R F4  gene.
® The inclusion o f the pIJ8714 plasmid caused the carbon flux profile to change, e.g. a
reduction in the carbon flux through the initial PPP reaction. This corroborated EMA 
findings, where the highest ACT yields were predicted to occur when no PPP activity 
occurred, allowing more carbon to flow through the glycolytic pathway to generate the 
carbon ACT precursor, acetyl-CoA.
© The Xgiy:Xppp ratio (ratio o f the carbon fluxes at the glucose-6-phosphate branch-point)
was found to be increased in all pIJ8714 strains and became increasingly flexible as the 
growth rate decreased, coinciding with an increase in ACT production.
© The XanaiXpyr ratio (ratio o f the carbon fluxes at the phosphoenolpyruvate branch-point/
anaplerotic reaction) was lower in all pIJ8714 strains, allowing more carbon to continue 
through the glycolytic pathway to generate pyruvate (and subsequently acetyl-CoA).
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3.3.1 Effect of the pIJ8714 Insert on Growth Dynamics and Antibiotic Production
Figure 3.1 displays the time course for both biomass and ACT production in two associated 
S. co elico lo r  strains, M510 and M510pIJ8714.
time (hours) 14,1,16 (hours)
Figure 3.1: Biomass and ACT production profiles for Y. coelicolor (A) M510 and (B) M510plJ8714 in 
batch culture.
Actinorhodin synthesis in S. co elico lo r  M510 followed typical secondary metabolite 
production kinetics, the maximum rate o f antibiotic production occurring after maximum rate 
o f biomass accretion (Figure 3.1 A). The insertion of the p IJ8714 construct into the 
chromosome resulted in growth-associated actinorhodin production kinetics with an enhanced 
yield o f the antibiotic (Figure 3. IB). These observations are consistent with reports describing 
so-called precocious antibiotic production, arising from the use o f the constitutive erm E * 
promoter (Bibb et al., 1985) to drive the pathway-specific activator gene actIl-O R F4 , and 
enhanced yield as a result o f an extra copy o f the actll-O R F4  gene (Gramajo et al., 1993, 
Bruheim et al., 2002b).
3.3.2 Antibiotic Yields Obtained in Batch Culture
In order to compensate for differential biomass productivity between strains, specific ACT 
productivity was calculated. Improvements in volumetric ACT concentrations are not 
necessarily indicative that ACT production is enhanced, if  it is accompanied by increased 
biomass concentrations.
ACT/X (g/g) =  [ACT] peak (g/L) -  [ACT] initial (g/L)
[Biomass] peak (g/L) -  [Biomass] initiai (g/L)
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The above equation was used to determine the specific ACT production, the results from 
which are presented in Figure 3.2. Where the term ‘peak’ has been used, it refers to the 
highest concentration o f e.g. biomass or ACT attained from the entire cultivation, and ‘initial’ 
refers to the concentration o f that particular constituent at the start o f the batch culture. Peak 
values for both biomass and ACT concentration were used due to the secondary metabolite 
profile o f ACT production observed in the strains that lacked the pIJ8714 insertion. Peak ACT 
and biomass concentrations did not necessarily coincide at the same time/sample point, hence, 
the biomass concentration used to determine the specific ACT production could not be taken 
at the same time point where ACT production was at its peak.
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Figure 3.2: Specific ACT production values for the various strains grown in batch culture.
The different S. co elico lo r  pIJ8714 strains tested (Section 2.1) generated higher specific ACT 
production values than the corresponding strains that lacked the additional copy o f the actll-  
ORF4 gene (Figure 3.2). This was in accordance with findings published by Gramajo et al., 
(1993) and Bruheim et a l ,  (2002b). Strains M510pIJ8714, M 717pIJ8714 and M716pIJ8714 
generated specific ACT values that were 2-, 2- and 1.5-fold higher, respectively, than their 
corresponding strains that lacked the pIJ8714 insert. The most significant difference was 
observed in strain M719pIJ8714 which generated almost a ten-fold increase in ACT (per gram 
biomass) than strain M719 alone. The effect o f the individual gene deletions will be 
discussed in chapter 4.
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ACT yields were also determined which provide an assessment o f the efficiency o f the 
conversion o f substrate to antibiotic. The calculation for this is given in the equation below 
and the results are presented in Figure 3.3.
ACT/S (g/g) =  [ACT] Peak (g/L) -  [ACT] initial (g/L)
[Glucose] initial (g/L) -  [Glucose] at peak [ACT] (g/L)
c 0.04CO
to
-<■
*  A zwf
♦ AscbA
£  0.03 —>
CL
c + control
%  0.02
TS>o>
Coo , ♦ AdevB
c 
8 
1—
£  o
0 0.01 0.02 0.03 0.04
ACT concn (gggiucose1) in strain lacking plJ8714
Figure 3.3: ACT yields generated by the various strains grown in batch culture.
The ACT yields observed (Figure 3.3) correlated well with the specific ACT production data 
(Figure 3.2). Figure 3.3 shows how possessing an additional copy o f the actlI-O R F4  gene, 
caused the efficiency o f substrate conversion to antibiotic, to increase by approximately 2-, 2- 
and 3-fold in strains M510pIJ8714, M716pIJ8714 and M717pIJ8714, respectively, compared 
to the associated ‘control’ strains. The most significant difference was seen in strain 
M 719pIJ8714, which generated a twenty-fold increase in the ACT yield compared to its 
control strain, M719. The pIJ8714 plasmid used would therefore be highly beneficial for 
future secondary metabolite production studies, as the desired compound could be produced 
precociously (presumably due to the erm E * promoter) and at higher concentrations, without 
affecting the growth kinetics o f the organism.
The observations described above could be solely attributed to possessing the additional copy 
o f the actll-O R F4  gene (in the pIJ8714 strains) as strains with the empty-cassette vector, 
pLST9828, were tested in batch culture. These strains were found to generate ACT yields 
comparable to the strains that lacked the pIJ8714 insert. (Appendix B).
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3.3.3 Elementary Modes Analysis (EM A):
An elementary flux mode was defined as the minimal set o f enzymes not operating in 
conjunction with any others, which proceed in the ‘correct’ direction according to their 
thermodynamic feasibility (Schuster et a l ,  1999).
EMA was performed (using FluxAnalyzer) on the metabolic model used in this study, and all 
feasible route(s) through the network were identified. In this way, the routes by which the 
maximal product yield can be attained are highlighted. Fifteen elementary modes were 
identified after declaring the macromolecular components o f biomass as external metabolites, 
a technique used to reduce the number o f elementary modes identified (Dandekar et al., 
2003). O f these fifteen elementary modes, three involved the production o f ACT. These 
elementary modes are presented in Figure 3.4 and in Table 3.1.
Figure 3.4: The three elementary modes generated for all routes synthesising ACT. (A) EM5 shows ACT 
production without any PPP activity. (B) EM8 shows ACT production with both glycolytic and PPP 
activity (although the glycolytic pathway is not fully functional as there is a lack of Pfk activity), and (C) 
EM 10 which has a fully operational glycolytic and pentose phosphate pathway.
Table 3.1: The three elementary modes (and stoichiometries) generated by the FluxAnalyzer program for 
all routes generating ACT and the theoretical yields obtained for each of them.
E le m e n ta r y  M o d e Reaction Theoretical Max. Yield 
(molACT * iiioIglucose *)
5 8 Glucose + 6 NADPH = ACT + 16 C02 + 35 NADP 0.125
8 16 Glucose = ACT + 64 C02 + 35 NADH + 90 NADPH 0.0625
10 48 Glucose = 5 ACT + 128 C02 + 175 NADH + 66 NADPH 0.1042
It was interesting to see that the mode that yielded the most ACT (EM5), did not feature any 
PPP activity, and that ACT production required a net consum ption  o f NADPH. This was in 
accordance with the work presented by Bruheim et al. (2002a), which showed that the 
synthesis o f ACT consumed NADPH. These results suggested, therefore, that the most 
efficient way to produce ACT would be to have an inactive PPP. However, obtaining a strain 
with no PPP activity resulted in reduced amounts o f ACT, as was shown by studies using 
S. lividans Azwfl, Azwf2, A devB  strains (Butler et ah , 2002). This suggested that NADPH 
generated by the TCA cycle and/or transhydrogenase activity alone is not sufficient to support 
significant ACT production and that designing strains with an impaired PPP is most likely to 
be the optimal strategy for enhancing ACT synthesis.
By growing strains with gene deletions associated with the PPP in batch and chemostat 
cultures, the validity and conclusions made from such EM analysis could be experimentally 
verified.
3.3.4 Metabolic Flux Analysis
Explaining the differences in ACT yields generated between the pIJ8714 strains and their 
corresponding ‘control’ strains was attempted using metabolic flux analysis (MFA). The 
carbon flux distribution profiles for the different strains could be compared, highlighting 
reactions that appeared to have changed in the e.g. pIJ8714 strains compared to their 
associated ‘control’ strain.
All MFA values generated by the FluxAnalyzer program were normalised to the glucose 
uptake rate and all values presented are therefore percentages o f this flux rate (100%). This 
facilitates the direct comparison o f carbon fluxes between different strains and conditions. 
The carbon flux values shown for each reaction (in the following figures) is an average o f the 
MFA values generated for that particular step from all the time points sampled in that growth 
phase. The two different coloured values represent the carbon fluxes at either the exponential 
or stationary phase. A negative sign indicated that the reaction proceeded in the opposite 
direction to what was stated in the stoichiometric network (Appendix F).
By comparing the carbon flux distribution profiles from the different strains and growth 
conditions, pathways associated with conditions o f low/high ACT production could also be 
identified and used for future strain development.
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Figure 3.5: The carbon fluxes for the glycolytic, anaplerotic and pyruvate dehydrogenase-catalysed 
reactions in (A) M510 (AredD), (B) M510plJ8714 (AredD, actII-ORF4), (C) M717 (AredD, Azwfl) and (D) 
M717pIJ8714 (AredD, Azwfl, act!l-ORF4) strains at both the exponential and stationary phase.
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Figure 3.6: The carbon fluxes for the glycolytic, anaplerotic and pyruvate dehydrogenase-catalysed 
reactions in (A) M719 (AredD, AdevB), (B) M719pIJ8714 (Am/D, AdevB, actU-ORF4), (C) M716 (Am/D, 
AscbA) and (D) M716plJ8714 (AredD, AscbA, actII-ORF4) strains at both the exponential and stationary 
phase.
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In strains M 510pIJ8714 and M 717pIJ8714, a higher carbon flux through the initial glycolytic 
reaction was observed (at both growth phases) compared to M 510 and M717, respectively, 
(Figure 3.5). This was also true for strain M 719pIJ8714 at the stationary phase (Figure 3.6B). 
However, the opposite was found in the AscbA  strains at both growth phases. This 
discrepancy suggests that the pIJ8714 insertion was not solely responsible for the increase in 
the carbon flux through the initial glycolytic reaction and that the gene deletions themselves 
played an important part. This will be discussed further in chapter 4.
The carbon flux through the glycolytic reactions converting 3 -phosphoglycerate to pyruvate 
were higher in the majority o f pIJ8714 containing strains compared to their associated strains 
that lacked die insert. The inclusion o f an additional copy o f the actII-O R F4  gene forced the 
organism to produce greater levels o f ACT and hence presumably, in having increased fluxes 
through these reactions, more pyruvate could be generated. From this, the carbon ACT 
precursor, acetyl-CoA could be synthesised.
The carbon flux through the reaction catalysed by pyruvate dehydrogenase (pyruvate to 
acetyl-CoA) was elevated in the majority o f strains that featured the pIJ8714 insertion. The 
inclusion o f the additional copy o f the actll-O R F4  gene caused the strain to overproduce ACT 
and hence the carbon flux through this reaction supported this.
Anaplerotic metabolism replenishes TCA cycle substrates by conversion o f glycolytic 
intermediates. The only anaplerotic reaction considered here is the conversion from 
phosphoenolpyruvate to oxaloacetate. The carbon flux through this reaction in the majority of 
strains/conditions, was found to be reduced in the overproducing strains, allowing more 
pyruvate to be generated (and hence more o f the carbon ACT precursor) and is most likely to 
be an effect o f the pIJ8714 insert.
3.3.5 Flux-Split Node Analysis
In addition to comparing the carbon flux distribution profiles between strains and conditions,
the effect o f the pIJ8714 insertion could be assessed by analysing the carbon flux-split ratios
at specific branch-point nodes within the stoichiometric network. A node is defined as a
compound from which two or more branches converge/diverge. Branch point nodes can be
described as prin cipal nodes i f  the product yield responds to changes at this point. They can
be further subdivided according to whether they are rig id  or flex ib le . A  rigid principal node
will be one that does not alter greatly when other carbon fluxes change around it, and is
therefore, highly sensitive to regulation. A flexible principal node is one that will change if
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variations occur in the carbon fluxes surrounding it, thereby not limiting the product yield. 
For instance, Stephanopoulos and Vallino, (1991) demonstrated that the principal nodes, 
glucose-6-phosphate, Xgiy:X PPp, (where carbon can flow through either the glycolytic pathway 
or the PPP) and phosphoenolpyruvate, Xana:Xpyr, (where carbon can either continue through 
the glycolytic pathway or through the TCA cycle) control the flux of carbon towards the 
synthesis o f lysine in C orynebacterium  glutam icum . Analysing such flux nodes can identify 
the rigid points in the metabolism of specific microorganisms. Such knowledge is important 
when designing high production strains (Zhao and Lin, 2002).
The carbon flux-split ratios at both these nodes were calculated for all strains and growth 
phases tested in this study (Table 3.2). The X giy:XpPp ratio was determined by dividing the 
carbon flux generated for the glucose-6-phosphate to fmctose-6-phosphate reaction by the 
carbon flux obtained for the glucose-6-phosphate to 6-phosphoglucono-8-lactone reaction. 
The Xana'.Xpyr ratio was calculated by dividing the carbon flux value obtained for the 
phosphoenolpyruvate to oxaloacetate reaction by the carbon flux generated for the 
phosphoenolpyruvate to pyruvate reaction.
Table 3.2: Carbon flux-split ratios obtained for all strains grown in batch culture, at two principal nodes.
Strain Xgiy:XppP
Exponential
Xgly’Xppp
Stationary
Xana'Xpy,-
Exponential
Xjinn*Xpyr
Stationary
M510 5.77 9.42 0.55 0
M510pIJ8714 6.44 10.40 0.27 0
M717 2.42 3.54 7.68 2.33
M717pIJ8714 3.22 7.36 0.93 0.09
M719 6.70 10.87 1.19 1.51
M719pIJ8714 8.54 18.28 0.07 0.09
M716 7.59 26.36 0.22 0.19
M7I6pIJ8714 7.37 9.90 0.12 0
The Xgiy:XppP ratio was found to be higher in the majority o f pIJ8714 strains compared to their 
corresponding ‘controls’ at both growth phases. Having an additional copy o f the actlI-O R F4  
gene placed a greater demand for ACT production and hence the flux split ratios found at the 
glucose-6-phosphate node changed accordingly, allowing more carbon to flow through the 
glycolytic pathway in preference to the PPP. This is in accordance with the findings from 
EMA (Section 3.3.3) whereby EM5 (Figure 3.4A) was predicted to generate the highest ACT 
yield.
The difference in Xgiy:XPPp between associated strains, was greatest (for the majority of 
strains) at the stationary phase, indicating that this branch point flux node was most flexible at 
lower growth rates allowing more carbon to enter pathways that generate the intermediates 
required for secondary metabolism, hence more NADPH and ATP are available for ACT
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synthesis. During the exponential phase, it is vital that carbon is prioritised into generating the 
intermediates that are necessary for biomass production. It is understandable therefore, that 
this principal node was more rigid during the exponential growth phase. This is in agreement 
with previous studies in which S. lividans strains were found to produce antibiotics at lower 
growth rates (Avignone-Rossa et a l ,  2002). The presence of an additional copy o f the actll-  
ORF4 gene also appeared to enhance flexibility at this node and may, therefore, be a direct 
effect o f the pIJ8714 plasmid. Identifying such principal nodes can therefore be invaluable i f  
one is wishing to improve the production o f a particular compound. The phase/growth rate at 
which it will be produced at its maximum can be identified and exploited for example, in 
chemostat culture.
Another principal node identified was the phosphoenolpyruvate branch point. Analysing the 
results presented in Table 3.2, the X^rXpyr ratios were reduced in the pIJ8714 strains at both 
growth phases, implying that less activity was seen through the anaplerotic reaction in these 
strains. This allowed more carbon to continue through glycolysis to generate pyruvate, (and 
ultimately acetyl-CoA) and hence could be a direct effect o f the actII-O R F4  gene.
There were significant differences in both node ratios depending upon the strain and growth 
phase analysed, indicating that both nodes are flexible in the S. co e lico lo r  strains tested, 
accommodating to changes in cellular demands.
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At both growth phases, (with the exception o f the AscbA strains at the stationary phase) the 
overproducing strains had lower carbon fluxes through the initial PPP reaction compared to 
their associated strains that lacked the additional copy o f the actII-O R F4  gene (Figures 3.7 
and 3.8). This was accompanied by an increased carbon flux through the initial glycolytic 
step. The inclusion o f the pIJ8714 plasmid caused more ACT to be generated and hence more 
carbon entered the glycolytic pathway so as to generate the carbon ACT precursor, acetyl- 
CoA. This confirmed findings made by Avignone-Rossa et a l , (2002) in which it was shown 
that a negative correlation existed between PPP activity and ACT production in S. lividans. 
This reduction in the carbon flux value was also observed for the following PPP reaction, 
further evidence for the existence o f an inverse relationship between PPP activity and ACT 
production. Such findings corroborated the results from elementary modes analysis (Section 
3.3.3) whereby EM5 was predicted to generate the most ACT. ACT produced via this mode 
would have no carbon flowing through the PPP, allowing more carbon ultimately to generate 
acetyl-CoA.
The pIJ8714 strains (with the exception o f the AscbA strains) had increased, but negative, 
carbon fluxes through the two reversible transaldolase (tai) and transketolase (tkt) catalysed 
reactions at both growth phases (Figures 3.7 and 3.8). The carbon fluxes were found to be 
increasingly negative in the pIJ8714 strains (i.e. higher levels o f carbon entered the PPP from 
the glycolytic pathway). Perhaps the decreased carbon fluxes through the oxidative PPP 
reactions required an enhanced level o f  carbon to enter these reversible reactions in order that 
sufficient amounts o f e.g. ribulose-5-phosphate, were generated for biomass synthesis. It 
appeared that possessing the pIJ8714 plasmid had little effect on the carbon fluxes through the 
remaining reactions associated with the non-oxidative pentose phosphate pathway.
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Figure 3.9: The carbon flux distributions for the TCA cycle reactions in strains (A) M510, 
(B) M510pIJ8714, (C) M717, (D) M717pIJ8714, (E) M719, (F) M719pIJ8714, (G) M716 and 
(H) M716pIJ8714, at both the exponential and stationary phase.
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For the majority o f strains and growth phases, reduced carbon fluxes through the initial TCA 
cycle reaction (generating citrate from acetyl-CoA and oxaloacetate) were found in the 
pIJ8714 strains compared to their associated control strains (Figure 3.9). A decrease in the 
carbon flux would allow more acetyl-CoA to be available for ACT synthesis. However, this 
was not seen in all strains/conditions and hence cannot be highlighted as a reaction affected 
by an additional copy o f the actII-O R F4  gene.
For the majority o f strains, the carbon fluxes through the NADPH-generating TCA cycle 
reaction (isocitrate to a-ketoglutarate) were reduced in the pIJ8714 strains at both growth 
phases. This was unexpected, as NADPH is one o f the cofactors required for ACT synthesis. 
However, this is in accordance with studies carried out by Butler et a l , (2002), in which it 
was shown that ACT production was not limited by NADPH availability.
Conversely, carbon fluxes through the reaction generating the other required cofactor for ACT 
production, ATP (succinyl-CoA to succinate) were increased in the pIJ8714 strains in the 
majority of cases. However, this reaction is not the main source o f ATP and hence cannot be 
regarded as the main contributor for the enhanced levels o f ACT observed in the pIJ8714 
strains. Carbon fluxes through the remaining TCA cycle reactions appeared to be affected by 
the gene deletions themselves rather than the presence o f an additional copy o f the actll-  
ORF4 gene and hence will be discussed further in chapter 4.
3.3.6 Amino Acid Synthesis
The carbon fluxes towards the synthesis o f specific amino acids (Appendix G) were growth- 
phase and strain dependent, rather than being affected by the presence o f the actII-O R F4  gene 
itself. The effect of the individual gene deletions/growth rates upon such carbon fluxes will 
therefore be discussed in chapter 4.
3.3.7 Macromolecular Composition Analysis
The composition o f macromolecules within the biomass was determined in order to carry out 
MFA (Section 2.4.4). Many studies have used the macromolecular composition o f E. co li 
cells, (Ingraham et a l ,  1983), as the biomass composition for the microorganism they are 
investigating, for example, Kim et a l , (2004) with S. co elico lo r  strains. However, this study 
has shown that the biomass composition in S. co elico lo r  is not the same as was found in 
E. co li cells (Appendix C). Macromolecular analysis should therefore be carried out on each 
strain and condition tested in order to obtain the most accurate results.
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It was interesting to see that the inclusion o f an additional copy o f the actII-O R F4  gene 
caused the biomass composition to change (Appendix C). The protein content was lower in 
the pIJ8714 strains (compared to their associated ‘control’ strains) at both growth phases.
The biomass o f die pIJ8714 strains had an increased carbohydrate content at both growth 
phases, the reason for this is not understood. Interestingly, the lipid content o f the biomass in 
the pIJ8714 strains was less than the levels found in their corresponding ‘control’ strains, and 
to a larger extent at the stationary phase (where ACT production was greatest). ACT follows 
similar biosynthetic routes as lipid synthesis and hence both lipid and ACT synthesis compete 
for common precursors and cofactors (acetyl-CoA, ATP and NADPH). A lower lipid content 
in the biomass would allow more cofactors etc. to be available for ACT synthesis therefore.
3.3.8 Conclusion
The inclusion o f the pIJ8714 plasmid affected many aspects o f central metabolism in the 
strains tested in batch culture. MFA results showed that the overproducing strains (with the 
exception o f the AscbA  strains) had reduced carbon fluxes through the initial PPP reaction, 
coinciding with increased fluxes through the initial glycolytic reaction. This was in 
accordance with EMA findings (Section 3.3.3) whereby the highest ACT yields were 
predicted to occur in strains that had no PPP activity, all carbon would flow through the 
glycolytic pathway, generating more pyruvate (the precursor for acetyl-CoA). These results 
were in accordance therefore with findings made by Avignone-Rossa et al., (2002) where an 
inverse relationship between ACT production and PPP activity was identified. However, in 
order for ACT production to take place, some PPP activity is required as S. lividans A zw fl, 
Azwf2, AdevB strains were found to be unable to synthesise ACT.
Analysing the flux-split ratios (Table 3.2), it was observed that the majority o f the pIJ8714 
strains had elevated X gty:XPpp and decreased Xana:Xpyr ratios. It was also noted that the 
flexibility at the Xgiy:XPPp principal node was greatest at the lower growth rates i.e. stationary 
phase, where the requirements for the intermediates/cofactors that are required for growth 
were reduced and hence more NADPH/ATP etc. was available for ACT synthesis.
Analysing the flexibility status at such principal nodes is important when growing strains for 
particular products, i.e. antibiotics. The optimal growth rates can be deciphered and exploited 
in chemostat culture to generate maximal product yields.
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C h a p t e r  F o u r
T h e  E f f e c t  o f  P P P - A s s o c i a t e d  G e n e  
D e l e t i o n s  a n d  G r o w t h  R a t e ,  o n  A C T  
P r o d u c t i o n ,  C a r b o n  F l u x  
D i s t r i b u t i o n s  a n d  G e n e  E x p r e s s i o n .
4.1 Aims
The results presented here aim to show how deletions for PPP-associated genes affect 
metabolic flux distributions and actinorhodin yields in S. co elico lo r  strains grown in batch 
and chemostat cultures. The effect o f varying the growth rate on these parameters would also 
be analysed. Such changes would be explained by examining fluxome and transcriptome data.
4.2 Introduction
NADPH is an essential cofactor for the synthesis o f many antibiotics, the majority generated 
through specific reactions o f the pentose phosphate pathway (Bminenberg, 1983a). Two PPP 
enzymes, glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase, 
catalyse such NADPH-generating reactions in S. coelico lor.
Mutants lacking either one o f the two zw f genes (coding for glucose-6-phosphate 
dehydrogenase) in S. lividans strains were constructed to investigate the role o f the PPP in 
ACT production, (Butler ei a l ,  2002). Such deletions caused glucose-6-phosphate 
dehydrogenase activity to decrease by approximately 50% (compared to the parental strain) 
suggesting the two Zwf proteins are equivalent isoforms in S', lividans strains. It was expected 
that these zw f deletion strains would produce lower levels o f antibiotic due to the reduced 
NADPH generated as a result o f the mutation. However, ACT production was higher in both 
strains compared to the wild type.
The devB  gene codes for 6-phosphoglucono-8-lactonase, which has a high catalytic 
efficiency, converting the unstable compound 6-phosphoglucono-5-lactone to 6- 
phosphogluconate (Scopes, 1985). Butler et a l ,  (2002) observed that S. lividans strains 
lacking this gene overproduced actinorhodin. 6-phosphoglucono-8-lactonase is the only 
known protein to be catalytically involved in the hydrolysis o f 6-phosphoglucono-5-lactone 
(Miclet et a l ,  2001). The A devB  strain demonstrated growth kinetics comparable to the 
control, suggesting that the accumulation o f the allegedly toxic compound, 6- 
phosphoglucono-5-lactone (Scopes 1985), had no obvious adverse effects. Although the 
lactone can undergo spontaneous hydrolysis, the carbon fluxes through the proceeding PPP 
reactions would be lower in a AdevB  strain compared to the fluxes observed in a wild-type 
strain. The reaction catalysed by the devB  product does not generate any NADPH, and as the 
carbon flux through the initial PPP reaction was found to be unaffected by the deletion (Butler 
et a l ,  2002), the amount o f NADPH generated would not be reduced in A devB  strains. 
Therefore, the increase in ACT production seen in these strains was most likely due to a
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change in the carbon flux through the proceeding PPP reactions. A S. lividans strain featuring 
all three gene deletions (A zw fl, Azwf2, AdevB), was constructed but was found to generate 
significantly reduced levels o f ACT. This suggested that a certain level o f PPP activity is 
required for ACT synthesis in order that a minimal critical NADPH concentration is 
maintained (which is mainly supplied from the PPP).
Butler et a l., (2002) demonstrated that a reduction in oxidative PPP activity caused the 
production o f actinorhodin to increase and that ACT was not limited by the supply o f 
NADPH. Avignone-Rossa e t al. (2002), grew S. lividans strains (able to produce both 
actinorhodin and undecylprodigiosin) in chemostat culture, at a range o f dilution rates. 
Results showed that a negative correlation between the carbon flux through the PPP and 
antibiotic production existed. It was also observed that by varying the growth rate o f  the 
culture, and by using different carbon sources (glucose/gluconate), variations in carbon flux 
occurred through primary metabolic pathways. However, this negative correlation between 
antibiotic production and PPP activity was not observed for ail four o f the main antibiotics 
produced by S. co elico lo r, as Obanye et a l., (1996), discovered that a positive correlation 
existed between methylenomycin production and PPP activity (which may suggest that this 
inverse relationship is applicable only to polylcetides).
Batch cultures were used in this study to ‘characterise5 each strain and to investigate what 
effect an additional copy o f the actII-O R F4  gene has upon both ACT yields and carbon flux 
distribution profiles in different strains (as discussed in chapter three). However, comparing 
data generated from batch cultures can often be difficult, as the growth rate is not defined 
(although it is a good means by which strains are characterised and the performance o f the 
strain can be identified in a much shorter time-scale). It is a good strategy therefore, to grow 
strains in chemostat culture where defined growth rates can be established and maintained 
(see 1.7.3) making such a culture technique invaluable for MFA and microarray analysis 
(Piper et a l ,  2002, Boer et a l ,  2003, Daran-Lapujade et al., 2004). The effect o f a specific 
gene deletion can be analysed, and any changes observed can be accredited to the gene 
deletion itself and not to differences in die growth rate.
Secondary metabolite production has been shown to occur once the growth rate o f a culture
decreases, for example, erythromycin production in S accharopolyspora erythraea  cultures
(Bushell et a l , 1997). Although these metabolites play a role in the life cycle o f an organism,
they are not essential for growth (unlike primary metabolites). A decrease in the growth rate
elicits the stringent response through an accumulation o f uncharged tRNA and ppGpp
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synthesis (see 1.3.1). Kang et al., (1998) demonstrated that ACT production was inversely 
proportional to the growth rate in S. co e lico lo r  strains, regardless o f the nutrient limitation. 
This was also in accordance with studies carried out by Avignone-Rossa et al. (2002) 
whereby S. lividans strains were used. At zero growth rates, 14% o f the glucose consumed 
was converted into ACT, whereas at O.lh' 1 this value decreased to 0.6%. Carbon fluxes 
through primary metabolic reactions, in addition to ACT production, were found to change 
with variations in the growth rate.
4.3 Results and Discussion
Main Findings
® Azwfl/Azw/2 strains generated higher ACT yields compared to the control in batch
culture, whereas AdevB  strains generated lower ACT yields.
• ACT production negatively correlated with an increasing growth rate in both Azw f strains. 
At lower growth rates the glucose-6-phosphate principal node was more flexible, allowing 
more NADPH (generated from the PPP) to be used for ACT production in preference to 
generating biomass.
• MFA data indicated that carbon flux values through the initial PPP reaction were 
increased in both Azw f strains compared to the control strain, in both batch and chemostat 
culture. This was confirmed by in vitro enzyme analysis and data derived from microarray 
studies.
© The transcription o f the majority o f genes associated with central metabolism did not
correlate with either growth rate, ACT production or with the carbon fluxes generated for 
the corresponding reactions, suggesting that many factors influence protein synthesis in 
such systems.
® Microarray and correlation analysis identified genes that were up/down-regulated and
reactions that were associated with high ACT production, respectively, and hence may 
highlight good candidates for future metabolic engineering studies to enhance ACT 
synthesis.
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4.3.1. Batch Culture Results
Strains with deletions for genes associated with the pentose phosphate pathway (some of 
which included an additional copy of the act!l-O R F4  gene) were grown in batch culture and 
ACT yields were calculated (Section 3.3.2).
The specific ACT production (ACT/X) for each strain is presented in figure 4.1.
Figure 4.1: Specific ACT production (ACT/X) for all strains grown in batch culture. The red dashed line 
indicates the specific ACT production generated by the corresponding control strains, M510 and 
M510plJ8714 for strains lacking or possessing the additional copy of the actII-ORF4 gene, respectively.
Analysing the results obtained for the strains that lacked the pIJ8714 insertion, it was 
observed that strain M717 generated higher specific ACT concentrations than strains M510 
and M719. Strain M719 produced reduced specific ACT production levels compared to the 
control. This was not in accordance with the work of Butler et al., (2002) in which S. lividans 
AdevB strains produced more ACT than the control. The fact that different Streptom yces 
species were used may be the explanation for the discrepancy seen. It has been shown 
(Dekleva and Strohl, 1988) that in S. lividans strains, the reaction proceeding the devB  
catalysed reaction, does not generate NADPH. Experiments carried out in this study have 
shown that this is not applicable to S. co elico lo r  strains (Table 4.1). In S. lividans strains, a 
deletion in the devB  gene would not alter NADPH production therefore, although presumably 
the carbon flux through the proceeding PPP reactions would be lower.
M717pIJ8714 and M720pIJ7814 generated the highest specific ACT production values (of 
identical levels) and both strains featured the rwfl gene deletion. This implied that no
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synergistic effect on specific ACT production (from Azw fl and AscbA) was observed in strain 
M720pIJ8714.
Strain M 718pIJ8714 was found to generate higher specific ACT concentrations than the 
control, M510pIJ8714. ACT production in this strain was comparable to the amount made by 
the other Azw f strain. The results seen for the two A zw f strains are in accordance with studies 
earned out by Butler et a l., (2002) in S. lividans.
M719pIJ8714 generated less ACT than the control strain (as did its associated strain, M719), 
and was the only mutant strain tested to do so. This was not in accordance with studies carried 
out by Butler et al., (2002) as has been stated previously. However, the presence o f an 
additional copy o f the actII-O R F4  gene did cause ACT production to be higher in 
M719pIJ8714 than in strain M719, but was still reduced compared to M510pIJ8714, 
suggesting that possessing a devB  gene deletion causes a deleterious effect on ACT 
production in S. co elico lo r  strains.
All mutant pIJ8714 strains, with the exception o f M719pIJ8714, produced similar specific 
ACT production values regardless o f their genotype (Figure 4.1). This may be indicative that 
the inclusion of an additional copy o f the actII-O R F4  gene caused a ‘saturation effect’ . As a 
result, the effect o f the individual gene deletions on ACT production was ‘masked’ in such 
over-producing strains and hence why larger differences in specific ACT production 
(compared to the control) were observed in strains that lacked the pIJ8714 insertion.
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T h e  A C T  y i e l d s  o b t a i n e d  f o r  e a c h  s t r a i n ,  g r o w n  i n  b a t c h  c u l t u r e ,  a r e  p r e s e n t e d  i n  f i g u r e  4 . 2 .
Figure 4.2: The ACT yields generated (ACT/S) for all strains tested in batch culture. The red dashed line 
indicates the ACT yield generated by the corresponding control strains, M510 and M5I0pIJ8714 for 
strains lacking or possessing the additional copy of the actll-ORF4 gene, respectively.
As with the specific ACT values, all strains featuring a deletion for either one o f the two zw f 
genes generated higher ACT yields compared to the corresponding control. The AdevB strains 
were once again found to generate reduced ACT yields compared to the control strains (this 
included strain M719pIJ8714, which featured an additional copy o f the actII-O R F4  gene). 
The reasons for all these observations will be explained subsequently by analysing both the 
distributions o f metabolic fluxes and transcriptomic data.
Biomass yields (Appendix B) obtained for each strain were of similar values, suggesting that 
the cells’ physiology (despite the specific gene deletions) acted to prioritise biomass 
production.
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4.3.2 Metabolic Flux Analysis for Strains Grown in Batch Culture
Data obtained from MFA was used to explain the differences in ACT yields observed for the 
various strains grown in batch culture. Only carbon flux distributions from the exponential 
and stationary phase were analysed due to the transient nature o f the lag phase.
Figure 4.3 presents a schematic diagram of the carbon flux distributions through the 
glycolytic pathway, the anaplerotic reaction and the step catalysed by pyruvate 
dehydrogenase. ACT yields generated at each growth phase were used as an indication to how 
much ACT was generated by a particular strain under a specific condition.
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Figure 4.3: The carbon flux distribution profile for the glycolytic, anaplerotic and ACT synthetic 
pathways in strains M510, M717 and M719 at the (A) exponential and (B) stationary phase. Carbon fluxes 
for strains M510pIJ8714, M717pIJ8714, M718pIJ8714, M719plJ8714, M716pIJ87l4 and M720pIJ8714 at 
the (C) exponential and (D) stationary phases are also presented.
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During the exponential and stationary phase, the carbon flux through the initial glycolytic 
reaction was reduced in strains with a deletion for either one of the two zw f genes 
(Figure 4.3), coinciding with an increased carbon flux through the initial PPP reaction (Figure 
4.4). The reason for this will be discussed in a subsequent section. Conversely, the carbon flux 
through the initial glycolytic reaction was elevated in the AdevB strains (for the majority o f 
cases), coinciding with decreased carbon fluxes through the initial PPP reaction (Figure 4.4). 
Surprisingly, these findings suggested that ACT yields negatively correlated with the carbon 
flux through this glycolytic reaction.
The carbon fluxes through the 3-phosphoglycerate to 2-phosphoglycerate reaction were 
reduced in strain M717 compared to strain M 510 but were elevated in the overproducing 
M 717pIJ8714/M 718pIJ8714 strains. It appeared that the pIJ8714 insertion caused more 
carbon to enter glycolysis, generating more pyruvate (and subsequently acetyl-Co A) in strain 
M 717pIJ8714 compared to strain M 717 alone. Strains M 717pIJ8714 and M 718pIJ8714 had 
decreased carbon fluxes through the reactions that generate cysteine and serine (derived from 
3-phosphoglycerate) and hence is another possible explanation for the elevated carbon fluxes 
through this reaction. This trend was also observed for the subsequent two reactions 
converting 2-phosphoglycerate to pyruvate. Carbon fluxes through the 3-phosphoglycerate to 
2-phosphoglycerate reaction were decreased in all AdevB strains at both growth phases. The 
reason for this is unknown but may be another contributing factor to the reduced levels o f 
ACT generated by these strains compared to the control.
Interestingly, the carbon fluxes through the reaction generating the carbon ACT precursor, 
acetyl-CoA from pyruvate, were reduced in strains M717 and M719 compared to the control. 
Flowever, this was not observed in the overproducing strains, where the majority o f strains 
had elevated carbon fluxes through the reaction at both growth phases, and hence positively 
correlated with the ACT yields generated. The reason for this discrepancy must be due to the 
presence o f an additional copy o f the actlI-O R F4  gene. An increase in the carbon flux through 
this reaction was required in order to support the increase in ACT production that ensued from 
the insertion.
For the majority o f growth phases, a deletion in any o f the PPP-associated genes caused an 
elevation in the carbon flux through the phosphoenolpyruvate to oxaloacetate reaction (an 
anaplerotic reaction) compared to the control strain. This was not the case for strains that
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possessed the scbA  gene deletion, where a reduction in the carbon flux through this 
anaplerotic reaction was observed (even in M720pIJ8714, which featured a z w f I  deletion).
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Analysing the data shown in figure 4.4, it was observed that strains featuring deletions for 
either one o f the two zw/genes had elevated carbon fluxes through all oxidative-PPP reactions 
in the majority o f circumstances. However, Butler et a l.t (2002) assessed glucose-6-phosphate 
dehydrogenase activity (in vitt'o) in S. lividans strains and found a 50% reduction in activity 
(compared to that seen in the control strain). The discrepancy observed between the results 
presented here and those o f Butler et al. (2002) is most likely due to S. lividans strains being 
used instead o f S. co elico lo r. It has been shown (Deldeva and Strohl, 1988) that S. lividans 
strains only produce one NADPH molecule from the PPP, as 6-phosphogluconate 
dehydrogenase in S. lividans uses NAD+ in preference to NADP+.
In order to elucidate whether the two oxidative PPP reactions (catalysed by glucose-6- 
phosphate dehydrogenase and 6-phosphogluconate dehydrogenase) used NADP+ as a cofactor 
in S. co elico lo r  strains (to generate NADPH), both NAD+ and NADP+ were added to cell free 
extracts obtained from steady state S. co e lico lo r  cultures. The specific activities from which 
were compared and the results are presented in table 4.1 (changes in absorbance are presented 
in Appendix D).
Table 4.1: The specific enzyme activity for two PPP enzymes ia S. cvatkahr strains grown at the same 
growth rate in chemostat culture, using either NAD+ or MADP+ as the cofactor.
Enzyine/Cofator Specific Activity 
(pinoi.min+nig protein"1)
Glucose-6-phosphate 
dehydrogenase/ NAD+
3.80
Glucose-6-phospbate 
dehydrogenase/ NADP+
38.16
6-Phosphogluconate 
dehydrogenase/ NAD+
3.90
6-Phosphogluconate 
dehydrogenase/ NADP+
18.00
As can be seen from table 4.1, the two PPP-associated enzymes in S. co e lico lo r  use NADP+ in 
preference to NAD+, hence two NADPH molecules are generated from the oxidative PPP. It 
appears that distinct differences in NADPH production exist between the two Streptom yces 
species, perhaps explaining the discrepancies observed in ACT yields.
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It appeared that the two zw f genes acted with each other to regulate the biosynthesis and 
activity o f its product, glucose-6-phosphate dehydrogenase. When one o f the two genes was 
deleted, the presumed negative control over the remaining gene was eliminated, perhaps 
inducing overexpression o f the remaining gene, causing the observed increase in glucose-6- 
phosphate dehydrogenase activity. This, however, is merely speculative and further 
experiments would be required to test this hypothesis.
Strains with either one o f the two z w f genes deleted were found to have reduced carbon fluxes 
through both reversible reactions that link the non-oxidative PPP with the glycolytic pathway 
(at both growth phases). Less carbon entered the PPP from the glycolytic pathway as a result, 
allowing more carbon to progress through glycolysis to eventually generate the carbon ACT 
precursor. It is possible that the increase in carbon flux through the oxidative PPP meant that 
less carbon was required to enter such non-oxidative reactions to generate e.g. ribulose-5- 
phosphate.
Strains featuring the devB  gene deletion had reduced carbon fluxes through the initial PPP 
reaction compared to their corresponding control strain. This may have been caused by an 
accumulation o f 6-phosphoglucono-S-lactone (due to the absence o f 6-phosphoglucono-8- 
lactonase) which could have caused an inhibitory effect on glucose-6-phosphate 
dehydrogenase activity. Hence a reduction in the carbon flux through both NADPH- 
generating reactions in the A devB  strains had detrimental effects on ACT synthesis. 
Additionally, the majority o f non-oxidative PPP reactions had elevated carbon fluxes at both 
growth phases. This included the reversible reactions linking the non-oxidative PPP with the 
glycolytic pathway. It appeared that in having a deletion for the devB  gene, more carbon 
entered the PPP from the glycolytic pathway, generating less o f the carbon ACT precursor. 
This is perhaps another explanation for the reduction in ACT synthesis observed in these 
strains. The elevated carbon fluxes through the non-oxidative PPP reactions could be due to 
the reduced oxidative-PPP activity. In these A devB  strains, no ribulose-5-phosphate is 
generated and hence an increase in the carbon flux through non-oxidative PPP reactions is 
required so as to supply the necessary levels o f such PPP intermediates required for growth.
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4.3.3 Flux-Split Nodes Analysis
As described in section 3.3.4, analysing the flux-split ratios at the principal nodes can help to 
explain how gene deletions and growth conditions affect the carbon flux distribution profile 
within a strain.
The flux-split ratios at the principal nodes, glucose-6-phosphate and phosphoenolpyruvate 
were studied. These are considered to be principal nodes because they link major biochemical 
routes. At the glucose-6-phosphate node, carbon can either proceed through the glycolytic 
pathway or enter the pentose phosphate pathway, and at the phosphoenolpyruvate node, 
carbon can either enter the anaplerotic reaction or continue through the glycolytic pathway to 
generate pyruvate. The carbon flux ratios at these nodes for strains M510, M717 and M 719 in 
batch culture are presented in table 4.2.
Table 4.2: Flux-split ratios at the gIucose-6-phosphate node (Xgjy:XPpp) and at the phosphoenolpyruvate 
node (Xana.Xpyr) for strains M510, M717 and M719 grown in batch culture, (gly = glycolysis, PPP = pentose 
phosphate pathway, ana = anaplerotic, pyr = pyruvate).
Strain Phase Xg.y XpP1, Xg|y;Xppp X anJ| X pJT Xana;Xpj-r
M510 
(A redD)
Exponential 70.40 12.21 5.77 11.27 20.61 0.55
Stationary 70.30 7.46 9.42 0 41.11 0
M717
(Azwfl)
Exponential 64.71 26.69 2.42 9.21 1.198 7.69
Stationary 67.92 19.20 3.54 11.56 4.97 2.33
M719
(AdevB)
Exponential 77.06 11.51 6.70 15.94 13.43 1.187
Stationary 76.69 7.06 10.86 3.84 2.55 1.51
The X giy:Xppp (flux-split ratio at the glucose-6-phosphate node) ratio in strain M717 decreased 
2.4- and 2.7-fold at the exponential and stationary phase, respectively, compared to the 
control strain. This reduction was most likely due to the Azw fl (which caused an increase in 
PPP activity and therefore a decrease in carbon flux through the initial glycolytic reaction). 
Strain M719 generated reduced ACT levels and was found to have a 1.16- and 1.15-fold 
increase in this ratio at the exponential and stationary phase, respectively, compared to the 
control strain. The carbon fluxes through the oxidative PPP reactions were reduced in strain 
M719 at both growth phases and hence the increase in this ratio. A decrease in this X giy:Xppp 
ratio was therefore associated with higher ACT yields and vice versa. These findings were not 
in accordance with EMA results (Section 3.3.3), which predicted ACT production would be 
highest in strains whereby no PPP activity occurred.
The Xana:Xpyr (the flux-split ratio at the phosphoenolpyruvate node) ratio in strain M717 
increased 14- and 2 .3-fold compared to the control strain at the exponential and stationary
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phase, respectively. A 2.2 and 1.5-fold increase in this ratio was also observed in strain M719, 
at the two growth phases. The Xana^ Xpyr ratio was highest at the exponential phase in both 
strains, suggesting that more oxaloacetate was required at higher growth rates e.g. for the 
synthesis of specific amino acids (e.g. aspartate and asparagine). This generated less pyruvate 
(and ultimately, acetyl-CoA) and possibly another explanation as to why a reduction in ACT 
production was observed in both strains at the exponential phase, compared to the stationary 
phase.
The carbon flux-split ratios at the two principal nodes for all pIJ8714 strains grown in batch 
culture are presented in table 4.3.
Table 4.3: Flux-split ratios at the giucose-6-phosphate node (Xgiy!XPpp) and at the phosphoenolpyruvate 
node (Xana:Xpyr) for all strains featuring the pIJ8714 insertion grown in batch culture, (gly = glycolysis, 
PPP = pentose phosphate pathway, ana = anaplerotic, pyr = pyruvate).
Strain Phase g^iy Xppp Xgiy:Xppp Xina x pyr Y Ya^nar^ pyr
M510pIJ8714 
(A redD)
Exponential 72.60 11.28 6.44 12.94 10.00 1.29
Stationary 74.57 7.17 10.40 0.606 9.73 0.062
M717pIJ8714 
(Azwfl)
Exponential 66.42 20.60 3.22 18.48 19,80 0.933
Stationary 74.02 10.06 7.36 2.04 22.44 0.091
M718pIJ8714 
(Azwfl)
Exponential 65.51 21.48 3.05 34.50 15.13 2.28
Stationary 72.08 5.99 12.03 3.96 12.74 0.31
M719pIJ8714 
(A devB)
Exponential 71.88 8.42 8.54 1.66 22.20 0.075
Stationary 81.16 4.44 18.30 0.91 9.66 0.094
M716pIJ8714
(AscbA)
Exponential 72.78 9.88 7.37 2.86 23.72 0.121
Stationary 69.91 7.06 9.90 0 35.9 0
M720pIJ8714 
(AzwfJ, AscbA)
Exponential 69.29 15.70 4.41 1.74 19.70 0.088
Stationary 71.77 15.40 4.66 0 0.057 0
Analysing the ratios at the exponential phase, a 2-fold d ecrease  was seen in the X giy:Xppp ratio 
for both M 717pIJ8714 and M 718pIJ8714, compared to the control strain. A 1.5-fold reduction 
in this ratio was observed in the other Azw f strain, M720pIJ8714. However, strains not 
featuring the zw f gene deletion (M 719pIJ8714 and M 716pIJ8714), had a 1.3- and 1.14-fold 
in crease  in this ratio. The decrease in this ratio was most likely due therefore to the deletion 
in either one o f the two z w f genes, (as these strains had increased carbon fluxes through the 
initial PP pathway). At the stationary phase, strains M717pIJ8714, M716pIJ8714 and 
M720pIJ8714 had a 1.4-, 1.1- and 2.2-fold d ecrease , respectively in the X giy:Xppp ratio 
compared to the control strain. However, strains M 718pIJ8714 and M 719pIJ8714 had a 1.2- 
and 1 .8-fold in crease.
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As was shown in the strains lacking the pIJ8714 insertion, the X giy:Xppp ratio was elevated at 
the stationary phase compared to the exponential phase, indicating that this node was found to 
be more flexible at the lower growth rates (where ACT yields were highest).
This indicated that strains prioritised NADPH for biomass production at higher growth rates. 
At lower growth rates, the competition for NADPH is reduced and hence more is available for 
ACT synthesis.
At the exponential phase, strains M717 and M 719 had increased Xaila:Xpyi ratios compared to 
the control strain. However, this was not seen for the majority o f pIJ8714 strains. A decrease 
in this ratio by 1.4-, 17-, 11- and 15-fold in M 717pIJ8714, M719pIJ8714, M 716pIJ8714 and 
M 720pIJ8714 strains, respectively, was observed at the exponential phase which may be an 
effect o f the pIJ8714 inclusion.
The Xana:Xpyr ratio at the stationary phase was increased in strains M 717pIJ8714, 
M 718pIJ8714 and M 719pIJ8714 compared to the control strain by 1.5-, 5- and 1.5-fold, 
respectively. No anaplerotic activity was observed in the M 716pIJ8714 and M 720pIJ8714 
strains in this phase, suggesting it may be due to the presence o f the scbA  gene deletion. The 
exact reason for this however, is not understood.
It is difficult to compare such flux-split nodes in batch culture because although the same 
phases o f growth are compared, differences in the growth rate will occur which affects the 
results. In order to identify reactions that correlated with ACT synthesis, it was important that 
these strains were grown at defined growth rates. This was achieved using chemostat cultures 
(Section 4.3.4).
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At the exponential phase, the carbon fluxes through the majority o f TCA cycle reactions were 
increased in all strains (with the exception o f strain M719pIJ8714) compared to their 
corresponding control strains. Perhaps the zw fl, zw fl, devB  and scbA  gene deletions caused an 
increased requirement for TCA cycle intermediates and cofactors e.g. for amino acid 
synthesis. Carbon fluxes through the reactions that generate die cofactors required for ACT 
synthesis (ATP and NADPH) were elevated in all mutant strains at the exponential phase. 
These cofactors are also required to generate biomass precursors hence at higher growth rates 
the need for their synthesis is raised. Conversely, at the stationary phase, carbon fluxes 
through the majority o f reactions were reduced in strains M717pIJ8714 and M 718pIJ8714 
compared to M510pIJ8714.
Carbon fluxes towards the synthesis o f alanine and valine (derived from pyruvate) were 
reduced in strains M717 and M 719, at both growth phases compared to those fluxes in the 
control strain (see Appendix G). Interestingly however, the opposite was found in the 
overproducing pIJ8714 strains. This was unexpected as pyruvate is used to generate the 
carbon precursor for ACT and yet these pIJ8714 strains produced the highest levels o f ACT 
yields observed. However, at both growth phases, carbon fluxes towards leucine synthesis 
(also derived from pyruvate) were reduced in all Azw f and AdevB strains, with or without the 
pIJ8714 insertion. These above observations were in accordance with results obtained from 
chemostat cultures.
Carbon fluxes towards the synthesis o f serine, cysteine and glycine (derived from 3- 
phosphoglycerate) were elevated in both M 717 and M719 at both growth phases compared to 
fluxes observed in the control. This coincided with decreased carbon fluxes through the 3- 
phosphoglycerate to 2-phosphoglycerate glycolytic reaction. Carbon fluxes towards the 
synthesis of such amino acids in strains M717pIJ8714 and M 718pIJ8714 were reduced 
however and the carbon fluxes through the 3-phosphoglycerate to 2-phosphoglycerate 
reaction reflected this finding. As with the results obtained from chemostat culture, carbon 
fluxes towards glycine synthesis were reduced in these strains at both growth phases. Strain 
M 719pIJ8714 presented elevated carbon fluxes towards the synthesis o f all three amino acids 
and once again, this finding was accompanied by reduced carbon fluxes through the 3- 
phosphoglycerate to 2-phosphoglycerate reaction. These findings suggest therefore, that ACT 
synthesis appears to be inversely proportional to the carbon flux through the reactions that 
generate serine and cysteine.
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The majority o f carbon fluxes towards die synthesis o f phenylalanine, tyrosine and tryptophan 
(derived from erythrose-4-phosphate and phosphoenolpyruvate) were reduced in strains M 717 
and M719. M 717pIJ8714, M 718pIJ8714 and M719pIJ8714 had elevated carbon fluxes 
towards the synthesis o f these amino acids at the exponential phase, but reduced carbon fluxes 
at the stationary phase o f growth. This result was in accordance with findings observed from 
chemostat cultures. Perhaps the reduction in the synthesis o f these amino acids (at the 
stationary phase) allowed more phosphoenolpyruvate to be converted into pyruvate and 
hence, subsequently, acetyl-CoA. This therefore, could be another contributing factor as to 
why higher ACT yields were observed at lower growth rates (i.e. stationary phase).
4.3.4 Macromolecular Composition Analysis
Determining the macromolecular composition o f the biomass was required for MFA. The 
values obtained are presented in Appendix C.
Generally, it was observed that strains with deletions for PPP-associated genes had a lower 
protein content compared to the corresponding control strains, and that these levels were 
higher at the exponential phase (compared to the stationary phase). Protein synthesis requires 
metabolism to generate amino acids and hence at the exponential phase many glycolytic 
precursors and cofactors are involved in synthesising these building blocks. This could 
perhaps be another reason as to why more ACT was generated at lower growth rates.
The lipid component in the biomass o f the AzwfHAzwf2 strains was less prevalent compared 
to the control strains. This was also hue when strains were grown at lower growth rates (i.e. 
stationary phase). Lipid and ACT biosynthesis follow similar biosynthetic routes, competing 
for similar precursors. It was interesting to see, therefore, that the strains and condition that 
generated the most ACT were those with a lower biomass lipid content.
Determining and comparing the macromolecular composition o f cells is more accurate from 
cells grown in chemostat culture due to the transient nature o f batch cultures. Results from 
both types o f cultivation are presented in Appendix C.
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4.3.5 Chemostat Culture
Strains M717pIJ8714 and M718pIJ8714 were grown in chemostat culture, along with the 
control strain, M510pIJ8714 at growth rates o f 0.04h‘J, 0.06h"' and 0.081T1, allowing the 
carbon flux distribution profiles generated by each strain to be compared. Unlike batch 
cultures, the growth rate could therefore be maintained and growth-related effects could be 
eliminated, allowing for more reliable results.
As with batch cultures, ACT yields were determined for each of the three strains at the three 
different growth rates tested (Section 3.3.2). The specific ACT production values generated 
by each strain is presented in figure 4.6.
0.04 0.06 0.08
G r o w t h  R a t e  ( h ‘ 1)
Figure 4.6: Specific ACT production for each strain and growth rate tested.
Specific ACT production in the control strain was directly proportional to the growth rate 
(although little variation was observed). The two Azwf strains generated the highest specific 
ACT values at 0.04h'* and this decreased in both strains as the growth rate increased. Strain 
M 718pIJ8714 at 0.061Y1 and 0.081T1 produced ACT levels that were comparable to the control 
strain. Strain M717pIJ8714 generated the highest specific ACT values compared to all other 
strains at every growth rate tested, which is in accordance with the results obtained from batch 
culture.
Comparing specific ACT production values generated in batch and chemostat cultures, it was 
observed that greater values were obtained when strains were grown in batch culture (Figures
4.1 and 4.6). Specific ACT production is calculated differently for the two culture techniques, 
hence the values generated are not comparable. For example, peak biomass and ACT 
concentrations may not necessarily coincide at the same time point in batch culture etc. and so
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different time points are used. However, in chemostat cultures, these two parameters are taken 
at the same point.
Figure 4.7 presents the ACT yield obtained for each strain at the three different growth rates.
0.04 0.06 0.08
G r o w t h  R a t e  ( h ' 1)
Figure 4.7: The ACT yields generated by each strain at the three different growth rates tested.
At 0.06h’' and 0.08h'\ the ACT yield was greatest in strain M717pIJ8714 (in accordance with 
batch culture results). However, strain M718pIJ8714 generated the highest ACT yield at 
0.04h'' compared to the other strains. M 510pIJ8714 produced similar ACT yields across all 
the growth rates tested, implying that ACT production was not affected by the growth rate in 
the control strain. This is probably due to the presence o f both zw f genes.
It was observed that when strain M 510pIJ8714 was grown in batch culture (Figure 4.2), ACT 
yields were higher than when it was grown in chemostat culture (Figure 4.7). However, the 
ACT yields generated by the two Azw f strains were comparable between the two different 
culture techniques. The differences in ACT production would be explained by analysing 
fluxome and transcriptome data.
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The carbon flux through the initial glycolytic reaction was reduced in all Azw f strains 
compared to the control strain at all growth rates, and was accompanied by elevated carbon 
fluxes through the initial PPP reaction. This observation was in accordance with batch culture 
results. Findings from EMA (Section 3.3.3) predicted that the highest ACT yields would be 
generated from strains with an inactive PPP, which was in accordance with findings made by 
Avignone-Rossa et a l., (2002). The overproducing strains (pIJ8714) grown in batch culture, 
had increased carbon fluxes through the initial glycolytic pathway, hence less NADPH was 
generated from the PPP, The introduction o f a zw f gene deletion (M 717pIJ8714 and 
M 718pIJ8714) inadvertently caused the carbon flux through the initial PPP reaction to 
increase, supplying the required NADPH, and hence could be a possible theory as to why 
more ACT was produced by these strains compared to M 510pIJ8714. The enhanced activity 
allowed more NADPH to be generated to fuel the high yielding elementary mode for ACT 
synthesis. This theory is further corroborated by the results from the A devB  strains. These 
strains were found to generate reduced ACT levels compared to the control strains and had 
decreased carbon fluxes through the initial PPP reaction. Hence, insufficient levels o f 
NADPH were generated to meet the demands from possessing an additional copy o f the a ctll-  
ORF4 gene, resulting in the observed reduced ACT levels.
Carbon fluxes through the majority o f reactions converting glyceraldehyde-3-phosphate to 
pyruvate were elevated in strains M 717pIJ8714 and M 718pIJ8714 at all three growth rates, 
which was in accordance with batch culture results. An explanation for this could be that 
having elevated carbon fluxes through oxidative PPP reactions caused less carbon to be 
required to enter the non-oxidative PPP reactions from the glycolytic pathway (via 
transketolases and transaldolases) allowing more carbon to progress through the following 
reactions (generating pyruvate). The carbon flux through the phosphoenolpyruvate to 
pyruvate reaction decreased as the growth rate increased in all three strains tested. This was in 
accordance with results published by Zhao and Lin (2002) in the closely related 
C orynebacterium  glutam icum . This reduction in carbon flux would allow less o f the precursor 
for acetyl-CoA synthesis to be generated.
The carbon flux through the reaction converting pyruvate to acetyl-CoA was elevated at the 
majority o f growth rates in the two Azw f strains compared to strain M 510pIJ8714. Having 
elevated carbon fluxes through the majority o f glycolytic fluxes in such strains allowed more 
pyruvate to be synthesised, and as a result, more acetyl-CoA.
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Both Azw f strains were found to have increased levels o f carbon through the reaction 
replenishing oxaloacetate from phosphoenolpyruvate (an anaplerotic reaction) at all growth 
rates tested. This was indicative that the Azw f strains required higher levels o f TCA cycle 
intermediates (e.g. for amino acids derived from oxaloacetate). This elevation in anaplerotic 
activity was also observed when these strains were grown in batch culture.
91

Higher carbon fluxes were observed through the oxidative PPP reactions in strains 
M717pIJ8714 and M718pIJ8714 compared to the control. In vitro enzyme activity 
measurements (Table 4.4) and gene transcription analysis (Figure 4.16) supported this 
finding.
Table 4.4: The specific enzyme activity (in vitro) for the PPP reactions generating NADPH, in all three 
strains grown in chemostat culture at three different growth rates.
Strain Specific Enzyme Activity: glucose-6-phosphnte 
dehydrogenase (pmol.min+mg protein1)
Specific Enzyme Activity: 6-phosphogluconatc 
dehydrogenase (pmoI.minTmg protein*1)
Growth rate (h'1) 0.04 0.06 0.08 0.04 0.06 0.08
M510pIJ8714 11.17 16.67 16.44 16.03 16.15 13.94
M717pIJ8714 20.16 25.49 32.88 19.11 13.38 18.90
M718pIJ8714 26.90 25.58 38.50 25.00 18.16 14.98
The glucose-6-phosphate dehydrogenase enzyme active in strain M717pIJ8714 was the 
product o f the zwf2 gene, (as the zw fl gene was deleted). The converse o f this was true for the 
M 718pIJ8714 strain, which presented the activity o f the zw fl gene product. The specific 
activity o f this enzyme in strain M 717pIJ8714 was lower than the activity observed in 
M 718pIJ8714 for the majority o f growth rates. Therefore, when a deletion in the zw fl gene 
was carried out (i.e. the M717pIJ8714 strain) less activity was measured (generating less 
NADPH) but more ACT was produced. Hence, although it has been speculated that the 
increase in ACT production in Azw f strains was due to the increase in NADPH generated from 
the PPP, these results show that there is a fine balance between how much NADPH is needed 
before ACT production appears to be inhibited by the cofactor.
For the majority o f non-oxidative PPP reactions, the Azw f strains had reduced carbon fluxes 
compared to the control strain. A possible explanation for this could be due to the elevated 
fluxes observed through the oxidative PPP reactions, resulting in a lower demand for carbon 
to enter these reactions to generate ribulose-5-phosphate. This allowed more carbon to flow 
through the glycolytic pathway and hence the elevated carbon fluxes seen in the Azw f strains. 
These findings were in accordance with those attained from growing the strains in batch 
culture.
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4,3.6 Flux-Split Nodes Analysis: Chemostat Culture
As in section 3.3.5, the flux-split ratios at the two principal nodes were calculated for all three 
strains grown at the three growth rates. The results from which are presented in Table 4.5.
Table 4.5: Flux-split ratios at the glucose-6-phosphate (Xgiy:Xppp) and phosphoenolpyruvate node 
(Xana.Xpyr) for all strains grown in chemostat culture at three different growth rates, (gly = glycolysis, 
PPP = pentose phosphate pathway, ana = anaplerotic, pyr -  pyruvate).
Strain Growth 
Rate (h1)
Xg|y Xa ppp Xgly: Xppp xana Xpyr Y Ya^nar^ pyr
M510plJ8714
0.04 73.77 5.00 14.75 2.51 16.97 0.148
0.06 78.29 6.13 12.77 9.14 11.73 0.78
0.08 77.13 6.73 11.46 11.27 10.03 1.12
M717pIJ8714
0.04 75.46 9.17 8.23 9.60 14.60 0.66
0.06 76.29 9.45 8.07 10.23 13.67 0.75
0.08 75.69 10.28 7.36 9.21 13.24 0,696
M718pIJ8714
0.04 71.74 8.84 8.12 3.29 20.13 0.163
0.06 76.30 9.06 8.42 9.87 12.99 0.76
0.08 75.96 10.49 7.24 15.94 12.82 1.24
It can be seen that as the growth rate increased, the X giy:Xppp ratio decreased in most cases, 
indicating that this node became increasingly rigid as the growth rate increased. This finding 
was also shown in batch culture experiments, (Tables 4.2 and 4.3), in which this node was 
more flexible at the stationary phase (which is analogous to the lower growth rates) compared 
to the exponential phase (which is synonymous with the higher growth rates). This allowed 
more carbon to enter the PPP (and less through the glycolytic pathway) as the growth rate 
increased in order to meet the increased demand for growth. Allowing such flexibility at the 
glucose-6-phosphate node is consistent with the notion that S. co elico lo r  prioritises NADPH 
production for growth, and that at lower growth rates, this NAPDH resource can be used for 
antibiotic production. These results are in accordance with studies carried out by Avignone- 
Rossa et al. (2002).
As with batch culture results (Tables 4.2 and 4.3), strains featuring either the Azwfl I A zw fl had 
reduced Xgiy:X PPp ratios compared to the control strain at all growth rates (ranging from a 1.5- 
to 1.8-fold decrease). Both A zw f strains had similar carbon flux split ratio values, suggesting 
that the carbon fluxes at this principal node were affected similarly by a deletion in either one 
o f the two z w f genes. These results were in agreement with those found from batch culture 
studies.
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It can be seen that generally, as the growth rate increased, the ratio at the X ana:Xpyr branch 
point also increased. The ratio was lowest at 0.04h'! in all strains tested suggesting that less 
anaplerotic activity was required, allowing more carbon to enter the phosphoenolpyruvate to 
pyruvate reaction (generating acetyl-CoA). The flexibility at this node became increasingly 
rigid as the growth rate decreased.
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Figure 4.10: The carbon flux distribution for the TCA cycle reactions for strains M5IOpIJ87l4 (in b l u e ) ,  
M7l7pIJ8714 (in p i n k )  and M718pIJ8714 (in g r e e n )  at growth rates (A) 0.04b'1, (B) 0.06b’1, (C) 0.08b'1.
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It was observed that strains M 717pIJ8714 and M718pIJ8714 had elevated carbon fluxes 
through the majority o f TCA cycle reactions, compared to the corresponding control strain at 
the three different growth rates. This included the reactions generating NADPH and ATP 
(with the exception of strain M 717pIJ8714 at 0.06b'1), that are required for e.g. ACT and 
amino acid synthesis.
Carbon fluxes towards the synthesis o f alanine and valine (derived from pyruvate) were 
elevated in both A zw f strains. However, they were found to have lower carbon fluxes towards 
the synthesis o f leucine (which is also derived from pyruvate). The reason for this observation 
is not understood but may be o f some physiological relevance, as it is in accordance with 
batch culture findings. The leuC  gene (SC 05553) product is an enzyme that participates in 
leucine biosynthesis. The transcript for this gene was down-regulated by more than two-fold 
in strain M 717pIJ8714 at O.OSh'1. A reduction in the transcription o f this gene would perhaps 
allow more pyruvate to be available for acetyl-CoA synthesis and ultimately for ACT 
production.
Carbon fluxes towards the synthesis o f amino acids derived from oxaloacetate (aspartate, 
asparagine, methionine, threonine) were generally elevated in the Azw f strains. These findings 
coincided with increased carbon fluxes through the anaplerotic reaction, which replenished 
oxaloacetate resources. The exception to this was isoleucine, where carbon fluxes were 
reduced in strains M717pIJ8714 and M 718pIJ8714 at 0.04h'! and O.O6I1' 1.
Carbon fluxes towards the synthesis o f serine and cysteine (derived from 3-phosphoglycerate) 
were reduced in both Azw f strains compared to the control strain at all growth rates tested and 
may explain why elevated carbon fluxes through specific glycolytic reactions were observed. 
However, carbon fluxes towards glycine synthesis were elevated in strains M717pIJ8714 and 
M718pIJ8714. These findings were in good agreement with those obtained from batch culture 
results.
Interestingly, amino acids derived from phosphoenolpyruvate and erythrose-4-phosphate 
(phenyalanine, tyrosine, tryptophan) had reduced carbon fluxes in the Azw f strains at 0.04b"1 
but at the two highest growth rates, the opposite o f this was found. This reflected the 
increased requirement for these amino acids at higher growth rates in strains M 717pIJ8714 
and M 718pIJ8714, and could perhaps be another contributing factor as to why more ACT was 
generated at lower growth rates. A reduced requirement for the synthesis o f these amino acids
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would allow more phosphoenolpyruvate to generate the carbon ACT precursor, acetyl-CoA. 
These results corroborated findings from batch culture results, whereby reduced carbon fluxes 
towards these amino acids were observed at the stationaiy phase (which is synonymous with 
the 0.041Y1 growth rate) and vice versa. To corroborate these findings, microarray results 
showed a more than two-fold decrease in the transcript level o f two genes (SCO 1547, 
SC 02147) that encode enzymes synthesising tryptophan, in the two strains that generated the 
highest ACT yields at 0.04h'\ Generally, the carbon fluxes towards tryptophan synthesis were 
also found to increase as the growth rate increased, where ACT levels were lowest in the Azw f 
strains. All these findings suggested that metabolic engineering around this pathway might 
enhance ACT production.
4,3,7 Correlation Analysis
Correlation analysis measures the relationship between two variables, by generating a 
correlation coefficient reflecting the degree to which these two parameters have a linear 
relationship (e.g. the carbon flux through a reaction and the ACT yield). The correlation 
coefficient (r) between two data sets (X  and Y ) is the ratio of the total sum of the deviations o f 
the two data sets and the total sum of the squared deviations o f the X  data set and the Y  data 
set, that is:
n
£  (Xi - X )( Yt - Y) 
i=l
r =  ------------------------------------------
n n
( £  (Xi - X )2 )( £  ( Yi - Y)2 ) 
i= l i=i
A correlation value o f 1.0 indicated a strong positive correlation with ACT production (e.g. 
high carbon flux coincides with high ACT production), whereas a value o f -1 .0  suggests a 
strongly negative correlating reaction (e.g. high carbon flux coincides with low ACT 
production). The results from which are presented in Appendix H.
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Table 4.6 presents the reactions that were found to have carbon fluxes that either positively or 
negatively correlated with ACT production in a ll three strains at a ll three growth rates.
Table 4.6: The correlation coefficients generated for reactions that were found to have either a positive or 
negative correlation with the ACT yields generated by all strains and growth rates tested.
Reaction M510pIJ8714 M717pIJ8714 M718pIJ8714
Fructose-6-phosphate = Fructose 1,6-bisphosphate 0.344 0.632 0.845
Pyruvate = Acetyl-CoA 0.977 0.826 0.965
R1B5P + XYL5P = GAP + SED7P 0.999 0.950 0.793
Glycine Synthesis 0.941 0.408 0.782
Ribulose-5-phosphate = Ribose-5-phosphate -0.895 -0.998 -0.649
Glutamate Synthesis -0.471 -0.862 -0.471
Tryptophan Synthesis -0.502 -0.931 -0.697
Glutamine Synthesis -0.690 -0.963 -0.164
The fact that carbon fluxes through the reactions presented in Table 4.6 either positively or 
negatively correlated with ACT synthesis in a ll strains and growth conditions, suggest that 
these would be ideal targets for future metabolic engineering studies to improve ACT 
production. As these results were found in all pIJ8714 strains, the association with ACT 
production may have been due to the presence o f the additional copy o f the actII-O R F4  gene, 
rather than due to the effect o f the zw f gene deletion itself, however. The negative correlation 
between carbon fluxes towards glutamate synthesis and ACT yields, was in accordance with 
findings made by Doull and Vining (1990), in S. co elico lo r  A3(2) strains, whereby high 
concentrations of glutamate were found to reduce ACT formation.
The way in which carbon fluxes through certain primary metabolic reactions correlated with 
ACT yields (i.e. either positively or negatively) appeared to be strain dependent as can be 
seen from Table 4.7. For example, specific oxidative-PPP reactions negatively correlated with 
ACT synthesis in the Azw f strains (but correlated positively with ACT in the control strain), 
whereas the opposite was observed for specific reactions o f the non-oxidative PPP. These 
changes highlighted how deletions in either zw f gene caused significant metabolic changes 
within the organism. Reactions leading to the synthesis o f specific amino acids are o f 
importance, particularly when designing media-feed strategies for the enhanced production of 
ACT. For example, in strains M 717pIJ8714 and M718pIJ8714, carbon fluxes towards serine 
and cysteine synthesis were found to negatively correlate with ACT yields, however, this was 
not observed in strain M 510pIJ8714 and hence these Azw f strains may perform differently in 
media supplemented with such amino acids. This reinforces the importance of metabolic flux 
analysis in metabolic engineering studies.
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Table 4.7: The different correlations obtained between carbon fluxes through specific reactions and ACT 
production in the control and the two zwf gene deletion strains. Reactions of the glycolytic pathway are 
shown in red, the PPP in blue, the TCA cycle in violet and those associated with amino acid synthesis in 
green. Positive (+) and negative (-) correlation between the carbon fluxes and ACT synthesis.
Reaction Correlation with ACT synthesis in 
M510pIJ8714
Correlation with ACT synthesis in 
both zwf deletion strains
Glucose-6-phosphate =  Fructose-6-phosphate + -
3-Phosphoglycerate =  2-Phosphoglycerate - +
Phosphoenolpyruvate =  Pyruvate - +
Glucose-6-phosphate =  6-Phosphoglucono-8-lactonate + -
6-Phosphoglucono-8-laetonate =  6-Phosphogluconate + -
Ribulose-5-phosphate = Xylulose-5-phosphate - +
ERY4P + XYL5P =  FRU6P + GAP - +
Acetyl-CoA =  Citrate + -
Citrate =  lsocitrate + -
Isocitrate =  a-Ketoglutarate + -
Phosphoserine Synthesis + -
Serine Synthesis + -
Cysteine Synthesis + -
Arginine Synthesis + -
Isoleucine Synthesis - +
Phenylalanine Synthesis - +
Alanine Synthesis + -
Histidine Synthesis * +
4.3.8 Macromolecular Composition Analysis
It was found (Appendix C) that the protein, RNA and lipid content o f the S. co elico lo r  cells 
tested in this study increased with an increase in growth rate, in both batch and chemostat 
culture. This was in accordance with studies carried out by Beste et a l. (2005), in which the 
closely related, M ycobacterium  bovis BCG, was studied. Lipid and polyketide synthesis 
follow similar biosynthetic routes, requiring acetyl-CoA, NADPH and ATP. Hence these two 
pathways compete for common precursors. It was interesting to see therefore, that the lipid 
content o f cells increased with the growth rate, coinciding with a decrease in ACT production. 
Carbohydrate synthesis requires glucose-6-phosphate and ATP, hence, a decrease in its 
production as the growth rate increased, allowed more glucose-6-phosphate to enter the PPP 
for biomass synthesis. The amount o f DNA within cells was similar for all strains and 
conditions tested, hence no correlation was found with either the growth rate or ACT 
synthesis. Shahab et a l., (1996) analysed the macromolecular composition o f Streptom yces 
co elico lo r  A3(2) grown over a range o f dilution rates and compared it to those reported for 
E scherich ia co li B/r. Similar trends were observed in the S. co elico lo r  A3(2) strains as those 
that have been reported here.
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4.3.9 M icroarray Analysis
In addition to assessing the effects o f gene deletions and growth dynamics by MFA, 
microarray analysis was carried out to compare the transcriptome o f strains grown at the 
same/different growth rates, as well as identifying other genes that were up/down-regulated 
under conditions of high/low ACT production. Studies (Daran-Lapujade et a l., 2004) have 
also examined how closely these two techniques correlate (Section 4.3.10). Comparing the 
transcriptome for specific genes across the different growth rates allowed genes that appeared 
to correlate with ACT synthesis, to be identified. All microarray data were normalised on a 
per spot (divided by control channel) and per chip (normalised to 50th percentile) basis using 
GeneSpring (Section 2.6.7). Raw data values are presented in Appendix J.
The initial glycolytic reaction (glucose-6-phosphate to fructose-6-phosphate) is catalysed by 
phosphoglucose isomerase, which is the product o f the p g i gene. In S. co elico lo r  there are two 
such genes, p g i and p g i2. The transcription profile for the p g i2 gene is shown in Figure 4.11.
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Figure 4.11: The transcription profile for the pgi2 gene for all strains grown at the three different growth 
rates. The product of this gene catalyses the initial reaction of the glycolytic pathway.
The transcription o f this gene was elevated in the two Azwf strains at 0.06b’1 and 0.08b'1, 
however, the converse o f this was true at the lowest growth rate. The transcription level o f 
this gene was similar for both Azw f strains at all growth rates, which suggested that the 
transcription o f this gene was affected equally by a deletion in either one o f the two z w f genes. 
It was also observed that the transcription o f the p g i2  gene had a positive correlation with the 
growth rate in the two Azw f strains. In most cases it also appeared that the p g i2 gene acted as 
a negative repressor for the production o f its product as in most examples, the carbon flux 
values for the reaction associated with this gene product were highest where its transcription 
level was lowest.
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The reaction converting 3-phosphoglycerate into 2-phosphoglycerate is catalysed by the 
phosphoglycerate mutase enzyme, the product o f two pgm  genes in S. coelico lor. The 
transcription profile for both genes is presented in Figure 4.12.
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Figure 4.12: The transcription profile for both phosphoglycerate mutase coding genes, (A) pgm and (B) 
pgm2, for all strains grown and growth rates.
The transcription level o f the pgm  gene was found to be raised in the two Azw f strains at 
0.04h‘1 and 0.08b"1. The converse o f this was true for the pgm 2  gene, where its transcription 
level was lowest in these strains at the majority o f growth rates. No correlation was found 
between the transcription of either of these genes and ACT production. MFA data obtained 
for the 3-phosphoglycerate to 2-phosphoglycerate reaction was not in agreement with the 
transcription profile for either pgm  gene. This may be due to the fact that two genes coded for 
the same enzyme, hence the MFA value obtained for that corresponding reaction was a 
combination o f the products generated by two different genes.
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Pyruvate kinase catalyses the reaction that converts phosphoenolpyruvate to pyruvate and is 
the product o f two genes in S. coelico lor, p y k l and pyk2, the transcription profiles o f which 
are presented in Figure 4.13.
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Figure 4.13: The transcription profile for the two pyk genes, (A) pykl and (B) pyk2 for all strains grown at 
three different growth rates. The product of this gene catalyses the phosphoenolpyruvate to pyruvate 
reaction, the final glycolytic reaction.
These two genes appeared to be co-regulated, in that an increase in the transcription level of 
one gene caused the transcription o f the other gene to be down-regulated. No correlation 
between the transcription o f these genes, with either ACT production or the MFA value 
corresponding to this reaction, was observed. The fact that there are two genes encoding the 
same enzyme may be the explanation (as was observed in the pgm  genes coding the 
phosphoglucomutase enzyme, for example). The transcription profile for both genes, in all 
strains tested was significantly increased compared to the ‘reference’ sample (S. co e lico lo r  
M l 45) which may be due to the inclusion o f the additional copy o f the actll-O R F4  gene. This 
could be explored further to engineer a strain that could, potentially, generate enhanced ACT 
concentrations.
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Pyruvate dehydrogenase catalyses the conversion from pyruvate to acetyl-CoA and is a 
product o f the pyruvate dehydrogenase gene cluster, a ceE l, aceE 2  and aceE 3. The 
transcription level for all three genes in all three strains is presented in Figure 4.14.
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Figure 4.14: The transcription profile for the (A) aceE l, (B) aceE2 and (C) aceE3 genes for all strains 
grown at three different growth rates. These genes form the pyruvate dehydrogenase complex that 
catalyses the conversion from pyruvate to acetyl-CoA.
No correlation was found between the MFA values generated for this reaction and the 
transcript levels for any o f the three a ceE  genes. The expression and regulation o f these genes 
has been shown to be very complex (Stryer, 1995) which may account for this lack of 
correlation in addition to the fact that more than one gene codes for the same enzyme. All 
three genes are located within the same operon, hence the transcription profile of these genes 
should show similar trends. The fact that this was not seen may be indicative that there are 
sensitivity problems with the microarrays used.
In S. co elico lo r, the SCO0582 gene encodes a protein that has similarities with the pdhR  gene 
found in E. coli. Its transcription in this study was found to negatively correlate with ACT 
production (Figure 4.15).
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In E. coli , the pyruvate dehydrogenase gene complex is negatively regulated by the p d h R  
gene, which belongs to the gwftf-family regulators. A homologue o f this gene was 
overexpressed in S t r e p t o m y c e s  s e o u l e n s i s and in S. lividans strains, in a study carried out by 
Youn et al, (2002). Results showed a significant reduction in the growth rate (in both strains 
overexpressing the p d h R  gene) in addition to a marked decrease in ACT production in 
S. lividans. The p d h R  gene regulates the expression o f the E lp  component in S. seoulensis. 
Hence, if  the p d h R  gene was down-regulated in S. lividans strains, repression o f the pyruvate 
dehydrogenase enzyme would be reduced, allowing more acetyl-CoA to be produced, and 
hence actinorhodin synthesis should also increase as a result. This theory was supported by 
the results from the microarray experiments generated in this study (Figure 4.15), where a 
negative correlation between the transcription o f this gene (that is homologous to the p d h R  
gene) and ACT production was found in all strains and growth rates tested.
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Figure 4.15: The transcription profile of the SCO0582 gene in three strains at the three different growth 
rates. This gene has similarities with the pdhR gene found in E. coli, which has repressive effects on 
pyruvate dehydrogenase synthesis.
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Glucose-6-phosphate dehydrogenase, is the product of the zwfl and zwfl genes in 
S. coelicolor. Only the zwfl transcription profile could be analysed as no primers had been 
selected for the zwfl gene on the microarray slide. Figure 4.16 presents the transcription 
profile for zwfl for all strains and growth rates tested.
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Figu re  4 .1 6 : T he tran scrip tion  profile for the zwfl gene for all strains and grow th rates tested. The  
p rod u ct o f this gene catalyses the initial reaction  of the pentose phosphate pathw ay.
It was observed that strain M717pIJ8714 showed transcription for zwfl despite having a 
deletion for it. The most likely explanation for this is cross-hybridisation. The zwfl and zwf2 
genes have an 85% amino acid sequence homology (Butler et al, 2002), hence what was most 
likely seen in strain M717pIJ8714 is the transcription level for zwfl. The transcription levels 
observed in strain M510pIJ8714 is therefore a combination of both the zwfl and zwfl genes.
The transcription level of the zwfl gene was elevated in strain M718pIJ8714 compared to the 
control strain at all growth rates tested (although to a lesser extent at the highest growth rate 
studied, 0.08h '). The transcription of what is believed to be the zwfl gene in strain 
M717pIJ8714, was also seen to be elevated compared to the control strain, at all growth rates 
tested. These findings were in accordance with results obtained from MFA and in vitro 
enzyme analysis studies (Table 4.4), and suggest that the increase in activity is derived at the 
transcription level.
The zwfl gene transcription profile in strain M510pIJ8714 had no correlation with either ACT 
production, growth rate or with the carbon flux values generated from MFA. This may be due 
to the presence of two zwf genes within the genome.
The zwfl gene transcription profile in strain M717pIJ8714 appeared to be positively 
associated with the growth rate and it correlated with the MFA values generated (hence
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negatively correlated with ACT synthesis). However, this was not the case with strain 
M718pIJ8714 in which the opposite was found. The discrepancy observed between these two 
strains suggests that both zwf genes play different roles and perhaps why different ACT yields 
were generated by these strains.
The transcript levels for the zwfl gene (i.e. those levels seen in strain M718pIJ8714) were 
highest at the lowest growth rates. The converse of this was true for the zwf2 gene (i.e. those 
seen in strain M717pIJ8714), whereby the transcript levels were highest at the higher growth 
rates. This may explain why a difference in the ACT yields were found between the two Azwf 
strains at 0.06b'1 and 0.08h_I. A deletion in the zwfl gene (that is transcribed at the highest 
growth rates) would have the largest impact at the highest growth rates, therefore, and hence 
why decreased levels of ACT were seen in strain M718pIJ8714 at 0.061Y1 and 0.08h_I. The 
zwfl gene is predominantly transcribed at the lower growth rates and hence why ACT 
production was greatest in M717pIJ8714 at 0.061Y1 and 0.08h_1 compared to those obtained in 
strain M718pIJ8714. Strain M510pIJ8714 had both zwf genes present and hence no such 
effects were seen, hence why ACT production was not affected by changes in the growth rate. 
Perhaps the zwfl and zwfl isoenzyme products are active at different stages of the 
developmental cycle. This may explain why the Azwfl strain generated reduced levels of ACT 
compared to the Azwfl strain at the higher growth rates. Perhaps it is more active at the part of 
the cycle concerned with vegetative growth rather than the sporulation phase where the 
growth rate is lower and where ACT production is believed to occur.
The second NADPH-generating PPP reaction is catalysed by 6-phosphogluconate 
dehydrogenase, which is encoded by three genes; zwf3, SC03877 and SC06658. The 
transcription profile zwfl is presented in Figure 4.17.
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Figu re 4 .1 7 : The tran scrip tion  profile for the zwf3 gene, the prod u ct o f w hich catalyses the second  
N A D PH -generating reaction  of the P P P .
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The transcription of this gene positively correlated with ACT production at 0.04h_1 and 
0.08b’1, which was in accordance with previous results whereby a positive correlation 
between ACT production and the carbon flux through this reaction was found. Additionally, 
the in vitro enzyme activity measured for the product of this gene (Table 4.4) correlated well 
with the transcription profile presented here.
The succinyl-CoA to succinate reaction generates ATP and is catalysed by the product of four 
genes in S. coelicolor, sucC, sucD, SC06585 and SC06586, the transcription of two of these 
genes is given in Figure 4.18.
M510pU8714 
M717pU87l4 
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Figu re 4 .1 8 : The tran scrip tion  profile for (A ) sucD  and (B ) S C 0 6 5 8 5  for all strains and grow th rates  
tested. T h e p rod u ct of both genes catalyses the reaction  converting succinyl-C oA  to succinate, generating  
A T P.
The transcript level for sucD and SC06585 were highest in the two Azwf strains at 0.041Y1 
compared to the control strain. At the two highest growth rates, the strain generating the most 
ACT, M717pIJ8714, had the highest transcription value for both genes. This reaction 
generates ATP that is required for ACT synthesis (amongst other processes) and hence this 
reaction may be of some importance for ACT production. The MFA values generated for this 
reaction did not correlate with the transcription of either gene and is most likely due to the 
presence of four genes encoding the same enzyme.
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108
When analysing the transcriptome of strains with the aim of identifying genes that appear to 
correlate with ACT synthesis, it was logical to investigate the transcript profiles of genes 
associated with ACT production itself. The figures presented below show some important 
examples.
The act I gene cluster is comprised of three genes, actl-l, act1-2, and actl-3, the transcription 
profiles for which are given in Figure 4.19.
The products of these genes aid in catalysing the reactions that are responsible for 
synthesising the type-II polyketide backbone.
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Figu re 4 .1 9 : The tran scrip tion  profile for all th ree genes of the actl gene cluster, (A ) actl-l, (B )
(C ) actl-3, for all th ree strains a t th ree  different grow th rates.
actl-l encodes the actinorhodin polyketide p-ketoacyl synthase a-subunit. The transcription 
profile for actl-l correlated well with the ACT yields generated at 0.04h"* and 0.06b'1. actl-2 
encodes the actinorhodin polyketide P-ketoacyl synthase p-subunit. The transcription of this 
gene was similar to that of actl-l, correlating well with ACT production for all strains grown 
at 0.04h'' and O.Obh'1. This was also true for actl-3.
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The actll gene cluster is comprised of four genes, actll-l, actll-2, actlI-3 and actlI-4 and their 
expression profdes are presented in Figure 4.20.
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Figu re 4 .2 0 : The tran scrip tion  profile for (A ) a ctll-l, (B ) actll-2, (C ) actII-3 and (D ) actII-4 of the actll 
gene cluster for all strains grow n and grow th rates tested.
actll-l encodes a transcriptional regulatory protein. The actinorhodin transporter protein, is 
encoded by actll-2. actlI-3 encodes a membrane protein associated with ACT production. The 
transcript profile for all three genes correlated well with ACT production in the majority of 
cases, as did the transcription profile for the pathway-specific activator gene, actll-ORF4.
actll-2 expression in strains M717pIJ8714 and M718pIJ8714 showed a negative correlation 
with the growth rate (and hence a positive correlation with ACT synthesis). The product of 
this gene was shown to export actinorhodin from the mycelium and hence a correlation with 
the transcription of this gene and ACT production was understandable. The inverse 
relationship with the growth rate may be due to the fact that ACT is traditionally associated 
with lower growth rates and hence this gene is transcribed under such conditions.
actlll codes for a ketoacyl reductase enzyme involved in ACT production, and its 
transcription profile was found to correlate with ACT yields generated by all strains and
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growth rates tested. This was also true for the SCO1272 gene, encoding an acyl carrier protein 
associated with ACT synthesis. This was in accordance with findings made by Gramajo et al, 
(1993), whereby possessing multiple copies of the actII-ORF4 gene caused the transcription 
of the actlll gene to be enhanced.
All four genes are located within the same operon and hence are co-transcribed and as a result 
similar expression trends were observed.
4.3.10 Correlation between MFA and Gene Expression Data
Analysing MFA and microarray data, little correlation between these two methods could be 
found. Studies carried out by Daran-Lapujade et al, (2004) examined Saccharomyces 
cerevisiae strains grown in chemostat culture and found no correlation between MFA values 
and data obtained from gene expression analysis for the genes associated with the glycolytic, 
TCA cycle or the pentose phosphate pathways. A correlation was found however, for genes 
associated with gluconeogenesis and the glyoxylate shunt, and is due to the pathways being 
solely transcriptionally regulated. The study concluded that in vivo fluxes in central 
metabolism are mainly under the control of post-translational processes and hence the lack of 
correlation between the two methods. As very few examples were found in this study where 
fluxome data was in agreement with transcriptome data, our results corroborate findings made 
by Daran-Lapujade et al, (2004). However, conflicting studies have shown that correlations 
do exist between these two methods in S. cerevisiae and E. coli strains, Sonderegger et al, 
(2004) and Gonzalez et al, (2002), respectively, and hence further research is required.
Results from this study and those of Daran-Lapujade et al, (2004), demonstrate that 
microarrays are a powerful tool for identifying differences in the expression levels of genes 
amongst different strains and growth conditions etc. However, they are not optimal for 
predicting what the carbon flux through a particular- reaction will be and hence microarrays 
have a limited use in metabolic engineering research when used in isolation.
Although transcript levels of genes may not correlate well with in vivo fluxes, it can be said 
that a change in transcription level of a gene indicates a change in the physiology of an 
organism, and has some relevance therefore.
4.3.11 Genes Associated with High ACT Production
As stated previously, microarray technology has been used as an exploratory tool to identify 
genes that are associated with a particular* (desired) condition e.g. high antibiotic production 
(Huang et al, 2001). This is a powerful method to use in metabolic engineering studies as it
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saves valuable time and resources, as studies in the past have merely relied upon random 
mutations and assessing the resulting product concentration.
In order to identify genes that were significantly up-regulated/down-regulated in conditions of 
high ACT production, microarray data was normalised on a per spot (divided by control 
channel) and per chip (normalised to 50th percentile) basis using GeneSpring (Section 2.6.7). 
The genes were subsequently filtered on a two-fold change ‘cut-off meaning that for 
example, all genes highlighted were at least either two-fold up-regulated or down-regulated in 
the high ACT test sample (i.e. M717pIJ8714, M718pIJ8714) compared to the control strain, 
M510pIJ8714 (Appendix I). Studies have shown this ‘cut off to be sufficient in order to state 
confidently that a particular gene is differentially expressed (Sonderegger et al, 2004).
At 0.04b'1, both Azwf strains generated higher ACT yields than the control strain and hence 
genes that were up/down-regulated in both these Azwf strains (compared to the control strain) 
were analysed. A total of 182 genes were found to be up-regulated but were mostly 
hypothetical proteins. However, amongst these, two genes encoding long-chain fatty acid 
ligase enzymes (SCO2720, SC06552) were found to be up-regulated. These enzymes are 
involved in fatty acid metabolism, which has a similar biosynthetic route to polyketide 
synthesis. The products of these genes catalyse the E.c. reaction 6.2.1.3 and hence it may have 
some relevance to ACT production and should be investigated further.
Another interesting gene found to be up-regulated was traAl (SC04621), a possible 
sporulation protein. At O.Obh'1, the traBl gene (SCO4620) was also found to be up-regulated 
in the Azwfl strain (which generated the most ACT). Hence therefore, these genes may have 
important associations with ACT production.
On the contrary, 339 genes were found to be down-regulated in the two Azwf strains at 
0.04b'1, compared to the control strain. Amongst these was SC06444, encoding a probable y- 
glutamyl-transferase involved in glycine, cysteine and glutamate synthesis. Carbon fluxes 
towards the synthesis of these amino acids were found to negatively correlate with ACT 
production and hence corroborated this finding. The hisB gene (SCO2052) was also found to 
have a more than two-fold reduction in expression level in the two Azwf strains, and encodes 
the enzyme involved in histidine synthesis. Results from MFA were in accordance with this.
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SC03356 encodes an RNA polymerase sigma factor belonging to the extracytoplasmic 
function (ECF) subfamily required to maintain normal cell wall structure. Studies earned out 
by Paget et al, (1999), have shown that S. coelicolor strains with similar gene deletions 
(sigE), precociously and overproduced actinorhodin (when in grown in media at low 
magnesium (~lmM) concentrations). The decrease in transcription of this gene seen in both 
Azwf strains is somewhat in agreement with these findings, therefore.
At 0.06b'1, strain M717pIJ8714 generated higher ACT yields than M510pIJ8714 and 
M718pIJ8714. Hence gene transcripts that were up/down-regulated (in only this strain) by 
two-fold or more were highlighted. A total of 324 genes were found to be up-regulated in 
strain M717pIJ8714, amongst these was SC06284, encoding an enzyme catalysing the 
reaction that generates propionyl-CoA, which is involved in fatty acid synthesis. As 
mentioned previously, polyketide formation undergoes similar biosynthetic routes and hence 
this finding was not surprising.
Gene SC07168, is part of the g?tfR-family of transcriptional regulators known to be repressors 
of the gluconate operon. Subfamilies of this group have various biological processes that are 
involved in bacterial metabolism. There are almost 300 members of the g??tR-family of 
regulators, whiH is amongst them and is essential for sporulation in Streptomyces strains. 
S. coelicolor has an unusually large number of such genes in its genome. A study carried out 
by Sprusansky et al (2003), analysed S. coelicolor strains with a disrupted SC07168 gene 
and found that they were unable to sporulate and produced significantly lower levels of ACT, 
suggesting a possible involvement with ACT synthesis. The results shown from the 
microarray experiments presented in this study are in accordance with those of Sprusansky 
et al, (2003).
SC04214 (possible abaA gene) is believed to be a pleiotropic gene involved in regulating 
antibiotic production in many Streptomyces species (Fernandez-Moreno et al, 1992). It was 
reported that this gene may regulate ACT, RED and CDA production and a decrease in ACT 
production was observed when the abaA gene was deleted. This was in accordance with the 
results presented here.
A sporalation-related protein encoded by traBl (SCO4620) was up-regulated in strain 
M717pIJ8714. As discussed earlier at 0.04h_1, a similar gene, traAl, (SC04621), was also up- 
regulated in high antibiotic producing strains and hence these genes may have an important 
association with ACT synthesis.
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A possible serine/threonine protein kinase encoding gene, (SC04377) was up-regulated more 
than two-fold in strain M717pIJ8714. The main function of this gene is to produce a product 
that will phosphorylate the afsR gene, which can then become an active regulator of antibiotic 
synthesis (by activating the transcription of the actII-ORF4 gene). An increase in the 
transcription level of the afsR gene causes an increase in ACT production, but only if it is in 
the phosphorylated form. The finding from this study was in agreement with those of Kim et 
al, (2001), in which a disruption in either afsK or afsR gene in S. coelicolor was found to 
reduce ACT production.
Interestingly, many genes involved in polyketide metabolism were up-regulated in the ACT 
overproducing strain (SCO5077, SCO5078, SCO5079, SCO5085, SCO5086) all of which 
would make good targets for metabolic engineering strategies to increase the production of 
polyketides. In doing so, it is more likely that cells would be viable than if strains with 
insertions/deletions for genes involved in central metabolism were constructed.
There were also a total of 188 genes that were found to be down-regulated in strain 
M717pIJ8714 at 0.06h"!. Amongst these was aceEl (SC02183). The product of this gene 
catalyses the conversion from pyruvate to acetyl-CoA. It was surprising to see therefore that 
this gene was down-regulated in a strain that generated high levels of ACT. Perhaps this gene 
has a negative regulatory role upon the activity of this enzyme and hence its down-regulation.
The absA gene in S. coelicolor is a two-component system comprising of an absAl and absA2 
gene. The absAl gene was up-regulated in strains that made the most ACT at 0.041Y1. 
However, absA2 was down-regulated under high antibiotic producing conditions. Anderson et 
al, (2001), demonstrated that the absA2 gene, a response regulator, is in fact a negative 
regulator of many antibiotic gene clusters in S. coelicolor. A mutation in this gene caused 
S. coelicolor strains to produce antibiotics precociously and at increased levels. 
The microarray results shown in this study are in accordance with the findings made by 
Anderson et al, (2001).
As with O.O6I1'1, strain M717pIJ8714 generated the highest ACT yields at 0.08h-1 compared to 
the other strains tested. Hence genes found to be either up or down-regulated in this strain, 
were associated with high ACT levels.
127 genes were identified as being more than two-fold up-regulated in strain M717pIJ8714 
compared to strains M510pIJ8714 and M718pIJ8714 at 0.08h_1.
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A total of 34 serine/threonine protein kinases have been identified in S. coelicolor to date, 
Petrickova and Petricek, (2003), which is unusual for prokaryotes as these genes are known to 
be fundamental in regulatory systems in eukaryotes. If these serine/threonine protein kinases 
are found in bacteria, they are found in ones that have complex life cycles or sophisticated cell 
communications. The afsIC and ramC genes have been identified as being involved in 
antibiotic production and are examples of such kinases. An increase in the transcription of a 
gene coding a serine/threonine protein kinase (SC03941) in strain M717pIJ8714 was found 
which may have similar actions as the afsK gene that is associated with ACT synthesis.
SCO 1272 was up-regulated in the higher ACT producing strain and encodes an acyl carrier 
protein, similar to the actI-ORF3 gene product involved in ACT biosynthesis. It is logical 
therefore, that this gene was up-regulated in such a strain and perhaps it could be 
overexpressed in S. coelicolor strains to see if an increase in antibiotic production occurs. The 
transcription of this gene was found to positively correlate with ACT production in all strains 
and growth rates tested.
The aceEl gene (SC02183) was up-regulated in the M717pIJ8714 strain and encodes a 
protein that catalyses the conversion from pyruvate to acetyl-CoA. However, the result found 
here conflicts with the result obtained for the M717pIJ8714 strain at 0.06h_1 where a down- 
regulation in this gene was observed. This may be due to differences in the growth rate.
A further gwtK-family transcriptional regulator (SCO1262) was up-regulated in the strain that 
made higher levels of antibiotic as was observed in this strain at O.O6I1"1. This further supports 
findings made by Sprusansky et al., (2003), whereby a strain with a disruption in such a gene, 
produced significantly reduced levels of ACT. Further research into the association between 
gwLft-family transcriptional regulators and ACT production may be important, therefore, for 
finding ways in which to enhance ACT synthesis.
A total of 176 genes were down-regulated in M717pU87I4 compared to the other two strains 
tested at 0.08h_1 and amongst these was SCG6253 that encodes a two-component sensor 
kinase. There are a number of such genes that have been associated with antibiotic 
production, absA, afsQ etc. Although the actual identity and function of this SC06253 gene is 
unknown, its down-regulation in a strain that was producing elevated amounts of ACT, could 
be indicative that it has a negative regulatory effect on ACT synthesis.
Gene SC02734, encodes a putative LysR-family transcriptional regulator of which there are 
many examples in S. coelicolor. Colombo et al, (2001) analysed a DNA fragment from
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Streptomyces antibioticus that featured genes similar to those previously known to be 
associated with polyketide synthesis. These genes contained a LysR-type family 
transcriptional regulator (ORFO) which is required for PICS gene expression (the protein 
product interacts with the actII-ORF4 promoter). They found that in S. antibioticus strains, 
the LysR-type transcriptional regulator positively regulated PKS genes. However, in 
S. lividans, this LysR-type regulator was shown to negatively control ACT production. The 
difference in these mechanisms is that in S', lividans, the LysR-type regulator does not bind to 
the actII-ORF4 gene. S. coelicolor and S. lividans are closely related and hence a similar 
mechanism is likely to occur in S. coelicolor strains. Therefore, down-regulation in this gene 
may cause a reduction in the negative regulation of the PKS genes and hence more ACT 
production occurs. The results from the microarray findings were in agreement with the study 
carried out by Colombo et al, (2001).
4.3.12 Conclusions
Previous work carried out by Avignone-Rossa et al, (2002) demonstrated that a negative 
correlation between the carbon flux through the PPP and ACT production exists. As a result, 
S. lividans strains with either one of the two zwf genes deleted were constructed and found to 
generate enhanced ACT concentrations. These genotypes were constructed in S. coelicolor 
strains and these too generated increased ACT levels in both batch and chemostat culture. 
However, the carbon flux through the initial PPP reaction was higher than that measured in 
the control strain. This finding was confirmed by in vitro enzyme and microarray analysis. 
This was not in agreement with results reported by Butler et al, (2002) in S. lividans, 
whereby a 50% reduction in activity was observed. The discrepancy may be explained by the 
fact that unlike S. lividans strains, 6-phosphogluconate dehydrogenase in S. coelicolor uses 
NADP+ as a cofactor (generating NADPH) in preference to NAD+. If S. coelicolor Azwf 
mutants had reduced carbon fluxes through the initial PPP reaction, lower fluxes would, as a 
result, be found through the subsequent reactions including the third NADPH-generating step. 
This would cause much lower NADPH levels to be generated compared to the levels found in 
S. lividans strains (which only generate NADPH from the first PPP reaction). NADPH levels 
might therefore be too low to meet cell demands in S. coelicolor strains if a reduction in the 
carbon flux through the initial PPP reaction occurred.
Perhaps a more likely explanation for the enhanced carbon fluxes through the initial PPP 
reaction is that the two zw?genes in S. coelicolor co-regulate each other. When one of the two 
genes was deleted, the negative control exerted was eliminated and hence an increase in gene 
product (and activity) was observed. Perhaps this control does not exist in 5*. lividans strains 
and hence the observed discrepancy.
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Possessing the pIJ8714 plasmid caused the carbon flux through the glycolytic pathway to 
increase, perhaps saturating the carbon flux through EM5 (Figure 3.4A) causing NADPH to 
become limited. Having an increased carbon flux through the initial PPP reaction in the Azwf 
strains supplied the NADPH that was in demand and may be the explanation for the enhanced 
ACT concentrations observed in these strains. In accordance with this, M719pIJ8714 
produced less ACT than the control and was found to have reduced carbon fluxes through the 
initial PPP reaction, NADPH levels were insufficient to meet the demands of possessing the 
pIJ8714 insert.
Another possible theoiy for the increased ACT levels generated by these strains uses the 
findings published by Lee et al., (1996). Amplification of the zwf copy number in E. coli 
strains caused an increase in polyhydroxybutyrate production due to a shift in flux partitioning 
of acetyl-CoA between the TCA cycle and polyhydroxybutyrate synthesis, itself. As a result 
of this zwf amplification, higher levels of NADPH were generated causing de-regulatory 
effects on e.g. citrate synthase. If the same regulation of this enzyme occurs in S. coelicolor it 
could be another theory as to why the Azwf strains generated higher ACT levels than the 
control(s). A reduction in citrate synthase activity would allow more acetyl-CoA to be 
available for ACT production. Certain results presented in this study conflict this theoiy 
however, hence further investigations would be required in order to establish if this was true.
In chemostat culture, ACT production was inversely proportional to the growth rate in the two 
Azwf strains. At lower growth rates, the glucose-6-phosphate principal node was found to be 
more flexible which is consistent with the concept that S. coelicolor has evolved to utilise 
NADPH as a priority for growth. Hence, when less biomass is required (i.e. low growth rates) 
more NADPH can be used for ACT synthesis, hence the increased ACT production observed.
In S. lividans, a AdevB strain was found to generate significantly higher levels of ACT, which 
contradicted results reported in this study. The discrepancy lies, once again, in the different 
concentrations of NADPH generated by the PPP in the two Streptomyces species. Lower 
levels of NADPH would be generated from the PPP in S. coelicolor strains with such a 
deletion as the third reaction (catalysed by 6-phosphogluconate dehydrogenase) of the PPP 
would not be active (due to the devB deletion) and hence no NADPH would be generated 
from this step. This reaction in S. lividans does not generate NADPH and hence the level of 
cofactor generated in S. lividans AdevB strains would not be affected. Perhaps levels of this 
cofactor were too low in AdevB S. coelicolor strains for enhanced ACT production, as most of
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the NADPH generated would be used to meet cell growth demands, rather than for ACT 
synthesis.
Results obtained from MFA highlighted many interesting areas of metabolism that could be 
exploited in future metabolic engineering studies. This included the discoveiy that high ACT 
producing strains had reduced carbon fluxes through non-oxidative PPP reactions and hence 
less carbon entered the PPP from glycolysis. This allowed more carbon to be available for 
pyruvate synthesis (and acetyl-CoA).
Chemostat cultures have been shown to be the optimal way in which to grow strains for the 
purpose of microarray analysis, as in batch cultures the concentrations of substrates and 
products continually change due to the fluctuations in growth rate, accumulation of products 
and so on. Hence metabolic fluxes/ gene expression levels are more accurate in a system 
whereby such parameters can be controlled. However, the fact that the MFA trends observed 
for the strains grown in batch culture were in good agreement with those obtained from 
chemostat culture, gives increased confidence in the results generated from both culture 
techniques.
As can be seen from section 4.3.9, much information can be generated from a microarray 
experiment. The gene transcription profiles of three pIJ8714 strains at three different growth 
rates, was analysed and differences in expression levels, assessed.
Many genes’ transcript levels were found to be more than two-fold up/down-regulated in the 
strain(s) that generated the most ACT. These would therefore be ideal candidates for 
insertion/deletion studies, respectively, in future metabolic engineering studies with the aim to 
enhance ACT production. However, before carrying out such constructs, MFA could be used 
to investigate if the genes in question are likely to be essential or non-essential for growth. 
This approach was used successfully by Edwards and Palsson (2000), for the analysis of 
in silico mutations in E. coli strains.
The transcription of the majority of genes associated with central metabolism did not correlate 
with the growth rate, ACT production or with the carbon fluxes generated for the associated 
reaction. This was indicative that other factors control the synthesis of gene products and 
hence for more accurate analysis the three -omic technologies (metabolomics, transcriptomics 
and proteomics) should to be employed and used in conjunction with one another.
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Conclusions and Further Work
5.1 Conclusions
5.1.1 Conclusions from Batch Cultures
It was observed that the Azwf I and AscbA strains generated higher levels of ACT compared to 
the control strain when grown in batch culture. Fur thermore, strains that featured an additional 
copy of the actII-ORF4 gene generated increased levels of ACT (which was produced 
precociously) compared to their associated strains that lacked the pIJ87l4 insert. These 
findings were in accordance with studies published by Butler et al., (2002, 2003). The AscbA 
strains generated more ACT than the control strains and the reasons behind this remain 
uncertain but a theory has been proposed by Takano et al, (2001), which has been discussed 
in section 1.5.1. Another theory as to why such AscbA strains generated higher ACT levels 
was proposed by Bibb (2005) based on the findings published by Takano et al, (2005). The 
scbA and scbR genes were found to regulate the Type I polyketide gene cluster, in particular 
ScbR directly regulated the pathway-specific regulatory gene, IzasO. This was the first work 
published to show that a y-butyrolactone binding protein directly regulated a secondary 
metabolite pathway gene in Streptomyces. The ScbR binds to the promoter region of the kasO 
gene, only in the total absence of SCB1 (i.e. in AscbA mutants). This represses its expression 
and hence the type I polyketide is not synthesised. This polyketide uses the same precursor for 
its synthesis as actinorhodin and hence in AscbA strains, presumably more of the precursors 
for ACT synthesis are available and hence the increased ACT production observed in these 
strains. The results published by Takano et al., (2005) and Bibb (2005) were corroborated by 
studies carried out by Huang et al, (2005) in which the transcription of the scbR and scbA 
genes correlated highly (> 0.8) with the expression of the genes in the type I polyketide 
cluster (SC06273 to SC06288).
Both AdevB strains, M719/M719pIJ8714, generated reduced levels of ACT compared to their 
corresponding control strains. This was most likely due to the reduced NADPH production 
(from the PPP) as a result of the deletion. In accordance with this, strains M717pIJ8714 and 
M718pIJ8714 were found to generate increased levels of ACT and this was most likely due to 
the increased carbon fluxes through the PPP, supplying the NADPH required for ACT 
synthesis. No synergistic effect on ACT production was observed in having both scbA and 
zwfl genes deleted, as strain M720pIJ8714 produced specific ACT values comparable to the 
AscbA and Azwfl strains alone.
A further reason for the observed differences in specific ACT values between the different
strains could be due to differing glucose utilisation/uptake rates. The gene deletions
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themselves may cause substrate affinities (e.g. glucose) to increase and hence if a strain is 
found to have an increased glucose uptake, it has more carbon available to produce greater 
amounts of ACT. Normalising the carbon flux values to the glucose uptake rate eliminated 
this problem, allowing accurate comparisons of the carbon flux distributions to be made 
between the various strains and growth conditions.
5.1.2 Conclusions from Chemostat Cultures
Specific ACT production was highest in the Azwf strains grown at the lowest growth rate 
(with M717pIJ8714 generating the most ACT at all growth rates), however, strain 
M718pIJ8714 generated ACT levels comparable to the control strain at 0.061Y1 and O.OSh"1. 
These results suggested that the two isogenes do not act in the same way at higher growth 
rates. A positive correlation was found between the growth rate and ACT production in the 
control strain (although ACT concentrations were very similar). Metabolic flux analysis and 
gene expression data were used to try to explain these observations.
5.1.3 Conclusions from Metabolic Flux Analysis
Acetyl-CoA (the carbon ACT precursor) is produced from pyruvate, and hence a positive 
correlation was observed (in the majority of strains and conditions) between the carbon fluxes 
through all reactions converting 3-phosphoglycerate to pyruvate, and the ACT yields 
generated by the individual strains.
The carbon flux through the initial PPP reaction was found to be reduced in all overproducing 
strains compared to their corresponding strains that lacked the pIJ8714 insert. This 
demonstrated that there is indeed a negative correlation between PPP activity and ACT 
production. However, possessing an additional copy of the actII-ORF4 gene causes the 
carbon flux through EM5 (the mode found to generate the most ACT (Figure 3.4A)) to 
increase, causing NADPH to become limited.
The M717pIJ8714/M718pIJ8714 strains were found to have increased carbon fluxes through 
the NADPH-generating reactions of the oxidative PPP compared to the control strain, and this 
has been hypothesised as the main reason for the observed increase in ACT synthesis. The 
increased carbon fluxes provided the NADPH that was in demand to fuel the high yielding 
elementary mode for ACT synthesis (due to the presence of the additional copy of the actll- 
ORF4  gene). This increase through the PPP was also observed in the AscbA strains but not in
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the A devB strains, which produced higher and lower ACT yields, respectively, hence supports 
this hypothesis.
It was also observed that the carbon fluxes through the anaplerotic reaction 
(phosphoenolpyruvate to oxaloacetate) were lower in the strains that made the most ACT. 
This allowed more pyruvate to be generated for acetyl-CoA synthesis, rather than replenishing 
oxaloacetate levels.
Analysing the results from the carbon flux-split ratios, it was found that the Xgty:Xppp node 
became increasingly flexible as the growth rate decreased, coinciding with an increase in 
ACT concentration (corroborating EMA findings). The opposite of this was true for the 
Xana^ Xpyr flux-split ratio. Furthermore, strains featuring the pIJ8714 insert were found to have 
increased Xgiy:Xppp and decreased Xana:Xpyr ratios compared to their corresponding control 
strains.
All these findings could be applied in future metabolic engineering strategies, as the optimal 
growth condition/rate for the production of a desired product could be identified and exploited 
in chemostat culture.
5.1.4 Conclusions from Microarray Analysis
Little correlation was observed between data derived from metabolic flux analysis and data 
derived from transcriptomic analysis. This was in accordance with findings made by Akesson 
et al, (2004) and Daran-Lapujade et al, (2004). However, microarray results do highlight 
genes that were up/down-regulated under conditions of high ACT synthesis and hence may 
highlight targets for future metabolic engineering studies.
It is important that the three —omic technologies (metabolomics, transcriptomics and 
proteomics) be used in conjunction with one another, therefore, in order that an optimal 
metabolic engineering strategy is performed.
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5.2 Further Work
5.2.1 Improvements to the Stoichiometric Network
The stoichiometric network used for MFA could be improved by including more primary 
metabolic reactions using the annotated genome sequence available from the Sanger Centre. 
Further research into the area of post-transcriptional processes, the effect of substrate and 
product concentrations on enzyme activity etc. in Streptomyces strains would be beneficial. 
The use of proteomics (through the use of 2D-gel analysis) would also be a great advantage, 
in order to identify the proteins that are synthesised. This would aid in deciphering which 
enzymes/reactions are ‘active’ within a strain/condition and in doing so would improve the 
metabolic network used for metabolic flux analysis by imposing further constraints.
In order to determine whether the results obtained from MFA are indeed an accurate 
representation of what is occurring in vivo, more enzyme activity measurements could be 
earned out and used for the iterative improvement to the stoichiometric network.
5.2.2 Metabolic Flux Analysis Results
Flux-node flexibility analysis at the glucose-6-phosphate branch-point, indicated that its 
flexibility was greatest at lower growth rates, coinciding with higher ACT levels. S. coelicolor 
strains prioritise biomass synthesis and hence at higher growth rates, the NADPH and ATP 
that is generated is mainly used for growth rather than for ACT production. This flexibility in 
the node at low growth rates could be exploited in future strategies to enhance the production 
of other polylcetides that follow similar biosynthetic routes.
Growing the same strains at the same rate, but using different concentrations of phosphate in 
the medium could also be interesting to investigate further the link between biomass/ACT 
production and the carbon fluxes through the PPP. Lowering phosphate levels in the medium 
has been shown to reduce the biomass concentration that is generated, and hence the carbon 
flux through the PPP should reflect this.
It would be interesting to apply some of the findings from MFA to constr uct new S.. coelicolor 
strains to assess whether the predictions were correct, i.e. if indeed ACT levels would be 
enhanced. For instance, MFA data showed that in the majority of cases, a reduction in 
anaplerotic activity was associated with higher ACT concentrations. Less carbon flux through 
this reaction would allow more carbon to be used to generate pyruvate (and hence acetyl- 
CoA), therefore deletions for such anaplerotic genes may cause ACT levels to increase.
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Carbon fluxes towards leucine synthesis were reduced in all strains/conditions associated with 
high ACT production. The transcript level of the leuC gene (SC05553) was also found to be 
more than two-fold down-regulated in strain M717pIJ8714 at 0.081T1 compared to the other 
two strains tested. This amino acid is derived from pyruvate and hence a reduction in its 
production may allow more to be used for acetyl-CoA synthesis.
It would also be interesting to see if feeding cultures with different amino acids would cause 
differences in the ACT yields generated by the different strains (as was suggested from 
analysing the correlation analysis data presented in table 4.7). For example, it can be 
speculated that supplying serine would have a negative effect on ACT synthesis in the Azwf 
strains but not in the control, M510pIJ8714, If this were indeed true, it would demonstrate 
another powerful application for MFA.
Analysing the results obtained from macromolecular composition analysis, it was found that 
the biomass of the overproducing ACT strains had a reduced lipid content compared to their 
associated controls that lacked the pIJ8714 insert. ACT production follows similar 
biosynthetic pathways as lipid synthesis and hence they compete for common precursors (e.g. 
acetyl-CoA, NADPH and ATP). Perhaps genes associated with lipid synthesis could be 
deleted and the resulting str ain grown to evaluate if indeed ACT synthesis is enhanced.
5.2.3 Microarrav Analysis Results
It was unfortunate that the transcription level for the zwf2 gene could not be analysed in 
addition to the zwfl gene in the microarray studies. It would have been interesting to analyse 
whether these two genes are indeed paralogous (as was stated by Bentley et al, 2002), that is 
if they are expressed during different stages of the growth cycle. This would account for the 
differences in ACT production observed in the two Azwf strains at 0.06b.'1 and O.O8I1'1.
There are three genes in S. coelicolor that encode the 6-phosphogluconate dehydrogenase 
enzyme (SCO0975, SC03877, SC06658), which catalyses the third step of the PPP 
(generating NADPH). If the same regulation occurs in these genes as was speculated for the 
zwfl I zwfl genes, it would be interesting to see whether deleting one of the three genes would 
cause an increase in the carbon flux through that reaction (generating more NADPH). 
Constructing a strain with a Azwfl, Azwfl genotype in addition to a multi-copy actII-ORF4 
plasmid (i.e. pIJ68, Passantino et al, 1991) would be interesting, as the increase in ACT
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production resulting from the plasmid should be supported by the increase in PPP activity 
resulting from the gene deletions (generating the required NADPH).
Microarray techniques could be applied to assess the effect of the pIJ8714 insert at the 
transcription level. Strains lacking the additional copy of the actII-ORF4 gene e.g. M510, 
M717 and M719 could be grown in chemostat culture and used as the common reference 
(gDNA) against their associated strains featuring the pIJ8714 plasmid (the test sample, 
cDNA). Genes that are up/down-regulated in such high ACT producing strains could 
subsequently be identified and manipulated to increase ACT production in modified strains.
It would also be interesting to compare the gene expression levels in the AscbA strains to the 
profile of the control strain(s) to see if the scbA gene deletion resulted in elevated 
transcription of the act genes and/or if the mutation caused a reduction in the level of 
expression of metabolic pathways that compete with ACT biosynthetic enzymes, as was 
suggested by Bibb (2005).
Genes that were up/down-regulated in the strain(s) that made the most ACT at the three 
growth rates tested, could be inserted/deleted from the S. coelicolor genome to see if indeed 
ACT synthesis increased. For example, those that were up-regulated include the ACT 
associated genes (SCO5077, SCO5078, SCO5079) and the traAl and traBl genes, for 
example. Those identified as being down-regulated included SCO0582, which is homologous 
to the pdhR gene found in E. coli that represses pyruvate dehydrogenase production/activity. 
A deletion in this gene might allow more of the carbon ACT precursor to be generated.
5.2.4 Experiments to Test Proposed Hypotheses
One hypothesis in this study, stated that reduced carbon fluxes through the initial PPP reaction 
in the AdevB strains was perhaps due to negative inhibition of the glncose-6-phosphate 
dehydrogenase enzyme from the accumulation of 6-phosphoglucono-8-lactone. One way in 
which this hypothesis could be tested would be to carry out a simple enzyme inhibition 
experiment using varying concentrations of 6-phosphoglucono-5-lactone and determining the 
specific activity of glucose-6-phosphate dehydrogenase. The reduction in ACT production in 
these AdevB strains has been accredited to the lower PPP activity observed and so it would be 
quite interesting to see whether this enzyme was indeed inhibited by an accumulation of 6- 
phosphoglucono-5-lactone in S. coelicolor strains.
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Another theory discussed, involved the lower carbon fluxes observed through the non- 
oxidative PPP reactions in the Azwf strains. It was hypothesised that the decrease could have 
been due to the higher fluxes through the oxidative-PPP reactions. This would cause increased 
production of ribulose-5-phosphate (which is needed for nucleic acid synthesis etc.) and hence 
less activity through the non-oxidative reactions would be needed, causing less carbon to 
enter the PPP from the glycolytic pathway. This theory was further supported by data 
generated from the devB mutant strains, where the opposite was found to occur. As a result of 
the devB deletion, less ribulose-5-phosphate was generated (compared to the control strain) 
and hence to compensate for this, increased carbon fluxes through the non-oxidative reactions 
were observed. To test this theoiy, genes associated with E.c. reaction 1.1.1.44, could be 
deleted (the third step of the PPP). This would generate no ribulose-5-phosphate from 
oxidative-PPP reactions and so more activity through the non-oxidative PPP reactions 
(presumably) would be required. Less carbon would be available to generate pyruvate (and 
hence acetyl-CoA), from the glycolytic pathway, and ACT production would presumably be 
lower in such strains. Conversely, additional copies of the genes associated with this reaction 
could be inserted and tested to see if the opposite occurred, which should lead to enhanced 
ACT yields.
It was observed that the Azwf strains generated less ACT as the growth rate increased. The 
most likely reason suggested, was that the increase in growth rate caused an increase in the 
demand for the cofactors required for biomass, e.g. NADPH, and hence less was available for 
ACT synthesis. If the same Azwf strains were grown at the same three growth rates but at 
lower phosphate concentrations, the requirement for biomass synthesis would be reduced and 
hence more ACT production should be observed at all growth rates (than the values presented 
in this study), as more of the required cofactors would be available for ACT synthesis.
Mutant S. coelicolor strains could be constructed and grown to reflect all these findings, and if 
indeed ACT production was found to increase, the importance of such -omic technologies 
would be realised and used more prominently by the pharmaceutical and biotechnology fields 
to enhance the synthesis of desired products.
125

Aiba, S. and Matsuoka, M. (1979). Identification of a 
metabolic model: Citrate production from glucose by 
Candida Jipolytica. Biotecfmol. Bioeng. 21: 1373-1386.
Bligh, E.G . and Dyer, W .J. (1959). A rapid method of 
total lipid extraction and purification. Can. J. Biochem. 
Physiol. 37: 911-917.
Akesson, M „ Forster, J ., Nielsen, J .  (2004). Integration 
of gene expression data into genome-scale metabolic 
models. Metab. Eng. 6: 285-293.
Anderson, T .B., Brian, P., Riggle, P ., Kong, R., 
Chanipness, W .C. (1999). Genetic suppression analysis 
of non-antibiotic producing mutants of the Streptomyces 
coelicolor absA locus. Microbiology. 145: 2343-2353.
Anderson, T .B., Brian, P., Champness, W .C. (2001).
Genetic and transcriptional analysis of absA, an antibiotic 
gene cluster-linked two-component system that regulates 
multiple antibiotics in Streptomyces coelicolor. Mol. 
Microbiol. 39: 553-566.
Avignone-Rossa, C., White, J . ,  Kuiper, A., Postma, 
P.W ., Bibb, M .J., Teixeira de Mattos, M .J. (2002).
Carbon flux distribution in antibiotic-producing 
chemostat cultures of Streptomyces lividans. Metab. Eng. 
4: 138-150.
Bentley, R . (2001). Polyketides. Encyclopedia of Life 
Sciences. 1-6.
Bentley, S.D., Chater, K .F ., Ccrdeno-Tarraga, A.M., 
Challis, G .L., Thomson, N.R., James, K.D., Harris, 
D.E., Quail, M.A., Kieser, H., Harper, D., Bateman, 
A., Brown, S., Chandra, G., Chen, C .W ., Collins, M., 
Cronin, A., Fraser, A., Goble, A., Hidalgo, J .,  
Hornsby, T ., Howarth, S., Huang C.H., Kieser, T., 
Larke, L ., Murphy, L ., Oliver, K., O ’Neil S., 
Rabbinowitsch, E ., Rajandream, M.A., Rutherford, 
K., Rutter, S., Seeger, K ., Saunders, D., Sharp, S., 
Squares, S., Taylor, K., W arren, T., Wietzorrek, A., 
Woodward, J ., Barrel!, B.G., Parkhill, J . ,  Hopwood, 
D.A. (2002). Complete genome sequence of the model 
actinomycete Streptomyces coelicolor A3(2). Nature. 
417: 141-147.
Bergmcyer, H.U. (1974). Glucose oxidase: assay 
method. In Methods of Enzymatic Analysis. Ed. 
Bergmeyer H.U. pp. 457-460. New York: Academic 
Press.
Bcstc, D .J.V., Peters, J . ,  Hooper, T., Avignone-Rossa, 
C,» Bushell, M .E., McFaddcn, J .  (2005). Compiling a 
molecular inventory for Mycobacterium bovis BCG at 
two growth rates: evidence for growth-rate mediated 
regulation of ribosome biosynthesis and lipid 
metabolism. J. Bacteriol. 187: 1677-1684.
Bibb, M .J., Janssen, G.R., W ard, J.M . (1985). Cloning 
and analysis of the promoter region of the erythromycin 
resistance gene (ermE) of Streptomyces erythraeus. Gene. 
38 : 215-226.
Bibb, M .J. (1996). 1995 Colworth Prize Lecture. The 
regulation of antibiotic production in Streptomyces 
coelicolor A3(2). Microbiology. 142: 1335-1344.
Boer, V.M., de Winde, J.H ., Pronk, J.T ., Piper, 
M.D.W. (2003). The genome-wide transcriptional 
response of Saccharomyces cerevisiae grown on glucose 
in aerobic chemostat cultures limited for carbon, 
nitrogen, phosphorus or sulfur. J. Biol. Chem. 278: 3265- 
3274.
Borodina, I., Krabben, P ., Nielsen, J .  (2005). Genome- 
scale analysis of Streptomyces coelicolor A3(2) 
metabolism. Genome Res. 15: 820-829.
Bruheim, P., Butier, M., Ellingseii, T .E. (2002a). A
theoretical analysis of the biosynthesis of actinorhodin in 
a hyper-producing Streptomyces lividans strain cultivated 
on various carbon sources. Appl. Microbiol. Biotechnol. 
58: 735-742.
Bruheim, P., Sletta, H., Bibb, M .J., White, J . ,  Levine, 
D.W. (2002b). High-yield actinorhodin production in 
fed-batch culture by a Streptomyces lividans strain 
overexpressing the pathway-specific activator gene actll- 
ORF4. J. Ind. Microbiol. Biotechnol. 28: 103-111.
Bruinenberg, P.M ., van Dijken, J.P ., Scheffers, W . A. 
(1983a). A theoretical analysis of NADPH production 
and consumption in yeasts. J. Gen. Microbiol. 129: 953- 
964.
Bruinenberg, P.M ., van Dijken, J .P ., Scheffers, W . A. 
(1983b). An enzymic analysis of NADPH production and 
consumption in Candida utilis. J. Gen. Microbiol. 129: 
965-971.
Burton, K.A. (1956). A  study of the conditions and 
mechanism of the diphenylamine reaction for the 
colorimetric estimation of deoxyribonucleic acid. 
Biochem. J. 62: 315-323.
Bushell, M .E., Smith, J.S .B ., Lynch, H. (1997).
Physiological model for the control of erythromycin 
production in batch and cyclic fed batch culture. 
Microbiology. 143: 475-480.
Butler, M .J., Bruheim, P ., Jovetic, S., MarincHi, F., 
Postma, P .W ., Bibb, M .J. (2002). Engineering of 
primary carbon metabolism for improved antibiotic 
production in Streptomyces lividans. Appl. Environ. 
Microbiol. 68 :4731-4739 .
Butler, M .J., Takano, E ., Bruheim, P., Jovetic, S., 
Marinelli, F ., Bibb, M .J., (2003). Deletion of scbA 
enhances antibiotic production in Streptomyces lividans. 
Appl. Microbiol. Biotechnol. 61 : 512-516.
Bystrykh, L.V., Fernandez-Moreno, M.A., Herrema, 
J .K ., Malpartida, F ., Hopwood, D.A., Dijkhuizen, L .
(1996). Production of actinorhodin-related “blue 
pigments” by Streptomyces coelicolor A3(2). J. 
Bacteriol. 178: 2238-2244.
Bibb, M .J. (2005). Regulation of secondary metabolism Chakraburtty, R. and Bibb, M .J. (1997). The ppGpp
in streptomycetes. Curr. Opin. Microbiol. 8 : 208-215. synthetase gene (relA) of Streptomyces coelicolor A3(2)
plays a conditional role in antibiotic production and 
morphological differentiation. J. Bacteriol. 179: 5854- 
5861.
126
Challis, G.L. and Hopwood, D.A. (2003). Synergy and 
contingency as driving forces for the evolution of 
multipie secondary metabolite production by 
Streptomyces species. Proc. Natl. Acad. Sci. USA. 100: 
14555-14561.
Chater, K .F. (1993). Genetics of differentiation in 
Streptomyces. Anna. Rev. Microbiol. 47 : 685-713.
Colombo, V ., Fernandez-de-H eredia, M ., M alpnrtida, 
F. (2001). A polyketide biosynthetic gene cluster from 
Streptomyces antibioticus includes a LysR-type 
transcriptional regulator. Microbiology. 147: 3083-3092.
Daae, E .B . and Ison, A.P. (1999). Classification and 
sensitivity analysis of a proposed primary metabolic 
reaction network for Streptomyces lividans. Metab. Eng. 
1: 153-165.
Dandekar, T., Moldenhauer, F., Bulik, S., Bertram, 
H., Schuster, S. (2003). A method for classifying 
metabolites in topological pathway analyses based on 
minimization of pathway number. Biosystems. 70: 255- 
270.
Daran-Lapujade, P., Jansen, M .L.A., Daran, J.M ., van 
Gulik, W ., de Windc, J.H ., Pronk, J .T . (2004). Role of 
transcriptional regulation in controlling fluxes in central 
carbon metabolism of Saccharomyces cerevisiae, a 
chemostat culture study. J. Biol. Chem. 279: 9125-9138.
Dauner, M. Siorni, T., Sauer, U. (2001). Bacillus 
subtilis metabolism and energetics in carbon-limited and 
excess-carbon chemostat culture. J. Bacteriol. 183: 7308- 
7317.
De Hollander, J.A . (1994). Potential metabolic 
limitations in lysine production by Corynebacteriam 
ghitamicum as revealed by metabolic network analysis. 
Appl. Microbiol. Biotechnol. 42: 508-515.
Dekleva, M .L. and Strohl, W .R. (1988). Biosynthesis of 
e-rhodomycinone from glucose by Streptomyces C5 and 
comparison with intermediary metabolism of other 
polyketide-producing Streptomycetes. Can. J. Microbiol. 
34: 1235-1240.
Doull, J .L . and Vining, L.C . (1990). Nutritional control 
of actinorhodin production by Streptomyces coelicolor 
A3(2): suppressive effects of nitrogen and phosphate. 
Appl. Microbiol. Biotechnol. 32: 449-454.
Dubois, M ., Gilles, K.A., Hamilton, J .K ., Rebers, P.A., 
Smith, F. (1956). Colorimetric method for determination 
of sugars and related substances. Anal. Chem. 28: 350- 
356.
Edwards, J.S . and Palsson, B.O. (2000), The
Escherichia coli MG1655 in silico metabolic genotype: 
its definition, characteristics and capabilities. Proc. Natl. 
Acad. Sci. USA 97: 5528-5533.
Evans, C.G.T., Herbert, D., Tempest, D.W. (1970).
The continuous culture of microorganisms. 2. 
Construction of a chemostat. In: Norris, JR, Ribbons, 
DW (eds.). Methods in Microbiology. Vol. 2. Academic 
Press, London, pp. 277-327.
Fernandez-Moreno, M.A., Caballero, J .L ., Hopwood, 
D.A., Malpartida, F . (1991). The act cluster contains 
regulatory and export genes, direct targets for 
translational control by the bldA tRNA gene of 
Streptomyces. Cell. 66: 769-780.
Fernandez-Moreno, M.A., Martin-Triana, A .J., 
Martinez, E ., Niemi, J ., Kieser, H.M., Hopwood, D.A., 
Malparida, F. (1992). abaA, a new pleiotropic 
regulatory locus for antibiotic production in Streptomyces 
coelicolor. J. Bacteriol. 174: 2958-2967.
Floriano, B., and Bibb, M .J. (1996). afsR is a 
pleiotropic but conditionally required regulatory gene for 
antibiotic production in Streptomyces coelicolor A3 (2). 
Mol. Microbiol. 21: 385-396.
Folch, J ., Lees, M., Sloane Stanley, G.H. (1957). A
simple method for the isolation and purification of total 
lipides from animal tissues. J. Biol. Chem. 226: 497-509.
Fuqua, C. and Greenberg, E .P . (2002). Listening in on 
bacteria: acyl-homoserine lactone signalling. Nat. Rev. 
Mol. Cell Biol. 3 : 685-695.
Gavrilescu, M. and Christi, Y . (2005). Biotechnology -  
a sustainable alternative for chemical industry. 
Biotechnol. Adv. 23: 471-499.
Glauert, A.M. and Hopwood, D.A. (1961). The fine 
structure of Streptomyces violaceoruber (S. coelicolor). 
III. The walls of the mycelium and spores. J. Cell Biol. 
10:505-516 .
Glock, G.E. and M cLean, P. (1953). Further studies on 
the properties and assay of glucose-6-phosphate 
dehydrogenase and 6-phosphogluconate dehydrogenase 
of rat liver. Biochem. J. 55 : 400-408.
Gonzalez, R ., Tao, H., Shanmugain, K .T., York, S.W ., 
Ingram L.O. (2002). Global gene expression differences 
associated with changes in glycolytic flux and growth 
rate in Escherichia coli during the fermentation of 
glucose and xylose. Biotechnol. Prog. 18: 6-20.
Griife, U., Reinhardt, F ., Schade, W ., Eritt, I., Fleck, 
W .F., Radies, L . (1983). Interspecific inducers of 
cytodifferentiation and anthracycline biosynthesis from 
Streptomyces bikiniensis and Streptomyces 
cyaneofuscattis. Biotechnol. Lett. 5 : 591-596.
Gramajo, H.C., Takano, E. and Bibb, M .J. (1993).
Stationary-phase production of tire antibiotic 
actinorhodin in Streptomyces coelicolor A3(2) is 
transcriptionally regulated. Mol. Microbiol. 7: 837-845.
Hakenbeck, R., Bahnelle, N., Weber, B., Gardes, 
Keck, W ., de Saizieu, A. (2001). Mosaic genes and 
mosaic chromosomes: intra- and interspecies genomic 
variation of Streptococcus pneumoniae. Infect. Immun. 
69: 2477-2486.
Haneishi, T., Kitahnra, N., Takiguchi, Y ., Arai, M., 
Sugawara, S. (1974), New antibiotics, methyienomycins 
A and B. I. Producing organism, fermentation and 
isolation, biological activities and physical and chemical 
properties. J. Antibiot. 27 : 386-392.
127
Hatzimanikatis, V., Emmerling, M ., Sauer, U., Bailey, 
J .E . (1998). Application of mathematical tools for 
metabolic design of microbial ethanol production. 
Biotechno!. Bioeng. 58: 154-161.
Herbert, D., Phipps, P .J ., Strange, R .E. (1971).
Chemical analysis of microbial cells. In: Norris, J.R., 
Ribbons, D.W.(eds.): Methods in Microbiology, vol. 5B. 
Academic Press, London, pp. 209-344.
Hesketh, A., Sun, J .,  Bibb, M .J. (2001). Induction of 
ppGpp synthesis in Streptomyces coelicolor A3(2) grown 
under conditions of nutritional sufficiency elicits actll- 
ORF4 transcription and actinorhodin biosynthesis. Mol. 
Microbiol. 39 : 136-144.
Hobbs, G., Frazer, C.M ., Gardner, D .C.J., Flett, F., 
Oliver, S.G. (1990). Pigmented antibiotic production by 
Streptomyces coelicolor A3 (2): kinetics and the influence 
of nutrients. J. Gen. Microbiol 136: 2291-2296.
Hopwood, D.A. and W right, H.M. (1983). CDA is a 
new chromosomally-determined antibiotic from 
Streptomyces coelicolor A3(2). J. Gen. Microbiol 129: 
3575-3579.
Hopwood, D.A., Bibb, M .J., Chater, K .F ., Kieser, T., 
Bruton, C .J., Kieser, H.M ., Lydiate, D .J., Smith, C.P., 
W ard, J.M ., Schrempf, H. (1985). Genetic manipulation 
of Streptomyces: A laboratory manual. The John Innes 
Foundation, F. Crowe & Sons. Ltd., Norwich, England.
Horinouchi, S. and Beppu, T. (1992). Autoregulatory 
factors and communication in Actinomycetes. Annu. Rev. 
Microbiol 46: 377-398.
Horinouchi, S. and Beppu, T, (1993). A-factor and 
streptomycin biosynthesis in Streptomyces griseus. 
Antonie van Leeuwenhoek. 64: 177-186.
Horinouchi, S. (2003). AfsR as an integrator of signals 
that are sensed by multiple serine/threonine kinases in 
Streptomyces coelicolor A3(2). J. Ind. Microbiol 
Biotechnol. 30: 462-467.
Huang, J .,  Lih, C .J., Pan, K.H., Cohen, S.N. (2001).
Global analysis of growth phase responsive gene 
expression and regulation of antibiotic biosynthetic 
pathways in Streptomyces coelicolor using DNA 
microarrays. Genes Dev. 15: 3183-3192.
Huang, J .,  Shi, J . ,  Molle, V., Sohlberg, B., W eaver, D., 
Bibb, M., Karoonuthaisiri, N., Lih, C .J., Kao, C.M., 
Buttner, M .J., Cohen, S.N. (2005). Cross-regulation 
among disparate antibiotic biosynthetic pathways of 
Streptomyces coelicolor. Mol Microbiol. 58 : 1276-1287.
Ingraham, J .L ., Maaloe, O., Neihardt, F .C . (1983).
Growth of the Bacterial Cell. Sinauer, Sunderland, MA.
Jin, W „ Kim, H .K., Kim, J .Y ., Kang, S.G., Lee, S.H.,
Kang, S.G., Jin, W ., Bibb, M .J., Lee, K .J. (1998).
Actinorhodin and undecylprodigiosin production in wild- 
type and relA mutant strains of Streptomyces coelicolor 
A3(2) grown in continuous culture. FEMS Microbiol. 
Lett. 168: 221-226.
Karoonuthaisiri, N„ Weaver, D., Huang, J„  Cohen, S., 
Kao, C. (2005). Regional organization of gene 
expression in Streptomyces coelicolor. Gene. 353: 53-66.
Kawabuchi, M., Hara, Y ., Nihira, T., Yamada, Y .
(1997). Production of butyrolactone autoregulators by 
Streptomyces coelicolor A3(2). FEMS Microbiol. Lett. 
68 : 170-173.
Kieser, H.M., Kieser, T., Hopwood, D.A. (1992). A
combined genetic and physical map of the Streptomyces 
coelicolor A3(2) chromosome. J. Bacteriol. 174: 5496- 
5507.
Kim, E.S., Hong, H .J., Choi, C .Y ., Cohen, S.N. (2001).
Modulation of actinorhodin biosynthesis in Streptomyces 
lividans by glucose repression of afsR2 gene 
transcription. J. Bacteriol 183: 2198-2203.
Kim, H.B., Smith, C.P., Micklefield, J . ,  Mavituna, F. 
(2004). Metabolic flux analysis for calcium-dependent 
antibiotic (CDA) production in Streptomyces coelicolor. 
Metab. Eng. 6 : 313-325.
Kirk, S., Avignone-Rossa, C., Bushell, M .E. (2000).
Growth limiting substrate affects antibiotic production 
and associated metabolic fluxes in Streptomyces 
clavuligerus. Biotechnol Lett. 22 : 1803-1809.
Klamt, S. and Schuster, S. (2002). Calculating as many 
fluxes as possible in underdetermined metabolic 
networks. Mol. Biol. Reports. 29 : 243-248.
Klamt, S., Stelling, J ., Ginkel, M,, Gilles, E.D. (2003).
FluxAnalyzer: exploring structure, pathways, and flux 
distributions in metabolic networks on interactive flux 
maps. Bioinformatics. 19: 261-269.
Lamond, A.I. and Travers, A.A. (1985). Genetically 
separable functional elements mediate the optimal 
expression and stringent regulation of a bacterial tRNA 
gene. Cell. 40: 319-326.
Lawlor, E J . ,  Baylis, H.A., Chater K .F. (1987). 
Pleiotropic morphological and antibiotic deficiencies 
result from mutations in a gene encoding a tRNA-like 
product in Streptomyces coelicolor A3(2). Genes Dev. 1: 
1305-1310.
Lee, I.Y ., Kim, M .K., Park, Y .H ., Lee, S.Y. (1996). 
Regulatory effects of cellular nicotinamides and enzyme 
activities on poly(3-hydroxybutyrate) synthesis in 
recombinant Escherichia coli. Biotechnol Bioeng. 52: 
707-712.
Lee, K .J. (2004). Cephamycm C production is regulated Lee, P.C ., Umeyama, T., Horinouchi, S. (2002). afsS is
by relA and rsh genes in Streptomyces clavuligerus a target of AfsR, a transcriptional factor with ATPase
ATCC27064. J. Biotechnol. 114: 81-87. activity that globally controls secondary metabolism in
Streptomyces coelicolor A3(2). Mol Microbiol. 43: 
Jonsbu, E ., McIntyre, M., Nielsen, J .  (2002). The 1413-1430.
influence of carbon sources and morphology on nystatin 
production by Streptomyces noursei. J. Biotechnol 95:
133-144.
128
Leskiw, B.K ., Law lor, E .J ., Fernandez-Abalos, J.M ., 
Chater, K .F . (1991). TTA codons in some genes prevent 
their expression in a class of developmental, antibiotic- 
negative, Streptomyces mutants. Proc. Natl. Sci. USA. 
88: 2461-2465.
Liras, P., Villanueva, J.R ., Martin, J .F . (1977). 
Sequential expression of macromolecule biosynthesis and 
candicidin formation in Streptomyces griseits. J. Gen. 
Microbiol 102: 269-277.
Lowry, O.H., Rosebrough, N .J., Farr, A .L., Randall, 
R .J. (1951). Protein measurement with the Folin Phenol 
reagent. J. Biol. Chem. 193: 265-275.
Lucchini, S., Thompson, A., Hinton, J.C.D . (2001).
Microarrays for microbiologists. Microbiology. 147: 
1403-1414.
Lynch, H.C. and Busheil, M .E. (1995). The physiology 
of erythromycin biosynthesis in cyclic fed batch culture. 
Microbiology. 141: 3105-3111.
Martin, J .  F . (2004). Phosphate control of the 
biosynthesis of antibiotics and other secondary 
metabolites is mediated by the PhoR-PhoP system: an 
unfinished story. J. Bacteriol. 186: 5197-5201.
M arx, A., Striegel, K ., de Graaf, A.A., Salim, H., 
Eggeling, L . (1997). Response of the central metabolism 
of Corynebacterium glutamicum to different flux 
burdens. Biotechnol. Bioeng. 56: 168-180.
Matsumoto, A., Hong, S.-K., Ishizuka, H., Horinouchi, 
S., Beppu, T. (1994), Phosphorylation of the AfsR 
protein involved in secondary metabolism in 
Streptomyces species by a eukaryotic-type protein kinase. 
Gene. 146: 47-56.
Miclet, E ., Stoven, V., Michels, P.A.M ., Opperdoes, 
F.R ., Latlemand, J.-Y ., Duffieux, F . (2001). NMR
spectroscopic analysis of the first two steps of the 
pentose-phosphate pathway elucidates the role of 6- 
phosphogluconolactonase. J. Biol Chem. 276: 34840- 
34846.
Musialowski, M.S., Flett, F ., Scott, G .B., Hobbs, G., 
Smith, C .P., Oliver, S.G. (1994). Functional evidence 
that the principal DNA replication origin of the 
Streptomyces coelicolor chromosome is close to the 
dnaA-gyrB region. J. Bacteriol. 176: 5123-5125.
Naeimpoor, F. and Mavituna, F. (2000). Metabolic flux 
analysis in Streptomyces coelicolor under various 
nutrient limitations. Metab. Eng. 2 : 140-148.
Obanye, A.I.C., Hobbs, G., Gardner, D .C.J., Oliver, 
S.G. (1996). Correlation between carbon flux through the 
pentose phosphate pathway and production of the 
antibiotic methylenomycin in Streptomyces coelicolor 
A3(2). Microbiology. 142: 133-137.
Oclii, K. (1986). Occurrence of tire stringent response in 
Streptomyces sp. and its significance for the initiation of 
morphological and physiological differentiation. J. Gen. 
Microbiol. 132: 2621-2631.
Oh, M.-K. and Liao, J .C . (2000). Gene expression 
profiling by DNA microarrays and metabolic fluxes in 
Escherichia coli. Biotechnol. Prog. 16: 278-286.
Olinishi, J . ,  Katahira, R., Mitsuhashi, S., Kakita, S., 
Ikeda, M. (2005). A novel gnd mutation leading to 
increased L-lysine production in Corynebacterium 
glutamicum. FEMS Microbiol. Lett. 242: 265-274.
Paget, M.S.B., Chamberlin, L ., Atrih, A., Foster, S.J., 
Buttner, M .J. (1999). Evidence that the 
extracytoplasmic function sigma factor, <yE, is required 
for normal cell wail structure in Streptomyces coelicolor 
A3(2). J. Bacteriol. 181: 204-211.
Paradkar, A., Trefzer, A ., Chakraburtty, R ., Stassi, D. 
(2003). Streptomyces genetics: A genomic perspective. 
Crit. Rev. Biotechnol. 23: 1-27.
Passantino, R ., Puglia, A.M ., Chater K .F. (1991).
Additional copies of the actll regulatory gene induce 
actinorhodin production in pleiotropic bid mutants of 
Streptomyces coelicolor A3(2). J. Gen. Microbiol 137: 
2059-2064.
Petrickova, K. and Petricek, M. (2003). Eukaryotic- 
type protein kinases in Streptomyces coelicolor; 
variations on a common theme. Microbiology. 149: 
1609-1621.
Piper, M.D.W., Daran-Lapujade, P., Bro, C., 
Regenberg, B ., Knudsen, S., Nielsen, J ., Pronk, J.T . 
(2002). Reproducibility of oligonucleotide microarray 
transcriptome analyses. An interlaboratory comparison 
using chemostat cultures of Saccharomyces cerevisiae. J. 
Biol Chem. 277: 37001-37008.
Pirt, S.J., (1975). Principles of Microbe and Cell 
Cultivation. Blackwell Scientific Publications. London, 
UK.
Queener, S.W. and Day, L .E . (1986). The Bacteria: A 
treatise on structure and function. Vol. IX. Antibiotic 
Producing Streptomyces. Academic Press. San Diego.
Richmond, C.S., Glasner, J.D ., Mau, R., Jin, H., 
Biattner, F .R . (1999). Genome-wide expression 
profiling in Escherichia coli K-12. Nuclei. Acids Res. 27: 
3821-3835.
Sato, K ., Nihira, T., Sakuda, S., Yanagimoto, M., 
Yamada, Y . (1989). Isolation and structure of a new 
butyrolactone autoregulator from Streptomyces sp. FRI-5. 
J. Ferment. Bioeng. 68: 170-173.
Schaaff, I., Heinisch, J . ,  Zimmermann, F.K . (1989).
Overproduction of glycolytic enzymes in yeast. Yeast. 5: 
285-290.
Schuster, S., Dandekar, T ., Fell, D.A. (1999). Detection 
of elementary flux modes in biochemical networks: a 
promising tool for pathway analysis and metabolic 
engineering. Trends Biotechnol 17: 53-60.
Scopes, R.K. (1985), 6-phosphogluconolactonase from 
Zymomonas mobilis. An enzyme of high catalytic 
efficiency. FEBS Lett. 193: 185-188.
129
Shaliab, N., Flett F., Oliver, S.G., Butler, P.R. (1996).
Growth rate control of protein and nucleic acid content in 
Streptomyces coelicolor A3(2) and Escherichia coli B/r. 
Microbiology. 142: 1927-1935.
Sola-Landa, A., Moura, R.S., Martin, J .F . (2003). The
two-component PhoR-PhoP system control both primary 
metabolism and secondary metabolite biosynthesis in 
Streptomyces lividans. Proc. Natl. Acad. Sci. USA 100: 
6133-6138.
Sonderegger, M., Jeppson, M., Hahn-Hagerdal, B., 
Sauer, U. (2004). Molecular basis for anaerobic growth 
of Saccharomyces cerevisiae on xylose, investigated by 
global gene expression and metabolic flux analysis. Appl. 
Em. Microbiol 70: 2307-2317.
Sprtisansky, 0 . ,  Zhou, L ., Jordan, S., White, J .,  
Westpheling, J .  (2003). Identification of three new genes 
involved in morphogenesis and antibiotic production in 
Streptomyces coelicolor. J. Bacteriol. 185: 6147-6157.
Stafford, D.E. and Stephanopoulos G. (2001).
Metabolic engineering as an integrating platform for 
strain development. Curr. Opin. Microbiol. 4 : 336-340.
Stephanopoulos, G. and Vallino, J .J .  (1991). Network 
rigidity and metabolic engineering in metabolite 
overproduction. Science. 252: 1675-1681.
Stephanopoulos, G., Aristidou, A., Nielsen, J .  (1998), 
Metabolic engineering : Principles and Methodologies. 
Academic Press. San Diego,
Stephanopoulos, G. (1999). Metabolic fluxes and 
metabolic engineering. Metab. Eng. 1: 1-11.
Stephanopoulos, G. and Stafford, D.E. (2002).
Metabolic engineering: a new frontier of chemical 
reaction engineering. Chem. Eng. Sci. 57: 2595-2602.
Strauch, E ., Takano, E ., Baylis, H.A., Bibb, M .J. 
(1991). The stringent response in Streptomyces coelicolor 
A3(2). Mol. Microbiol 5: 289-298.
Stryer, L . (1995). Biochemistry. WH Freeman, 4th Ed.
Sun, J.H ., Hesketh, A., Bibb, M .J. (2001). Functional 
analysis or re!A and rshA, two relA/spoT homologues of 
Streptomyces coelicolor A3(2). J. Bacteriol 183:3488- 
3498.
Takano, E „  Chakraburtty, R„ Nihira, T ., Yamada, Y ., 
Bibb, M .J. (2001). A complex role for the 
y-butyroiactone SCB1 in regulating antibiotic production 
in Streptomyces coelicolor A3(2). Mol Microbiol 41: 
1015-1028.
Takano, E ., Kinoshita, H., Mersinias, V., Bucca, G., 
Hotchkiss, G., Nihira, T ., Smith, C.P., Bibb, M .J., 
Wohlleben, W ., Chater, K. (2005). A bacterial hormone 
(the SCB1) directly controls the expression of a pathway- 
specific regulatory gene in the cryptic type I polyketide 
biosynthetic gene cluster of Streptomyces coelicolor. 
Mol. Microbiol. 56 : 465-479.
Taucli, A., Homann, I., Mormann, S., Ruberg, S., 
Billault, A., Bathe, B., Brand, S., Brockman-Gretza, 
O., Ruckert, C., Schischka, N., Wrenger, C., Hoheisei, 
J . ,  Mockel, B., Huthmacker, K ., Pfefferle, W ., Puhler, 
A., Kalinowski, J .  (2002). Strategy to sequence the 
genome of Corynebacterium glutamicum ATCC 13032: 
use of a cosmid and a bacterial artificial chromosome 
library. J. Biotechnol 95: 25-38.
Vallino, J .J .  and Stephanopoulos, G. (1994). Carbon 
flux distribution at the pyruvate branch point in 
Corynebacterium glutamicum during lysine 
overproduction. Biotech. Prog. 10: 320-326.
van Dijken, J .P ., van Tuijl, A., Luttik, M.A.H., 
Middelhoven, W .J., Pronk, J .T . (2002). Novel pathway 
for alcoholic fermentation of 5-gIuconolactone in the 
yeast Saccharomyces btdderi. J. Bacteriol 184: 672-678.
Vogtli, M., Chang, P. C., Cohen, S.N. (1994). afsR2: a 
previously undetected gene encoding a 63-amino acid 
protein that stimulates antibiotic production in 
Streptomyces lividans. Mol Microbiol 14; 643-653.
White, J ,  and Bibb, M. (1997). bldA dependence of 
undecylprodigiosin production in Streptomyces 
coelicolor A3(2) involves a pathway-specific regulatory 
cascade. J. Bacteriol 179: 627-633.
Wilson, G.C. and Bushel!, M .E. (1995). The induction 
of antibiotic synthesis in Saccharopolyspora eiythraea 
and Streptomyces hygroscopicus by growth rate decrease 
is accompanied by a down-regulation of protein synthesis 
rate. FEMS Microbiol. Lett. 129: 89-96.
Wilson, M., DeRisi, J . ,  Kristensen, H.H., Imboden, P., 
Raise, S., Brown, P.O., Sclioolnik, G.K. (1999).
Exploring drug induced alterations in gene expression in 
Mycobacterium tuberculosis by microarray hybridization. 
Proc. Natl Acad. Sci. USA 96: 12833-12838.
Yamada, Y ., Sugamura, K., Kondo, K., Yanagimoto, 
M., Oknda, H. (1987). The structure of inducing factors 
for virginiamycin production in Streptomyces virginiae. 
J. Antibiot. 40: 496-504.
Yang, Y.H. and Speed, T. (2002). Design issues for 
cDNA microarray experiments. Nat. Rev. Genet. 3 : 579- 
588.
Yoon, S.H and Lee, S.Y. (2002). Comparison of 
transcript levels by DNA microarray and metabolic flux 
based on flux analysis for the production of poly-y- 
glutamic acid in recombinant Escherichia coli. Genome 
Inform. 13: 587-588.
Youn, H., Kwak, J . ,  Kim, D.W., Lee, C .J., Yim, Y .I., 
Lee, J .W ., Kim, I.K., Yu, J .I ., Yim, H.S., Kang, S.O. 
(2002). Sequence analysis and functional expression of 
the structural and regulatory genes for pyruvate 
dehydrogenase complex from Streptomyces seoulensis. J. 
Microbiol 40: 43-50.
Zhao, Y . and Lin, Y-.H. (2002). Flux distribution and 
partitioning in Corynebacterium glutamicum grown at 
different specific growth rates. Process Biochem. 37 : 
775-785.
130

Appendix A : Data from Batch Cultures
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Figu re A l :  Growth and A CT production profiles for (A ) M 510, (B ) M 717, (C ) M 719, (D ) M 716, (E )  
M 510p lJ8714 , (F ) M 717p lJ8714 , (G ) M 718p IJ8714 and (H ) M 719p lJ8714 grown in batch culture.
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F igu re A 2 : Growth and A C T  production profiles for strains (A ) M 716p IJ8714 and (B ) M 720p lJ8714  grown in 
batch culture.
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The figures below show the data obtained from supernatant analysis for all strains grown in 
batch culture.
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F igu re A 3: Supernatant analysis for strains (A ) M 510, (B ) M 717 and (C ) M 719 grown in batch culture.
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Figu re A 4: Supernatant analysis for strains (A ) M 5 l0 p IJ8 7 l4 , (B ) M 7 l7 p lJ8 7 l4  and (C ) M 7l8 p IJ8 7 1 4  grown 
in batch culture.
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Figu re A 5: Supernatant analysis for strains (A ) M 719p lJ8714 , (B ) M 716, (C ) M 716p lJ8714 , (D ) M 720p IJ8714  
grown in batch culture.
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Appendix B: Overview of ACT and Biomass Yields obtained in Batch and Chemostat Culture
Table B l: Data generated for all strains grown in batch culture.
Strain Peak Biomass (g/L) Peak ACT (g/L) Specific ACT
(g/gbiomass)
ACT Yields
(g/gfilucose)
Biomass Yields
(g/gglucose)
M510 7.91 0.398 S.lxlO'2 1.2x l0"2 2.4x10-*
M716 5.47 0.521 9.7xl0"2 2.2x1 O'2 3.8x10-'
M717 8.76 0.638 7.4xl0"2 1.5x1 O'2 2.3x10*'
M719 5.84 0.022 3.9xl0"3 6.0x 10"4 1.9x10''
M510pLST9828 7.15 0.410 5.89x1 O'2 1.7xl0"2 3.0x10-'
M510pIJ8714 8.95 0.862 9.80x1 O'2 2.6x 1 O’2 2.9x10*'
M716pLST9828 10.11 0.921 9.30x1 O'2 2.4x1 O’2 3.5x10-'
M716pIJ87I4 6.81 0.999 1.45x10-' 3.5x1 O'2 3.0x10-'
M717pLST9828 7.85 0.465 6.10x 10'2 2.1x l0*2 3.4x10-'
M7l7pIJ87i4 * 7.36 1.09 1.54X10'1 3.8xl0"2 2.6x 10-'
M717pIJ8714 7.91 1.07 1.39x10-' 3.5x10‘2 2.6x 10-'
M718pIJ8714 8.00 1.11 1.43x10'' 3.6x10"2 2.6x 10-'
M719pIJ8714 7.77 0.289 3.80xl0"2 1.2x l0"2 3.6x10-'
M720pIJ8714 8.67 1.31 1.54x10-' 4.7xl0"2 3.0x10-'
Table B2: Data generated for all strains grown in chemostat culture.
Strain Growth Rate 
(If1)
Peak Biomass 
(g/L)
Peak ACT (g/L) Specific ACT
(g/gbiomim)
ACT Yields
(g/ggtucosc)
Bioinass Yields
(g/gglucost)
M510pIJ8714
0.04 7.59 0.352 4.63x1 O'2 1.85 xlO4 4.00x10-'
0.06 6.17 0.329 5.30x1 O'2 1.94 xlO’2 3.63x10-'
0.08 5.51 0,304 5.51 xlO'2 2.02x1 O'2 3.67x10-'
M717pIJ8714
0 .04* 5.65 0.780 1.38x10-' 5.78x1 O’2 4.19x10-'
0.04 17.17 1.890 1.09x10-' 5.96x1 O’2 5.43x10-'
0 .06* 7.75 0.628 8.10 xlO’2 3.80 xlO'2 4.69x10-'
0.06 8.56 0.677 7.90x1 O'2 3.47x10‘2 4.39x10-'
0.08 8.00 0.616 7.71 xlO’2 3.85 xlO"2 5.00x10-'
0.10 7.04 0.337 4.80xl0"2 2.04xl0"2 4.27x10-'
M718pIJ87I4
0.04 9.97 1.132 1.14x10-' 7.30 xlO'2 6.43x10-'
0.06 7.40 0.334 4.50 xlO'2 2.09 xlO4 4.62x10-’
0.08 6.73 0.330 4.91 xlO'2 2.64 xlO’2 5.38x10''
M719pIJ8714 0.04 8.66 0.253 2.92x10"2 1.13xl0"2 3.85xl0‘*
JL
The experiment/value reported in the study
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Table C l; The macromolecular composition of biomass for strains grown in batch culture.
Appendix C: Macromolecular Composition Analysis
Strain Condition Protein (%) Carbohydrate
(%)
Lipid (%) RNA (%) DNA (%) Total (%)
M510 Exponential 48.9 11.6 17.4 22.2 5.2 105.3
Stationary 47.7 12.7 15.1 20.4 5.0 100.9
M717 Exponential 46.3 11.2 15.3 23.6 5.1 101.5
Stationary 44.9 13.1 13.9 21.5 4.9 98.3
M719 Exponential 45.6 12.5 17.1 24.1 4.9 104.2
Stationary 42.7 13.9 15.4 20.9 5.0 97.9
M716 Exponential 48.3 10.4 16.7 20.7 5.2 101.3
Stationary 46.9 12.8 14.5 25.1 5.7 105.0
M510pIJ8714 Exponential 44.9 14.9 16.8 21.2 5.3 103.1
Stationary 43.4 15.4 14.6 20.9 5.4 99.7
M717pIJ8714 Exponential 44.6 14.7 14.4 23.2 5.3 102.2
Stationary 42.9 15.6 11.3 22.3 5.2 97.3
M718pIJ8714 Exponential 47.3 13.6 12.9 23.2 5.4 102.4
Stationary 44.6 10.3 14.2 23.5 5.9 98.5
M719pIJ8714 Exponential 43.4 14.9 16.4 20.4 5.4 100.5
Stationary 42.9 14.4 16.2 23.2 5.4 102.1
M716pU8714 Exponential 43.4 13.7 11.0 21.7 5.3 95.1
Stationary 41.2 13.2 12.4 21.4 5.2 93.4
M720pIJ8714 Exponential 42.6 15.2 13.2 24.3 5.9 101.2
Stationary 48.2 14.8 14.7 21.8 5.6 105.1
Table C2: The macromolecular composition of biomass for strains grown in chemostat 
culture.
Strain Growth 
rate (If1)
Protein (%) Carbohydrate
<%)
Lipid (%) RNA (%) DNA (%) Total (%)
M510pIJ8714
0.04 41.2 15.7 13.1 20.3 4.9 95.2
0.06 45.3 15.5 15.4 21.9 5.4 103.5
0.08 45.7 15.4 16.8 22.7 5.0 105.6
M717pIJ8714
0.04 44.8 14.8 9.3 21.9 5.2 96.0
0.06 40.1 14.5 10.5 22.3 5.8 93.2
0.08 46.2 13.0 15.7 24.2 5.1 104.2
M718plJ8714
0.04 43.7 15.2 12.4 22.2 5.0 98.5
0.06 44.5 14.8 14.2 23.3 5.0 101.8
0.08 45.9 13.5 20.1 22.9 5.3 107.7
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Appendix D: Determining the cofactor used bv the oxidative PPF enzymes in S. coelicolor strains
In order to elucidate which cofactor is used by the two oxidative PPP-associated enzymes 
(glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase), both NAD+ 
and NADP+ were applied to cell free extracts obtained from steady state S. coelicolor 
cultures. The change in absorbance (relating to the generation of NADPH at 340nm) was 
monitored and presented in figure Dl.
t im e  ( m in s )  t im e  ( m in s )
time (mins) time (mins)
F ig u re  D l :  T he change in ab sorb an ce is presented fo r glucose-6-phosphate dehydrogenase w hen (A ) 
N A B + and (B ) N A D P+ w ere applied as well as fo r 6-phosphogluconate dehydrogenase when (C ) NAD+ and
(D ) N A D P+ w ere  present. T h e change in ab so rb an ce  is indicative o f  N A D PH  generation  and  hence large  
changes indicate th a t N A D P+ is being utilised in p referen ce to NAD+.
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Reactions Used in the Stoichiom etric Network:
The biochemical reactions listed below were used for the metabolic flux analysis program. 
C e n tra l M etabolism :
Glycolysis:
1 A T P +  1 G LU C =  1 G LU C 6P  
1 G LU C 6P  =  1 FR U 6P  
1 A T P +  1 FR U 6P  =  1 F R U 16P  
1 F R U 16P  =  1 GAP +  1 DHAP  
1 D HAP =  1 GAP  
1 GAP =  1 NADH  +  1 3PDGP  
1 3PDG P =  1 A T P +  1 G3P  
1 G 3P =  1 2PG  
1 2PG  =  1 PEP  
1 P EP  =  I A TP +  1 P Y R
Tricarboxylic Acid Cycle (T C A ):
1 P Y R  =  1 A CCO A  +  1 C 0 2  +  1 NADH  
I A CCO A  +  1 O AA =  1 CIT  
1 CIT =  1 ISOC1T
1 ISO CIT =  1 AKG  +  1 C 0 2  +  1 N ADPH  
1 A KG  => 1 C 0 2  +  1 NADH +  1 SUCCO A  
1 SUCCO A  =  1 A TP +  1 SUC  
1 SUC =  1 FA D H  +  1 FU M  
1 FU M  =  1 M A L  
1 M A L =  1 NADH  +  1 OAA
Pentose Phosphate Pathway (P PP ):
1 G LU C 6P  =  1 N ADPH +  1 6PPG L  
1 6P PG L  =  1 6PPG
1 6PPG  =  1 C 0 2  +  1 N A D PH  +  1 R U 5P  
1 R U 5P  =  1 R IB 5P  
1 R U 5P  =  I X Y L 5 P
1 R IB 5P  +  1 X Y L 5 P  =  1 GAP +  1 SED 7P  
1 GAP +  1 SED 7P =  1 E R Y 4 P  +  1 FR U 6P  
1 E R Y 4 P  +  1 X Y L 5 P  =  1 FR U 6P  +  1 GAP
Appendix E ;
Anaplerotic Metabolism: 
1 C 0 2  +  1 P E P  =  1 OAA
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Primary Metabolism:
Amino Acid Synthesis:
1 AKG + 1 NADPH + 1 NH4 = 1 GLU 
1 ATP + 1 GLU + 1 NH4 = 1 GLN 
1 ATP + I ERY4P + 1 NADPH + 2 PEP = 1 CHOR 
1 CHOR = 1 PREPH 
1 PREPH = 1 C02 + 1 PHENPYR 
I GLU + 1 PHENPYR = 1 AKG + 1 PHE 
I PREPH = I C02 + I NADH + 1 p-HYPPYR 
I GLU + 1 p-HYPPYR = 1 AKG + 1 TYR 
1 ATP + 1 GLU = 1 GLU-5-P 
1 NADPH + 1 GLU-5-P = 1 GLUSEMALD 
1 NADPH + 1 GLUSEMALD = 1 PRO 
1 ACCOA + 1 GLU = 1 ACEGLUT 
1 ATP + 1 ACEGLUT = 1 ACEGLUP 
1 GLU + 1 ACESEMALD = 1 AKG + 1 ACETORN
1 ACETORN = 1 ORN
2 ATP + 1 GLN = 1 GLU + 1 CARBP 
1 ORN + 1 CARBP = 1 CITRUL
1 ASP + 1 ATP + 1 CITRUL = 1 ARG_SUC 
1 ARGSUC = 1 ARG + 1 FUM 
1 ASP + 1 ATP = 1 ASP-4-P 
1 NADPH + 1 ASP-4-P = 1 ASPSEMALD 
1 G3P = 1 3PPHYDPYR 
1 GLU + 1 3PPHYDPYR = 1 AKG + 1 3PPSER 
1 3PPSER = 1 SER 
1 SER = 1 GLY
I ACCOA + 1 SER = 1 ACESER 
I ACESER = 1 CYS 
1 GLU + 1 OAA= 1 AKG + 1 ASP 
1 NADPH + 1 ASPSEMALD = 1 HSER 
1 ATP + 1 HSER = 1 PPHSER 
1 PPHSER = 1 THR 
1 SUCCOA + 1 HSER= 1 SUCHSER 
1 CYS + 1 SUCHSER = 1 SUC + 1 CYSTA 
1 CYSTA = 1 NH4 + 1 PYR + 1 HCYS 
1 HCYS = 1 MET 
1 THR= 1 OXOBUT
1 P Y R  +  1 O X O B U T  =  1 C 0 2  +  1 A C E 2H Y D -B U T  
1 N ADPH  +  1 A C E 2H Y D -B U T  =  1 2 ,3 ,D H Y D 3M V A L  
1 2,3  JD H YD 3M V A L =  1 2K E T 3M V A L  
1 G LU  +  1 2K E T 3M V A L  =  1 A KG  +  1 I L E
1 PYR + 1 VAL = 1 ALA + 1 2KETOISOVAL
2 PYR = 1 C02 + i 2-ACETOLAC
1 2-ACETOLAC = 1 2,3DHISOVAL 
1 2,3DHISOVAL = 1 2KETOISOVAL 
1 GLU + 1 2KETOISOVAL = 1 AKG + 1 VAL 
1 ACCOA + 1 2KETOISOVAL = 1 3C3HYDISOCAP 
1 3C3HYDISOCAP = 1 2DTHYD3CISOCAP 
1 2DTHYD3CISOCAP = 1 2KETO-4M-PENT 
1 GLU + 1 2KETO-4M-PENT = 1 AKG + 1 LEU 
1 GLN + 1 CHOR= 1 GLU + 1 PYR+ 1 ANT 
1 ANT + 1 PRPP = 1 N5PHORIBANT 
1 N5PHORIBANT = 1 CARBDEOXY5P 
1 CARBDEOXY5P = i C02 + 1 IND-3-GLYP 
1 SER + 1 IND-3-GLYP = i GAP + 1 TRP
1 A TP +  1 PR PP =  1 PPR IBA TP  
1 PPR IB A T P -  1 PPR IBA M P  
1 PPR IB A M P -  1 PPR IBFO R M P  
1 PPR IB FO R M P =  1 PPR IB U L O F ORM P
1 GLN +  I PPR IB U LO F ORM P =  1 G LU  +  1 D E R Y IM IG L Y  +  1 A ICA R  
1 D E R Y IM IG L Y  =  1 IM IACEP  
1 G LU  +  1 IM IACEP =  1 AKG  +  I HISP  
1 HISP =  1 H ISTO L  
1 H ISTO L =  I H Y S
1 G LU  +  1 N A D PH  +  1 P Y R  +  1 SUCCO A  +  1 A SPSEM A LD  =  1 AKG +  1 C 0 2  +  1 L Y S  +  1 SUC  
1 A SP +  1 A TP +  1 N H 4 =  1 ASN  
1 N ADPH +  1 A C E G L U P  =  1 A C ESEM A LD
1 A SP +  4  A T P +  1 C 0 2 +  1 G L Y +  1 PR PP =  2 G L U +  1 M A L +  1 A ICA R  
1 A T P +  1 R IB 5P  =  1 PR PP
E n erg y  M etabolism :
Oxidative Phosphorylation:
2 NADH +  1 0 2  =  4  A TP  
2  FA D H  +  1 0 2  -  2  ATP
Transhvdroeenase:
1 N ADPH  -  1 NADH
M acrom olecules:
P ro te in :
0 .7 9  A L A  +  0 .4 5 4  ARG  +  0 .7 4  A SP +  2 5 .4  A T P +  0 .141  C Y S  +  0 .943  G L Y  +  0 .7 7 7  GLN +  0 .0 3 4  G LU +  0 .1 4 6  
H Y S  +  0 .4 4 6  IL E  +  0 .6 9 4  L E U  +  0 .5 2 9  L Y S  +  0 .2 3 7  M E T  +  0 .2 8 5  PH E +  0 .34  PRO  +  0 .3 3 2  SER  +  0 .3 9  TH R  
+  0 .0 8 7 6  T R P +  0 .2 1 2  T Y R  +  0 .651 V A L  =  P R O T
C a rb o h y d rate :
5 .55  A TP +  5 .55  G LU C 6P =  P S A C  
Lipids:
3 1 .25  A CCO A  +  2 7 .3 4  A TP +  5 4 .6 9  N ADPH  =  L IP  
R N A :
4 .5 4  A SP +  3 3 .4 9  A TP +  1.72 C 0 2  +  1.72 G L Y  +  7 .1 0 3  GLN +  3 .6 8 6  R U 5P =  R N A  
DNA:
2 .6  A SP +  2 4 .1 4  A TP +  1.3 C 0 2  +  1.3 G L Y  +  6 .51  G LN  +  0 .5 0 6  NADPH +  2 .6  R U 5P  =  DNA  
P ro d u ct F o rm atio n :
Actinorhodin Biosynthesis:
16 A CCO A  +  16 A T P +  6  N A D PH  -  1 A C T  +  3 NADH
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Appendix H: Correlation Analysis
Correlation analysis was carried out in Excel to measure the relationship between (in this 
case) the carbon flux through a particular reaction and ACT synthesis in individual strains 
grown at three different rates. A correlation value of 1.0 indicated that there was a strong 
positive correlation with ACT production, whereas a value of -1.0 indicated a strongly 
negatively correlating reaction (see section 4.3.7).
T ab le H I : T he correlation  coefficients gen erated  from  M F A  results fo r s train  M 5 1 0 p IJ8 7 1 4  grow n a t  
th ree different rates. Selected reaction s corre la tin g  to specific A C T  production a re  presented , w hich eith er  
positively o r  negatively correlated  w ith A C T  synthesis.
Reaction Correlation Coefficient
Isocitrate to a-Ketoglutarate 0.999
RIB5P +  XYL5P =  GAP +  SED7P 0.999
Glyceraldehyde-3-phosphate to 1,3-Bisphosphoglycerate 0.993
6-Phosphoglucono-S'lactone to 6-Phosphogiuconate 0.992
Glucose-6-phosphate to 6-Phosphoglucono-S-lactone 0.990
Pyruvate to Acetyl-CoA 0.977
Serine Synthesis 0.955
Glycine Synthesis 0.941
Cysteine Synthesis 0.909
Methionine Synthesis 0.894
Citrate to Isocitrate 0.887
Acetyl-CoA to Citrate 0.876
Glucose-6-phosphate to Fructose-6-phosphate 0.739
Fructose-6-phosphate to Fructose 1,6-bisphosphate 0.344
6-Phosphogluconate to Ribulose-5-phosphate -0.353
Glutamate Synthesis -0.471
Tryptophan Synthesis -0.502
Glutamine Synthesis -0.690
ERY4P +  XYL5P =  FRU6P +  GAP -0.817
Asparagine Synthesis -0.876
Leucine Synthesis -0.890
Ribulose-5-phosphate to Ribose-5-phosphate -0.895
Aspartate Synthesis -0.917
GAP +  SED7P -  ERY4P +  FRU6P -0.939
Isoleucine Synthesis -0.952
Phosphoenolpyruvate to Pyruvate -0.968
Glyceraldehyde-3-phosphate to 2-Phosphoglycerate -0.987
2-Phosphoglycerate to Phosphoenolpyruvate -0.989
1,3-bisphosphoglycerate to 3-Phosphoglycerate -0.997
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Table H2: The correlation coefficients generated from MFA results for strain M717pIJ8714 grown at 
three different rates. Selected reactions correlating to specific ACT production are presented, which either 
positively or negatively correlated with ACT synthesis.
Reaction Correlation Coefficient
GAP +  SED7P -  ERY4P +  FRU6P 0.997
Isoleucine Synthesis 0.997
Histidine Synthesis 0.996
Aspartate Synthesis 0.993
3-Phosphogiycerate to 2-Phosphogiycerate 0.983
ERY4P +  XYL5P =  FRU6P+ GAP 0.953
RIB5P +  XYL5P =  GAP +  SED7P 0.950
Methinone Synthesis 0.946
Phosphoenolpyruvate to Pyruvate 0.943
2-Phosphoglycerate to Phosphoenolpyruvate 0.941
Pyruvate to Acetyl-CoA 0.826
Fructose-6-phosphate to Fructose 1,6-bisphosphate 0.632
Glycine Synthesis 0.408
Asparagine Synthesis -0.630
6-Phosphoglucono-8-lactone to 6-Phosphogluconate -0.671
Glucose-6-phosphate to 6-Phosphoglucono-5-Iactone -0.681
6-Phosphogluconate to Ribulose-5-phosphate -0.692
Cysteine Synthesis -0.891
Tyrosine Synthesis -0.846
Glutamate Synthesis -0.862
Threonine Synthesis -0.878
Isocitrate to a-Ketoglntarate -0.912
Leucine Synthesis -0.920
Tryptophan Synthesis -0.931
1,3-Bisphosphoglycerate to 3-Phosphoglycerate -0.939
Glutamine Synthesis -0.963
Citrate to Isocitrate -0.993
Serine Synthesis -0.994
Ribulose-5-phosphate to Ribose-5-phosphate -0.998
Acetyl-CoA to Citrate -0.998
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Table H3: The correlation coefficients generated from MFA results for strain M718pIJ8714 grown at 
three different rates. Selected reactions correlating to specific ACT production are presented, which either 
positively or negatively correlated with ACT synthesis.
Reaction Correlation Coefficient
Isoleucine Synthesis 0.999
ERY4P +  XYL5P =  FRU6P +  GAP 0.996
Phosphoenolpyruvate to Pyruvate 0.993
Phenylalanine Synthesis 0.989
Pyruvate to Acetyi-CoA 0.965
Aspartate Synthesis 0.963
Histidine Synthesis 0.963
6-Phosphogluconate to Ribulose-5-phosphate 0.936
Succinyl-CoA to Succinate 0.926
GAP +  SED7P =  ERY4P +  FRU6P 0.913
Leucine Synthesis 0.902
RibuIose-5-phosphate to Xylulose-5-phosphate 0.852
Fructose-6-phosphate to Fructose L 6-bisphosphate 0.845
RIB5P +  XYL5P =  GAP +  SED7P 0.793
Glycine Synthesis 0.782
3-Phosphoglycerate to 2-Phosphoglycerate 0.529
2-Phosphoglycerate to Phosphoenolpyruvate 0.378
1,3-bisphosphoglycerate to 3-Phosphoglycerate -0.014
6~Phosphoglucono-8-lactone to 6-Phosphogluconate -0.379
Glutamate Synthesis -0.471
GIucose-6-phosphate to 6-phosphoglucono-S-Iactone -0.524
Ribulose-5-phosphate to Ribose-5-phosphate -0.649
Acetyl-CoA to Citrate -0.924
Citrate to Isocitrate -0.938
Alanine Synthesis -0.958
Cysteine Synthesis -0.991
Serine Synthesis -0.995
Glucose-6-phosphate to Fructose-6-phosphate -0.999
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Appendix I: Genes Associated with High ACT Conditions
At 0.041Y1, strains M717pIJ8714 and M718pIJ8714, generated higher ACT yields than the 
control strain, hence genes that were up/down-regulated in both these strains were analysed. 
Applying such a filtering method meant that despite the lack of replicates, genes that were 
up/down-regulated in both strains were considered. Table II lists a selection of genes that 
were found to be up-regulated twofold or more in the zwf deletion mutant strains compared 
to strain M510pIJ8714 at 0.04h_1.
Table II: A list of genes that are up-regulated twofold or more in the zwf deletion strains at 0.041F1 compared to strain M510pIJ8714. 
A total of 182 genes were found to be up-regulated but most were hypothetical proteins etc. Therefore, only genes that are associated 
with antibiotic production, growth or metabolism are listed.
SCO Number Common
Name
Annotation E.C. Number
SC07119 SC4B 10.20 A possible D-3-phosphogiycerate dehydrogenase 1.1,1.95
SC03225 absAl Sensor kinase
SCO2720 SCC46.05c Possible long-chain fatty acid ligase 6.2.1.3
SC00706 SCF42.16c Possible lipoprotein. Leu-, isoleu-, thr-, ala- 
binding protein precursor
SC06284 SC1G7.10 Probable decarboxylase. Similar to 
simocyclinone biosynthesis involved in 
polyketide formation
4.1.1.41
SC06962 SC6F7.15C Possible glutamine synthetase
SC06552 SC4B5.02c Possible long-chain fatty acid-CoA ligase 6.2.1.3
SC04621 traAl Possible spondation related protein
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Table 12 presents genes that were found to be down-regulated by at least twofold in the two 
zwf deletion strains compared to the ‘control’ M510pIJ8714 strain at 0.041Y .
Table 12: Genes that are down-regulated twofold or more in the zwf deletion strains at 0,04h_1 compared to strain M510pIJ8714. A 
total of 339 genes were found to be down-regulated but most were hypothetical proteins etc. Therefore, only genes that are associated 
with antibiotic production, growth or metabolism are listed.
SCO number Common Name Annotation E.C. number
SC06444 SC9B5.11 Probable y-glutamyl transferase (towards glutamate 
synthesis)
2.3.2.2
SC07412 SC6D 11.08 Possible pyruvate dehydrogenase 1.2.4.1
SC05483 SC2A11.17c Probable transcriptional regulator, tetR family
SCO5042 fuinC Fumarate hydratase C 4.2.1.2
SC05236 nagB Probable glucosamine phosphate isomerase 5.3.1.10
SC01746 sal Secreted serine protease
SC01547 SCL11.03c Possible anthranilate synthase 4.1.3.27
SCO2052 hisB Imidazoleglycerol-phosphate dehydratase 4.2.1.19
SCO2014 pykl Pyruvate kinase 2.7.1.40
SC02147 trpDl Phosphoribosylanthranilate transferase 2.4.2.18
SC01912 SCI7.30 Probable dihidrodipicolinate synthase 4.2.1.52
SC01889 SCI7.07c Probable dihydropicolinate synthase
SCO2450 SCC24.21 Possible protein kinase. Serine/threonine protein kinase
SC04214 2SCD46.28c Possible Aba-A like regulatory protein. Pleiotropic 
regulatory protein
SC03356 SCE94.07 ECF sigma factor
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At 0.06h4 , strain M717pIJ8714 generated the highest ACT yields, hence genes found to be 
up/down-regulated by twofold or more in the M717pIJ8714 strain alone compared to strains 
M510pIJ8714 and M718pIJ8714, were investigated. Table 13 lists the up-regulated genes 
found in the M717pIJ8714 strain.
Table 13: Genes up-regulated twofold or more in strain M717pIJ8714 at 0.06b'1 compared to M510pIJ8714 and M718pIJ8714. A 
total of 324 genes were found to be up-rcgulatcd but most were hypothetical proteins etc. Therefore, only genes that are associated 
with antibiotic production, growth or metabolism are listed.
SCO number Common
Name
Annotation E.C. number
SC06284 SC1G7.10 Probable decarboxylase, involved in polyketide formation 4.1.1.41
SC07168 SC9A4.30 Probable gntR-family transcriptional regulator
SC07040 gap2 Probable glyceraldehyde-3-phosphate dehydrogenase 1.2. 1.12
SC0237I aceE2 Pyruvate dehydrogenase E l component 1.2.4.1
SC02266 uiap3 Methionine aminopeptidase 3.4.11.18
SC02518 SCC121.21c Possible two-component sensor kinase
SC01838 SCI8.23c Possible enoyl-CoA hydratase-isomerase
SCO3350 SCE94.01c Alanine-rich protein
SC01568 SCL24.04c Probable tetR-family transcriptional regulator
SCO 1612 SCI35.34c Probable aldehyde dehydrogenase 1.2.1.39
SCO4850 SC5G8.18C Possible tetR- family transcriptional regulator
SCO5077 actVA2 Hypothetical protein in foe actinorhodin biosynthetic gene 
cluster
SCO5078 actVA3 Hypothetical protein in the actinorhodin biosynthetic gene 
cluster
SCO4808 sucC Succinyl-CoA synthetase p-chain 6.2.1.5
SCO5079 actVA4 Hypothetical protein in foe actinorhodin biosynthetic gene 
cluster
SCO5085 actII-4 Actinorhodin cluster activator protein
SCO5086 actlll Ketoacyl reductase
SC04214 2SCD46.28c Possible AbaA-like pleiotropic regulatory protein
SCO4620 traBl Possible sporulation-related protein
SC04377 SCD10.09 Possible serine-threonine protein kinase, AfsK 2.7.1.37
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Table 14 presents a list of genes that were found to be down-regulated in the M717pIJ8714 
strain compared to both strains that made less actinorhodin, (M510pIJ8714 and 
M718pIJ8714) at 0.06h'‘.
Table 14: Genes that are down-rcgulatcd by twofold or more in strain M717pIJ8714 at O.O6I1'1 compared to strains M510pIJ8714 and 
M718pIJ8714. A total of 188 genes were found to be down-regulated but most were hypothetical proteins etc. Therefore, only genes 
that are associated with antibiotic production, growth or metabolism are listed.
SCO number Common Name Annotation E.C. number
SC07221 SC2H12.20C Possible polyketide synthase
SC02183 aceEl Probable pyruvate dehydrogenase El component 1.2.4.1
SCO0582 SCF55.06 Possible transcriptional regulator. Sim. to E.coli pyruvate 
dehydrogenase complex repressor PdhR.
SCO0992 2SCG2.05 Possible cysteine synthase 2.5.1.47
SC05845 SC9B10.12 Possible thymidine kinase 2.7.1.21
SC06254 SCAH10.19 Possible two-component response regulator. Sim. to 
S. coelicolor AbsA2.
SC04223 2SCD46.37C Possible AraC-family transcriptional regulator
SC03471 dagA Extracellular agarase precursor 3.2.1.81
At O.OBh"1, strain M717pIJ8714 once again generated higher ACT yields compared to the 
other two strains, M510pIJ8714 and M718pIJ8714. Hence, this reflected the way in which the 
analysis was carried out at this growth rate. Table 15 presents a selection of genes found to be 
up-regulated in strain M717pIJ8714 compared to both M510pIJ8714 and M718pIJ8714.
Table 15: Genes that are up-regulated by twofold or more in strain M717pIJ8714 strain at O.OSh"1 compared to strains M510pIJ8714 
and M718pIJ8714 (which generated reduced concentrations of ACT). A total of 127 genes were found to be up-regulated but most 
were hypothetical proteins etc. Therefore, only genes that are associated with antibiotic production, growth or metabolism are listed.
SCO number Common Name Annotation E.C. number
SC04145 ppk Polyphosphate kinase 2.7.4.1
SC03941 SCD78.08c Probable serine/lhreonine phosphatase
SC01272 2SCG18.19c Probable acyl carrier protein. Sim. S. coelicolor ACT 
polyketide synthase acyl carrier protein
SC02183 aceEl Probable pyruvate dehydrogenase El component 1.2.4.1
SC06745 SC5F2A.28c Alanine-rich protein
SCP1.236 mmyK Possible ATP/GTP-binding protein
SCO 1262 2SCG18.09c Probable gntR-family transcriptional regulator
SC01263 2SCG18.10c Probable ECF-sigma factor
SC02814 SCBAC17F8.05c Possible methylotransferase. Sim. to doxorubicin 
polyketide biosynthesis gene cluster
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Table 16 displays the genes that were found to be at least twofold down-regulated in the 
strain M717pIJ8714 compared to M510pIJ8714 and M718pIJ8714, grown at O.O8I1'1.
Table 16: Genes that were down-regulated by twofold or more in strain M717pIJ8714 at 0.08b1 compared to M510pIJ8714 and 
M 7l8plJ8714 (which produced reduced concentrations of ACT). A total of 176 genes were found to be down-regulated but most 
were hypothetical proteins etc. Therefore, only genes that are associated with antibiotic production, growth or metabolism are listed.
SCO number Common Name Annotation E.C. number
SC06253 SCAH10.18 Possible two-component sensor kinase
SC06237 SCAH10.02 Possible regulatory protein, sim. to ORFA in abaA gene
SC06979 SC8F 11.05 Probable solute-binding lipoprotein
SC04778 pkal Serine/threonine protein kinase
SC05553 leuC 3-isopropyimalate dehydratase large subunit 4.2.1.33
SCO0578 SCF55.02c Possible triosephosphate isoinerase
SC03851 SCH69.21c Probable glutamine amidotransferase 6.3.S.8
SCO3820 SCGD3.21c Probable serine/threonine protein kinase
SC04223 2SCD46.37C Possible AraC-family transcriptional regulator
SC02734 SCC57A.05 Possible LysR-family transcriptional regulator
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Appendix J :  Raw  M icroarray  D ata
The table below presents the expression values for the genes associated with primary 
metabolism and ACT production at the various growth rates tested. A value of 1.0 indicates 
an expression level equal to that of the level found in the reference strain, S. coelicolor Ml 45. 
Table Jl: Raw gene expression data for genes associated with primary metabolism and ACT synthesis in 
the various strains and conditions tested. The value presented is an average of two expression values 
(replicates) generated by the ImaGene program.
Gene/E.c M 5 1 0 p IJ8 7 1 4 M 7 1 7 p IJ8 7 1 4 M 7 1 8 p IJ8 7 1 4
0 .0 4 b 1 0 .0 6 b '1 o .o s ir1 0 .0 4 b 1 0 .0 6 b '1 0.081T1 0 .0 4 b 1 0 .0 6 b '1 0 .0 8 b '1
glk 
2.1 A 2
0 .72 1.12 0 .8 6 1.08 0 .8 9 0 .99 0 .87 1.07 0 .8 6
pgi2
5 .3 .1 .9
2 .7 2 1.22 1.48 1 .07 1.62 2 ,55 1.39 1.66 2.31
pflcA
2 .7 .1 .1 1
1.15 0 .7 4 0 .7 5 0 .9 9 1.32 1.00 1.39 1.40 1.14
fba
4 .1 .2 .1 3
0 .98 1.10 1.71 1 .20 1.13 1.40 0 .93 0 .8 9 1.45
tpiA 
5 .3 .1 .1
1.45 0 .8 2 1.59 0 .9 4 1.36 1.56 0 .9 4 0 .7 7 1.30
gapl
1 .2 .1 .12
1.64 1.23 5.75 2 .0 4 2 .8 5 3 .67 2 .1 4 2 .95 5 .46
Sap2
1 .2 .1 .12
1.42 0 .4 6 2 .8 4 0 .9 8 1.16 0 .77 0 .3 8 0 .2 2 1.07
Pgk
2 .1 2 3
0 .57 1.11 1.67 1.19 0 .9 9 2 .0 4 1.06 1.52 2 .4 4
pgm2
5.4 .2 .1
0 .7 2 0 .85 0 .65 0 .4 2 0.71 0 .5 0 0 .4 5 0 .4 4 0.71
eno
4 .2 .1 .11
0 .8 0 1.15 0 .9 6 0 .8 7 0 .9 9 0.91 0 .8 9 0 .7 5 0 .83
eno2
4 .2 .1 .1 1
0 .7 9 0 .73 0 .7 6 1.01 0 .7 4 0 .7 0 0 .8 8 1.03 0 .8 8
pykl
2 .7 .1 .4 0
9 .3 7 3 .3 7 7 .45 2 .8 9 5 .8 4 4 .1 9 2 .33 1.72 3.31
pykl
2 .7 .1 .4 0
15.29 7.73 7 .9 4 18.24 6 .4 2 13.36 16.92 17.74 13.18
aceEl 
1.2.4.1
1.00 1.98 0 .8 9 1.40 0 .7 6 2 .1 0 0 .87 2 .7 0 0.71
aceE2 
1.2.4.1
0 .53 0.211 0 .5 6 0 .4 8 0.81 0 .4 0 0 .3 0 0 .1 6 0 .4 8
aceES 
1.2.4.1
0 .6 8 1.08 0 .81 0 .7 7 1.05 0 .8 2 1.11 1.98 0 .7 2
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Gcnc/E,c M510pIJ8714 M717pIJ8714 M718pIJ8714
0.04h_1 o.oeh1 o.osir1 0.04IT1 O.O6I11 0.08H'1 0.04h1 O.O6I11 0.08h_1
citA 
2 .3 .3 .1
1.30 0 .7 0 2 .1 6 0 .9 7 1.37 1.09 1.08 0.71 0 .97
S C 0 4 3 8 8  
2 .3 .3 .1
1.67 1.60 0.81 1.65 0 .5 9 0 .6 5 1.89 1.10 0 .7 2
sacA 
4 .2 .1 .3
1.24 1.18 1.37 1.03 1.06 0 .8 6 1.22 0 .52 0 .8 7
idh
1 .1 .1 .42
0.71 0 .96 0 .8 5 0.81 1.21 0 .94 1.37 0 .60 0 .97
S C 0 6 2 6 9  
1.2.7.3
0 .8 2 0 .5 8 0 .95 0 .58 0 .63 0 .7 4 0 .6 8 0 .3 8 0 .8 4
S C O 6270  
1.2 .7 .3
0 .6 6 0.51 0 .71 0 .5 0 1.65 0 .60 0.51 1.27 0 .6 5
sucC  
6 .2 .1 .5
1.69 0 .9 5 3 .8 0 2 .05 2 .9 4 1.90 1.79 1.22 2 .1 7
sucD  
6 .2 .1 .5
1.14 1.70 2 .0 0 2 .03 1.97 2.41 2 .1 2 1.14 1.94
dhsA
1.3.99.1
0 .98 1.05 1.16 1.01 1.22 0 .99 0 .9 4 2 .8 5 1.17
dhsB
1.3.99.1
3 .1 5 0.91 3 .39 2 .1 8 1.71 1.99 1.85 2 .55 3 .6 5
fum C  
4 .2 .1 .2
1.73 0.71 0 .9 9 0 .6 8 0 .4 7 1.56 0.51 2 .1 7 0 .5 9
fumB 
4 .2 .1 .2
2 .9 7 2 .8 8 4 .1 7 2 .2 9 2 .01 1.55 2.91 2 .6 6 2.41
mdh
1 .1 .1 .37
2 .1 8 1.32 2 .3 4 1.72 1.78 2.21 1.43 1.06 1.61
zwfl
1 .1 .1 .49
0 .7 8 0 .37 0 .9 6 0 .9 4 1.06 1.27 1.36 0 .9 9 1.02
(idevB) 
3 .1 .1 .31
0 .38 0.41 0 .49 0 .6 4 0 .6 2 0.61 0 .93 0 .3 2 2 .8 2
zwfi
1 .1 .1 .44
0 .53 1.18 0 .6 2 0 .7 0 0 .9 7 0 .88 0.81 1.41 0 .61
SC O 0579  
5 .3 .1 .6
0 .47 0 .7 8 0 .4 9 0.63 0 .6 4 0 .65 0 .6 7 0 .37 0 .5 8
SCO 1224  
5 .3 .1 .6
0 .5 0 0 .7 6 0 .50 0 .7 8 0 .5 8 0.71 0 .5 4 0.43 0.61
S C 0 2 6 2 7  
5 .3 .1 .6
0 .67 0 .8 7 0.71 0.73 0 .5 8 0 .45 0 .5 4 0 .8 9 0 .53
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Gene/E.c M 5 1 0 p IJ8 7 1 4 M 7 1 7 p IJ8 7 1 4 M 7 1 8 p IJ8 7 1 4
0 .0 4 h “l 0 .06h _1 O.O8I1'1 0 .0 4 1 I1 o.06i r l O.O8I1'1 0.04111 0 .0 6 b '1 O.OSh'1
rpe 
5 .1 ,3 .1
1.17 1.06 1.45 1.04 1.08 1.29 1.05 0.71 0 .9 9
tlctAl 
2 .2 .1 .1
0 .9 4 0 .8 9 1.41 1.09 0 .9 0 1.21 1.36 0 .9 5 0 .9 6
tktA2 
2 .2 .1 .1
0 .8 8 1.66 1.07 1.00 0 .9 5 1.05 0.91 0 .72 0 .9 2
tal2 
2 .2 .1 .2
0 .4 5 0 .63 1.66 0 .58 0 .6 0 0.71 0 .77 1.24 0 .7 7
S C 0 4 9 7 9
4 .1 .1 .3 2
0 .63 0 .3 0 0 .3 9 0 .98 0 .3 9 1.20 0 .20 1.01 1.28
pntA 
1 .6 .1.2
1.27 1.30 1.69 1.46 2 .03 2 .0 5 1.99 1.88 2.21
gdhA 
1 .4 .1 .4
1.18 0 .63 1.16 0 .6 9 1.00 0 .8 9 0 .8 8 0.93 0 .9 6
glnA 
6 .3 .1 .2
1.22 1.45 1.20 1.21 0 .8 2 1,01 0 .85 2 .13 1.12
glnll 
6 .3 .1 .2
1.06 0 .7 9 0 .9 9 0.61 0 .6 8 0 .9 0 0 .4 0 0 .4 2 0 .9 4
pheA
4 .2 .1 .5 1
0 .6 7 0 .73 0 .5 5 1.22 0 .5 6 0 .4 2 0 .6 8 0 .8 9 0 .4 8
hisCl 
2 .6 .1 .9
1.30 0 .77 2 .2 9 1.39 1.52 1.25 1.03 1.04 1.20
hisC2 
2 .6 .1 .9
0 .8 0 0 .58 0 .7 2 0 .5 7 0 .8 0 0 .7 4 0.61 0 .3 4 0 .6 8
aspC 
2 .6 .1 .1
0 .58 0 .7 2 0 .98 1.16 1.08 0 .69 0 .3 8 0.65 0 .9 6
proC  
1.5 .1 .2
0 .5 6 0 .6 9 0 .63 0 .7 2 0 .6 7 0 .72 0 .7 5 0 .5 7 0 .7 8
arcB 
2 .1 .3 .3
0 .6 8 1.04 0 .6 5 0 .83 0 .87 0 .78 1.35 0 .8 6 0 .5 2
argH  
4 .3 .2 .1
1 .30 1.39 1.15 1.59 1.20 1.05 1.48 0 .87 1.00
SCO 1808  
3 .1 .3 .3
3 .5 4 2 .1 9 2 .6 5 2 .1 6 2 .1 0 2 .1 4 1.79 3 .5 7 2 .5 8
glyAl
2.12.1
0 .8 7 0 .98 0 .9 2 0 .95 0 .75 0 .72 0 .81 1.10 0.81
glyA2 
2 .1 .2 .1
2 .8 9 2.91 1.21 1.79 1.87 1.33 1.01 1.05 1.78
SCO 1028  
2 .5 .1 .4 7
0 .5 6 0 .5 7 0 .6 4 0 .8 5 0 .9 5 0 .6 6 0 .5 6 0 .6 4 0 .6 9
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Gene/E.c M 5 1 0 p IJ8 7 1 4 M 7 1 7 p IJS 7 1 4 M 7 1 8 p IJ8 7 1 4
0 .0 4 b 1 0 .0 6 b 1 0 .0 8 b 1 0 .0 4 b '1 0 .0 6 b 1 0 .0 8 b '1 0.04b"1 0.06b*1 0 .0 8 b '1
SC O 2910
2 .5 .1 .4 7
1.08 1.18 0 .8 9 0 .8 6 0 .95 1.06 0 .93 0 .8 6 0 .9 7
aspC 
2 .6 .1 .1
0 .5 8 0 .7 2 0 .9 8 1.16 1.08 0 .69 0 .3 8 0 .65 0 .9 6
thrC 
4 .2 .3 .1
1.18 0.71 2.01 1.40 1.31 1.06 0 .8 4 0 .86 0 .9 8
S C 0 4 2 9 3  
4 .2 .3 .1
0 .61 0 .67 0 .5 2 1.74 0 .6 0 1.37 3 .8 9 1.09 1.60
SCO 1546  
2 .6 .1 .4 2
0 .6 0 0 .7 4 1.02 0 .5 6 0 .6 6 0 .56 0 .73 1.47 0 .5 6
ilvE
2 .6 .1 .4 2
0 .9 4 0 .7 2 1.07 0 .8 8 0 .63 0 .6 0 0 .9 2 1.27 0 .5 9
leuC
4 .2 .1 .3 3
0 .75 0 .7 6 0 .8 6 0 .8 0 0 .9 0 0 .0 0 .6 6 0 .1 4 0 .75
trpA
4 .2 .1 .2 0
0 .8 5 0 .7 0 1.03 0 .7 9 0 .7 8 0 .9 8 0 .8 0 0 .6 7 0 .8 2
tipB
4 .2 .1 .2 0
1.84 1.37 1.18 1.78 2 .1 2 1.45 2 .7 9 1.27 1.68
hisD
1.1.1.23
0 .54 0 .7 7 0 .8 6 0.61 0.61 0 .6 4 0 .7 9 0 .28 0 .6 4
SCO 1657  
2 .1 .1 .1 3
0.51 0 .6 7 1.11 0 .4 7 0.61 0 .75 0 .6 6 3 .4 6 0 .6 5
metE
2 .1 .1 .1 4
0 .6 7 0 .5 7 0 .7 5 0 .63 0 .6 0 0.53 0 .5 5 0 .4 4 0 .5 2
pdhR 3 .85 3 .10 3 .0 5 2.21 2 .1 2 2 .2 5 2 .61 3.13 2 .95
actl-l 1.07 1.29 3 .3 7 1.94 2 .2 3 1.85 1.52 0.83 2 .5 7
actl-2 1.85 1.57 3 .0 6 2 .61 2 .9 7 2 .83 2 .1 5 1.60 2 .2 9
actI-3 1.50 2 .1 0 3 .2 4 2.81 2.81 2 .5 4 2 .3 4 1.06 2.71
actll-l 1.60 1.44 1.87 2 .2 8 2 .7 4 1.95 2 .2 7 1.28 2 .4 5
actll-2 1.13 1.56 1.15 1.94 1.78 1.47 1.91 1.53 1.30
actlI-3 0 .9 8 1.11 1.17 1.31 1.38 1.54 1.78 1.11 1.23
actII-4 2 .35 2 .0 0 3 .7 0 3.61 4 .6 4 4 .03 2 .2 9 1.83 2 .8 4
actlll 2 .5 6 1.44 3 .4 6 3 .47 5 .79 4 .2 5 1.18 1.12 3 .2 6
actVB 0 .9 0 1.21 1.57 1.15 1.35 1.40 1.06 0 .67 1.27
S C 0 1 2 7 2 7 .5 5 8 .16 1.94 19.8 9 .92 8 .14 6 .4 6 0 .6 0 1.20
absAl 0 .7 4 1.57 0 .4 7 1.48 2 .0 2 1.38 5 .6 4 1.00 1.79
absA2 1.88 1.46 1.33 1,22 1.16 1.38 1.15 1.88 1.24
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